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Abstract 
 
Background:  
Muscle paralysis occurring due to nerve injury is a common clinical presentation. Re-
innervation of skeletal muscle can occur spontaneously, or require surgical treatment. 
The return of movement after re-innervation occurs slowly, and never attains normal 
function (Birch & Quick 2016). Methods commonly used to assess this recovery of 
function have not changed significantly for over 7 decades. This study addresses the 
way re-innervated muscle function is assessed and how this might be improved. 
Muscle re-innervation is in itself an important clinical aim; but, as muscle re-innerva-
tion occurs through a process of nerve regeneration, its assessment could also po-
tentially present a method for study of this biologic process: That is to say that the 
clinical assessment of muscle function can be viewed as a surrogate for the success 
of nerve regeneration. 
This thesis builds from a review of the historic approach to muscle assessment to-
wards more modern methods for establishing validated outcomes for skeletal muscle 
motor re-innervation in humans. For use both as a research tool and as a nuanced 
clinical assessment for patients with nerve injury.  
The traditional method used to assess muscle function has been to focus only on 
one aspect of force: the assessment of peak force, and to use a discrete ordinal 
assessment for this (the MRC, Medical Research Council grading of force). This ap-
proach is discussed in chapter three. A review of the historic literature (chapter two) 
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demonstrates that motor recovery is a complex phenomenon, and even in the area 
of peak force assessment; there is much to be improved upon. The benefits of utilis-
ing a continuous measurement of force rather than the discrete MRC scale are de-
scribed, and then, in Chapter six, deployed in the clinical environment to examine 
outcome. 
The characterisation of the severity of human nerve injury, in its vast variation, pre-
sents an unmet clinical challenge. There is no method available which characterises 
the injury in any way other than in a piecemeal way, and no method which standard-
ises clinical outcome across the many modalities of nerve injury.  To address this the 
operation of ‘nerve transfer’ is presented (in chapter 4) as an ideal ‘standard model’ 
for the study of human nerve regeneration. The history and development of nerve 
transfer are described and the utility of viewing this operation as a controlled experi-
ment set out: Nerve transfer is a complete, intentional, iatropathic, injury to a pure 
motor nerve with a single motor outcome. In this operation a nerve injury is created 
by disconnecting an expendable function to improve a more desirable function 
through the re-growth of nerves into this muscle. It is a discrete intervention which is 
undertaken to lead to an isolated improvement of a single assessable motor function. 
The methods in current use to assess re-innervated muscle function are explored in 
chapter five where a cohort of international experts were invited to contribute. This 
study (n= 18) displays and describes the responses of national leaders in this speci-
ality from 10 countries. The results show that MRC grade is the universal assessment 
standard, and yet this specialist group recognise the need for more in depth assess-
ments of motor function. Only 17% (n=3) agreed that the MRC system was very use-
ful for a thorough assessment of force, whereby 45% considered peak force to be 
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the most useful assessment of muscle function. There was acceptance of the method 
of using continuous force to assess maximal volition force. 
Chapter six presents a study whereby the expert cohort agreement for the need for 
continuous assessment of peak force outcomes (from chapter five) are applied to a 
cohort of patients who have undergone nerve transfer to return elbow bending force. 
These data, have been published in the eminent peer reviewed Bone and Joint Jour-
nal (BJJ). This publication was recognised by peers as the first clinic based publica-
tion deploying a continuous measure of outcome for this procedure. The results 
demonstrate similar findings to the only other cohort study Carlsen 2011) (where pa-
tients were assessed in an engineering laboratory). This study demonstrated validity 
of the clinical use of Hand Held dynamometry for assessment. The data described a 
population of outcomes whereby the mean was 7.2 KgF ±3.3. 
If a continuous measure of force is to be the method used to (as presented in chapter 
six) to study the impact of any novel difference in care to improve outcome: It is 
important to determine the degree of improvement which would be characterised as 
clinically relevant. This concept is termed the Minimum Clinical Important Difference 
(MCID). There are many suggested methods within a wide literature on this subject 
and it is accepted that they return a widespread of responses. The calculations in this 
chapter have been based upon published methods and include recommendations 
from the IMMPACT (Initiative on Methods, Measurement, and Pain Assessment in 
Clinical Trials) consensus document, patient anchor data, expert Delphi and statisti-
cal distribution methods. The results of which have provide a wide range of MCID 
(from 793gF- 6.52KgF); such a spread of data is typical in research into this area.  
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Having taken the expert objective view that peak force is still considered a key out-
come parameter; a study was performed (described in chapter eight) to explore the 
subjective experience of motor outcome. It has been explored whether peak force is 
an outcome considered relevant by patients. A questionnaire of satisfaction with out-
come is undertaken with a group of individuals who have undergone muscle re-in-
nervation (having had a nerve transfer to restore elbow flexion). The results of this are 
that the single outcome of peak force is not seen (by patients) as directly related to 
outcome nor correlated with the patients’ satisfaction. 
The results of the quantitative study in chapter eight are explored in more depth in 
chapter nine through a qualitative methodology: To explore the subjective experience 
in more depth a review of a group discussion between patient-participants was as-
sessed in chapter nine; using the widely used methodological approach of phenom-
enology. These data highlight the ‘lived experience’ of motor recovery: highlighting 
the issue of fatigue, and also the problem of co-contraction. (Fatigue being the symp-
tom of a feeling of loss of sustainability of force over time and co-contraction is a 
symptom of other muscles acting against the indented action to weaken the effect 
for a given force of another muscle.) 
In view of the contribution from the subjective qualitative and quantitative studies 
(chapters eight and nine) the original study (chapter six) is revisited in chapter ten 
with a novel cohort and re-designed to include assessments of fatigue and co-con-
traction. Novel data regarding the function of re-innervated muscles was produced 
using the hand-held dynamometer assessment (as described in chapter six) in con-
junction with surface EMG measurements. It was shown in this study that re-inner-
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vated muscle has a lesser median EMG biceps frequency (-22.35Hz t=0.005) sug-
gesting a change in the muscle type from the normal controls. There was no differ-
ence in rates of co-contraction (-2.3% t=0.698) in an unfatigued single maximal voli-
tional contraction. There was no sign of fatigue seen in the biceps under repetitive 
contraction (an accepted model of 3 sequential maximal attempts). Under sustained 
contraction (>80% maximal force sustained for 60seconds) the force was maintained 
in both re-innervated biceps and the controls. The degree of co-contraction in re-
innervated arms under sustained force was greater than that of the controls (at 25.6% 
vs 15.6%) but this decreased to a normal level (14.5%) with fatigue (this change did 
not reach significance however t=0.101). The re-innervated biceps were seen to fa-
tigue however via a drop in the median frequency (-12.343Hz t=0.001) prior to any 
such change in the control population of non nerve-injured muscles (3.15Hz t=0.343). 
Thus demonstrating an earlier fatigue and pointing towards potential mechanisms for 
this via a change in the muscle fibre type (more fatigable) and a trend suggesting a 
contribution from afferent control and co-contraction. 
 
Methods: 
A mixed methodological approach; of qualitative and quantitative methods, have 
been undertaken in this study. Chapters six and ten are quantitative assessments of 
outcomes in a cohort of patients who have undergone a nerve transfer to elbow flex-
ion. Peak power is assessed in chapter six using a hand held dynamometer in chapter 
ten this is used in conjunction with surface EMG assessments. A Delphi method is 
used in chapter five to poll experts in the field on their practice and opinions of as-
sessing motor recovery. The MCID calculations in chapter seven are undertaken by 
	 8	
an assessment of Qualitative data in a number of ways to quantify and estimate 
based on a number of approaches, this varied method widely used in the literature 
produces a spread of results.  
 
Summary 
This thesis is a structured investigation of the key issues in motor recovery following 
nerve injury. The thesis is cyclical; and returns (in chapter ten) to, improve upon, the 
original study (chapter six) design to hone the question and produce a more informa-
tive, valid set of results; relevant to the patient cohort. 
Re-innervated muscle function is a subjectively complex experience however there 
are themes of fatigue, co-contraction and pain which are not commonly assessed. 
Experts and patients agree we should move on from purely relying on the MRC 5 
point scale to describe the complex phenomenon of re-innervation muscle function. 
It has been demonstrated that hand held dynamometry and sEMG provide a method 
to assess peak force, fatigability and co-contraction. This provides an assessment 
that correlates with the issues deemed most pertinent by an expert group and most 
relevant by a patient cohort. 
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“And such being the imperfect state of our knowledge; in the sound state of the nerves,  
it is not to be wondered at if our reasoning; respecting their disease,  
is very limited and fallacious” 
 
Joseph Swan 1820 
A Dissertation on the Treatment of Morbid Local Affections of Nerves:   
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1. 
Preface  
London 2017  
The author is a peripheral nerve surgeon and has been a consultant in this field for five years. This 
thesis is the combination of a number of threads that have been stimulated by his clinical work towards 
improving patient outcomes in the area of motor recovery.  
It is accepted that it is a flawed approach to consider any aspect of nerve injury recovery symptomol-
ogy in isolation; any patient will clearly articulate this: The experience is that all the modalities of nerve 
function are inter-related. Restoring motor function to an insensate, or painful, body part has much 
less impact that improving all of the problems. To consider the problem in the round does little to allow 
focus on what can be improved. However; to study one has to dissect, to pull apart the features to 
study them first in isolation. To understand the parts in isolation is a necessary primary step, prior to 
attempting to comprehend the next layer of complexity when recombining those parts. This is an in-
vestigation of the isolated issues of motor recovery following nerve injury.  
It occurred to the author in 2012 that nerve transfer would provide an ideal surgical model to study 
human nerve injury and all the subsequent chapters here have flowed from this first idea. It was thanks 
to a pump priming grant from the RNOH Charity that this work commenced and started first with the 
study via hand held dynamometer of a cohort of nerve transfers.  
The author has learnt much on this past two-year period of part time study; a wider appreciation of 
the clinical and basic science literature, the essential steps of study design, of the importance of robust 
systems of data collection, of the benefits of true team work and of the character of himself and those 
around him. If these studies were to be run again they would be carried out in a very different manner 
with the knowledge that has been accrued. 
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2. 
Introduction to nerve injury 
2.1 Challenges of nerve injury treatment  
Peripheral nerves represent a huge anatomic concentration of functional ability; facilitating move-
ment, sympathetic function and sensations of touch, temperature and pain. They are frequently 
damaged in trauma, from external agents, and also through misadventure by treating doctors and 
surgeons. The outcomes of recovery from these injuries are infrequently commensurate with pre-
injury function or the patient's own expectations (Birch & Quick 2016). 
The nature of human nerve injury means that the controlled binary animal experimentation models 
of injury; crush (Bridge 1994), transection (Batt 2013) or even stretch (Wall 1992) are not repre-
sentative of the diverse degrees of injury or complexity of human outcome. In the complex inter-
play of random injury mechanism there are no standardised injuries. Nor is there any reliable 
method to absolutely assess the degree of injury, at the time of injury. Beyond these anatomic 
considerations (the impairment); the complex ways that humans react to physiologic and psycho-
logical disturbance (and how they express those problems to health care providers) mean as-
sessment of nerve injury outcomes are mostly subjective. 
Of all the functions of nerve; motor function (at first glance) appears to offer the most objective 
and assessable outcome: the ability of a muscle to contract can be measured in objective ways 
that sensation or pain cannot so easily. Studies of injuries to pure motor nerves could be envis-
aged, comparing differing techniques of repair or therapy regimens where the differential force 
outcomes of motor recovery are measured. The questions are still- have we chosen the correct 
objective motor measures, and do those objective measures reflect the patient experience? 
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In nerve recovery there are numerous objective and subjective outcome measures. The assess-
ment of motor function has been isolated to the objective measurement of the peak force the 
muscle can generate. Subjective assessments of individual muscle functions are rare. However; 
general clinical assessment of function (or well being, or satisfaction) are often swayed by more 
pervading aspects of the recovery- underlying physiology, other injuries, other medical conditions 
rather than being specific to the limb which sustained the nerve injury in question. These scores 
often focus on the very isolated function or the very general assessment. Separating out the im-
pact of the specific recovery of a re-innervated muscle to the overall subjective experience of the 
patients is complex (Birch & Quick 2016, Wang 2013). 
It a common report from many patients that any discussion regarding the importance of peak 
power does not translate to their day to day experience of function. They talk with much more 
‘texture’ or ‘depth’ in their description of the experience of motor recovery than objective assess-
ment has the ability to detect. 
2.2 Historical development of nerve injury understanding  
The form and function of nerves have interested man and attracted study for the earliest days; 
Herophilus (Staden 1989, p159) demonstrated in the third Century BC that motor and sensory 
nerves roots were separate. Galen described the course that sensory nerves follow from cortex 
down to the digital nerves, but he also wrote that ‘once divided they could not be repaired’ (Little 
et al. 2004). From these early historical assessments followed the widespread recognition of the 
nerves as the tissue which control movement and sensation leading to the subsequent recogni-
tion that they are amenable to repair after injury: 
It is interesting to take up the modern story of nerve surgery in London, with William Cruickshank 
(who was an assistant to William Hunter). In 1776 Cruickshank was tasked to undertake a number 
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of experiments dividing the Vagus and intercostal nerves in dogs. He excised a piece of ‘some 
15mm in length’ (Ochs 1977) at ‘differing lengths’ along their course.  
In two of these experiments the animal survived for several weeks and he found on subsequent 
autopsy that “when a portion of nerve is removed by incision its place is supplied by blood and 
lymph, which first becomes vascular and organised, and is afterwards converted into 
a substance of the same colour as nerve” Illustration of this tissue was presented to the Royal 
Society by John Hunter on the 13th June 1776.  
 
 
 
Figure 2.1: 
Illustration plate from Cruickshank 1795. Marked as 
“Figure shows both the complete reunion of the nerve after division and its regeneration after the loss 
of substance.” 
In a later report (Cruickshank 1795)  he recorded in his own words… 
"The divided nerves were united by a substance of the same colour as nerve . . . and the 
extremities formed by the division were still distinguished by swellings in the form of ganglions 
. . . (thus) I found the nerves regenerated, a circumstance never hitherto observed." 
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Figure 2.2: 
A figure taken from ‘The early history of nerve regeneration beginning with Cruikshank's observations 
in 1776 by Sidney Ochs” (Ochs 1977) showing a reproduction of the prosection in the Hunterian        
Museum on which the illustration Figure 2.1 is based. 
This work was challenged at the time, and went unpublished for many years. Interestingly though 
it led directly to another advance in nerve regeneration understanding when, in 1778, Father Felice 
Fontana visited Hunter's laboratory. He met Cruikshank whereby they discussed his experimental 
findings. Fontana then undertook similar work (excising sections of the Vagus nerve in rabbits) 
and using the new advances in ‘microscopic study’ was able to show that the material [that 
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regenerated] between the cut nerves demonstrated the characteristic spiral banded appearance 
of nerve (Skinner 1788). 
The story continued in London (in 1795) when John Haighton (a physiologist and physician) con-
tinued similar work on dogs. One of Haighton’s subjects survived 6 months and over this time 
regained the ability to bark, which had been silenced by division of branches of the Vagus nerve 
in the neck. At 19 months following nerve lesion an autopsy specimen was examined and de-
scribed to show a ‘neuromatous swelling’; but Haighton did not undertake any microscopic ex-
amination of the tissue. The two cases were represented to the Royal Society and the concept of 
the ability of nerve tissue to repair across short gaps started to gain acceptance.  
This was furthered when a paper presented by Joseph Swan in 1820 at the Royal College of 
Surgeons was awarded the Jacksonian Prize. In “On the Treatment of Morbid Local Affections of 
Nerves” (Swan 1820) Swan first gives support to the galvanic theory or electric function of the 
nerves  
“the galvanic influence on the nerves of an animal apparently dead, will produce the same 
motions in the parts to which these nerves are distributed, that were produced in them when 
the animal was alive”  
“we know that when a part has been deprived of the nervous influence by its communication 
with the sensorium being intercepted, the functions of the part of which the nerve is disturbed 
are suspended and are incapable of being reproduced until the divided portions of nerve have 
become reunited, except through electricity; but beyond this we know little” 
Swan describes how he followed the motor recovery of dogs following sciatic nerve division 
where he noted that only in short gaps [not defined] was regeneration possible but he did not 
follow this forward to an argument to support suture repair. 
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“When a nerve has been divided, reunion in course of time generally becomes perfectly estab-
lished, so that it performs its functions as well as if no division had ever taken place. When a 
portion of a nerve has been removed, and especially if it be a large portion, the breach is with 
the greatest difficulty, if ever repaired, when it happens in the case of a nerve of the largest 
size. For instance, when a portion of the sciatic nerve has been re- moved, the separation of 
the divided extremities is very extensive, the superior portion pre- pares for the reunion by an 
increased vascularity; but though the inferior does so it is in a much less degree; and after a 
time this vascularity is very greatly diminished, and the restorative process appears at a stand.” 
The scientific demonstration of the principles of nerve regeneration and repair seen in animals 
were not accepted by those treating human disease though. G.J Guthrie (a surgeon active in the 
Napoleonic wars) in his 1827 text “Treatise on Gunshot Wounds and Nerve Injuries” that: He knew 
of “no case in man of recovery of function after division of a main nerve”. The belief, pervasive in 
clinical medicine and surgery at that time, was that there was no benefit in trying to repair an 
injured nerve. This view appeared to be supported by experimental findings by Neurologist Albert 
Eulenburg and Leonard Landois, a physiologist. They reported from their experiments (Eulenburg 
Landois 1865) on many differing animal models of division and end to end nerve repair that func-
tion did not return immediately following anatomic nerve repair. They stated that nerve suture is 
‘positively dangerous’. Considering the suture material provides a ‘hindrance to regeneration’. 
The expectation of immediate restoration of function is clear in their work and that of their peers. 
It is most likely that this time delay (from repair to recovery of function), which we now know is 
necessary for nerve to regenerate to its distal target, meant that successful outcomes so often 
evaded detection.  
In America (during the Civil war) a well renowned surgeon; Silas Wier Mitchell, saw significant 
clinical benefit from nerve repairs by suture and described (Mitchell et al. 1864)  the means by 
which he considered it should be carried out. However, through the 1800’s across the whole 
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western world there was very little acceptance of any utility of nerve repair. Mainly; it seems, again 
due to the fact that physiologic function did not immediately return following nerve repair.  
The first steps to considering the mechanism of regeneration (and thus to comprehend the nec-
essary time lag to recovery) came when microscopic analysis of nerve tissue was undertaken. 
The study of neural micro-pathology by Thodore Schwann (Schleiden 1839), Franz Nissl (Franz 
Nissl 1898), Heinrich Waldeyer (Waldeyer 2009), Camillo Golgi (Golgi 1995), and Carl Weigert 
(Weigert 1897) slowly focused understanding. However until Waller’s treatises on ‘Experiments 
on the section of the glosso-pharyngeal and hypoglossal nerves of the frog and observations on 
the alteration produced thereby in the structure of their primitive fibres’ (Waller 1843)  were pre-
sented at the Royal Society in London (1901) did the time delay in nerve degeneration and  re-
generation start to be understood in the Eglnglsih medical establishment. This was further ad-
vanced as the work of Santiago Ramon y Cajal became available in the English literature (Cajal 
1928). 
Therefore; piece by piece, the natural history, microanatomy and physiology of nerve injury came 
together. It became accepted that unlike any other biologic system’s recovery; peripheral nerve 
regeneration was dependent on a large time lag. The frustration with the delay to recovery is 
evident still today (as the lived patient experience demonstrates in chapter eight). These devel-
opments which reset the expectations for outcome set up the development of the future surgical 
techniques: 
2.3 Development of surgical nerve repair techniques 
First, the concept of primary nerve repair (suturing cut ends directly back together) was developed 
and subsequently improved upon as the fascicular pattern of the internal topography of the nerve 
was understood (mainly through the work of Sunderland Sunderland 1945; Sunderland & Ray 
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1948; Sunderland. 1959).  The challenge of the ‘nerve repair gap’ (where the cut nerve ends can-
not be apposed without tension) was addressed by Huber in the US medical corps in World War 
I. Investigating autograft (nerve transplanted from elsewhere in the body) allograft (nerve trans-
planted from other people) and xenograft (animal nerve tissue) to bridge these gaps. This experi-
ence was applied in civilian practice by Seddon (1947) who’s reported satisfactory results of au-
tograft nerve in between 38-52% of his cohort and Millesi (who’s 42 years of grafting experience 
was reported in 1993 (Millesi 1993). This widely popularised the application, utility and efficacy of 
‘nerve grafting’. Thus; from these foundations the clinical speciality of peripheral nerve surgery 
grew. From work performed in the war (Millesi 1990; Penkert & Fansa 2004), this knowledge and 
expertise was disseminated across civilian practice in the western world though the 1950’s; the 
primary challenges were now to develop classification systems, a lexicon of disease and building 
clinical experience. The speciality was at a proof of concept stage of its development. The expo-
nents still met much resistance to the thought that intervention in nerve injury could offer the 
patient benefit. The practicalities of the surgical procedures and the academic approach to this 
work underwent a great evolution to reach the state of the art today.  
The last step to bring this story of surgical advance up to date has been the widespread uptake, 
over the last decade, of a further technique; that of nerve transfer. This story of nerve transfer 
(using axons originally destined for one muscle, with expendable function, to re-innervate directly 
a more proximal muscle) has run parallel to the more traditional approach of nerve grafting. Nerve 
grafting aims to recreate continuity to a damaged nerve, nerve transfer looks to reconstruct it by 
‘re-wiring’ it with another nerve. This is not a new concept; In 1903 Harris and Low (Harris & Low 
1903) described the implantation of the distal stump of an injured upper trunk, in an end-to-side 
fashion, to the root C7. They discussed the technique but did not provide the outcome. There 
were other early reports of nerve transfer (Tuttle 1913, Feiss 1912), but as previously befell the 
reports of repair; these were reported without sufficient follow-up were considered a poor option, 
and gained no traction in the profession. In 1963, Seddon reported the successful re-innervation 
of the biceps muscle with a nerve transfer from two intercostal nerves (using a denervated ulnar 
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nerve as a graft) At a year follow-up, the patient had regained ‘some active flexion’ of the elbow. 
In 1994, Oberlin et al described the use of an ulnar nerve fascicle to re-innervate the biceps mus-
cle, directly; Avoiding the need for a nerve graft. This technique was widely adopted as a powerful 
tool for returning function to elbow flexion and has been modified by many (Liverneaux et al. 2006; 
Thomas H Tung 2003). The era of improving nerve injury surgery outcomes has started. The ability 
to deliver axons close to a muscle when its own nerve has been damaged allowed quicker return 
of function. This method has been widely adopted now and has many applications in nerve injury 
reconstruction. 
2.4 Challenges for the speciality of nerve surgery 
Nerve injury surgery has now been accepted as a recognised field of surgical care where the 
specialities of Neurosurgery, Plastic and reconstructive surgery and Orthopaedic surgery overlap. 
Today there is an active international nerve injury community who agree on much: The methods 
of assessment, the requirement for intervention in the unfavourable degenerative lesion, and the 
methods of supportive care necessary to gain the most from the period of rehabilitation.  
There are however now new challenges. The current state of the art is represented as follows: 
“[Current] assessment of outcome is often blunt and simplistic focusing on motor and 
sensory outcome” (Novak et al. 2009). 
The wonder in the success of nerve repair and reconstruction and the complexity of the function 
of nerve has led to the commonly held simplistic view of assessment. 
“From a surgeon’s perspective, the goals of surgery have largely focused on the return of 
motor function and restoration of protective sensation.” (Bengtson et al. 2008) 
More recently, the trends in outcomes research after nerve injury have been directed toward more 
functional results and patient-reported outcomes.  
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Christine Novak goes further saying: 
“Patient-reported outcome and disability using valid and reliable measurement tools are 
rarely included in published reports, and few studies have evaluated functional outcome 
or health-related quality of life after peripheral nerve injury.” (Novak et al. 2009) 
The use of quality of life (QoL) measures to quantify and describe the morbidity created by bra-
chial plexus injury is growing and starting to be integrated into the lexicon of study in this area 
(Kitajima et al. 2006; Choi et al. 1997; Ahmed-Labib et al. 2007; Franzblau 2013). 
QOL measures have had their validity measured as an outcome. There are none though specific 
to brachial plexus injury recovery; nor are there any which are validly reflective or necessarily 
reactive to the fields of change that the patient experiences. The specificity of an outcome meas-
ure can only come from having their design informed by patient experience and expert opinion. 
To develop an outcome assessment requires an idea of what is thought of as a significant change 
is necessary. When these measures have been agreed and characterised it is important to define 
minimal clinical important difference (MCID) for these scales. MCID is a concept which sets the 
minimum reactivity of an outcome measure and as such is a key concept in designing such an 
outcome measure. It is also central to determining a power analysis for the proper design of a 
prospective trial (Wright et al. 2012). 
These advances in defining and characterising meaningful and responsive outcomes are neces-
sary to facilitate, support and assess the next stage in the evolution of therapeutic modalities 
(conduit design, biologic manipulation of inflammation, personalised medicine, genetic therapy 
etc.) for nerve injury treatment. 
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3. 
Introduction to the surgical model 
The following is an introduction to the nerve transfer to re-animate elbow flexion which has been 
used throughout this thesis as an experimental model.  
3.1 Background 
Human nerve injury is a complex pathology. The challenge to compare outcomes in nerve injury 
is made more complex by the fact that the initiating injuries are often so diverse and it is currently 
impossible to sensitively detect with specificity the specifics of the injury. Across any nerve there 
are tens, if not hundreds of thousands of neuronal axons. Each of these can be injured in degree 
of severity. This complexity can not be easily diagnosed nor characterised and its recovery will 
rely on varying factors; such as the degree of the local tissue injury and the response of this tissue 
in repair or scarring. 
Nerve injury creates changes in the efferent functions of; sweating, hair growth, muscle bulk tone 
and volitional contraction, and the afferent functions of; proprioception, pain, light touch and tem-
perature. The neuronal axons (that are in their tens or hundreds of thousands in most nerves) 
which make up the functional aspect of the nerve can be injured in a wide variety of degrees. 
From the binary state of ‘neurotmesis’ or complete nerve division (where all the of axons have 
been incised along with all the supportive tissue) to the non degenerative conduction block lesion 
(where there is physiologic dysfunction but anatomic continuity of all the constituents of nerve). 
There is, between these two extremes, a wide spectrum of degrees of injury which can befall each 
individual of the myriad axons within the nerve, each with a differing outcome. The exact numbers 
of axons which have suffered each grade of severity is impossible to determine at the time of 
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injury. Thus exactly quantifying the severity of any ‘wild type’ or non-experimental nerve injury is 
not currently possible. 
In addition to this, other tissues are often injured in association with the nerve tissue- vascular 
injuries, muscle damage, joint dislocation and fractures all make it more difficult to dissect the 
contribution of the nerve injury to the clinical situation from the other factors. 
On top of the fact that human nerve injuries are (even in isolation from the other concomitant 
injuries), often too complicated to grade at the time of injury, there is the added complication of 
the long time periods necessary for recovery. Success of motor re-innervation reduces with time 
(Wu 2014) and in humans can continue to be possible up to 18 months after injury (Elkington 
1944) and clinical experience suggests sensory re-innervation is possible for even a year or so 
after that. 
There are no perfect outcome measures for nerve injury, the ones that have been used regularly 
for assessment address only a small part of the interrelated whole. Visual Analogue Score (VAS) 
pain assessment and Medical Research Council (MRC) motor assessments are the two most 
widely used outcome measures and neither of these are close to ideal measures.  
Thus if one were to assess the naturally occurring nerve injury it would only be those complete 
injuries of nerve (neurotmesis) that could be standardisable. These injuries, being incisive, have 
other associated tissue damage around the area of injury. The location of the injury will be hugely 
variable, the amount of function affected by the injury variable and all of these variables uncon-
trollable. Further the psychology of the individual patients; in terms of concepts such as engage-
ment, activation, catastrophisation and kinesophobia have all now been shown to be strong af-
fectors of outcome (Monticone 2013, Bright 2014, Sullivan 1998).  Thus taking all of this together, 
when assessing median nerve lacerations amenable to primary repair as a group (even when 
combining multiple series (Birch & Quick 2016) in order to assess motor recovery, sensory recov-
ery and pain (and perhaps also assessments of sweating and proprioception) the groups will be 
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so varied as to offer little ability to compare or control for any of the variables other than for rather 
general statements to be made. 
It is accepted that human peripheral nerve regeneration is inferior to that in the mammalian mod-
els that are studied (Höke 2006). Transferring the advances made through animal experimentation 
to trials of safety (then efficacy) in humans presents the next challenge. To advance such studies 
a standardised nerve injury model is needed in humans. An ideal operation would be one where 
a complete nerve injury is created at a standard distance from a target organ where its re-inner-
vation can be easily assessed. Ethical concerns arrest any wish to undertake this on un-injured 
people but the operation of nerve transfer provides such an opportunity for ‘experimentation’ to 
be undertaken which is analogous to the animal models.  
The first nerve transfer animal experiments (cross innervation) were reported by Buller (1960). This 
paper identified that the characteristic of a re-innervated muscle (particularly the type of energy 
supply for ATP re-synthesis -whether glycolytic or oxidative) is determined by the nerve supplying 
it. Needham (Needham 1971) developed this idea further and demonstrated across a number of 
studies, how (after re-innervation) these differing types of muscle  (type I, type IIa and IIb  mus-
cles1) become much less different from each other, the changes taking place mainly in the IIb, 
both as regards to weight loss and enzymatic constitution.  
Nerve transfers to re-innervate elbow flexion in humans return an essential function: to move the 
hand in space (specifically to bring the hand to the face and mouth). From the point of view of 
                                                
1 Type I fibres are slow twitch, have low ATPase activity (*at pH 9.4), and have high oxidative and low glycolytic capacity, and 
are relatively resistant to fatigue. Type IIA fibres have high myosin ATPase activity*, are fast twitch and have high oxidative/ 
glycolytic capacity. They are relatively  fatigue resistant. Type IIB fibres have high myosin ATPase activity*, repond with a  fast 
twitch, have low oxidative and high glycolytic capacity. They fatigue rapidly. 
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assessing motor outcomes elbow flexion is an easily assessable function; The elbow can be mod-
elled as a simple hinge joint and in comparison to other muscles (such as prime movers of the 
shoulder or the fingers) its activity is directly relatable to a simple uniplanar recordable movement. 
Nerve transfers are a nerve injury created de novo by the surgeon in a functioning nerve (Oberlin 
1994). The surgeon cuts functioning parts of a nerve (whereby the loss of this function is tolerable) 
to use these axons to renervate a muscle with an essential function [Figure 3.1]. This is a control-
lable injury- it is a complete injury (that is to say all the axons complete neurotmesis) and it is 
made at a known distance from the target muscle. The recovery is intended to be pure motor 
recovery. It is performed with little local tissue damage and is akin to the early experimentation 
(Needham 1971, Buller, et al 1960). We would expect the same muscle type changes that have 
been documented in animal models (Needham 1971) but the effect on muscle type has not yet 
been shown in humans. It would be expected that this re-innervated muscle would demonstrate 
signs of this change and have a different threshold for fatigue due to it (this is assessed in chapter 
ten). 
 
3.2.1 Technique of the model used 
This nerve transfer is named after the surgeon who first described it in detail (Oberlin et al. 1994). 
The operation is to first confirm that the musculocutaneous nerve has sustained a degenerative 
injury and is non-functional. Then, in order to identify sacrificable axons, intact uninjured nerves 
are incised into and the constitutive fascicles are dissected free. These functioning nerve fascicles 
are then examined with stimulatory electric currents to assess their function. One or two are se-
lected as supplying a function which can sustain their loss. These fascicles are then divided (com-
plete nerve injury) and redirected to grow in to the motor components of the denervated distal 
stump of the musculocutaneous nerve. This then over time results in the re-innervation of the 
function of elbow flexion. The original single nerve transfer re-innervates one of the muscles of 
elbow flexion (biceps). There has been a subsequent advance on the technique where both biceps 
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and brachialis are re-innervated. 2 The technique that is used as the surgical model in these stud-
ies of re-innervation of elbow flexion is that of the double Oberlin transfer (or the Leecheven-
gongs). 
 
 
 
                                                
2 This technique of a double transfer was first described (it now seems) by Somsak Leechevengongs and subsequently by 
Susan Mackinnon (this ‘race to publish’ produced a rather famous surgical spat published in the literature (Mackinnon 2006). 
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Figure 3.1 
 Graphic representation of an Oberlin transfer- Pre op above – operative procedure below–Where the musculo-
cutatnous nerve (red) to biceps BBi and brachialis BBr are not functional and fascicles from the functioning 
(blue) ulnarUN  and (green) median nerves are used to re-innervate the function of elbow flexion. 
.Taken from:  Nerve Transfer for Restoration of Elbow Flexion in Upper Brachial Plexus Injuries. Orthopaedic-
sOne Articles . In: OrthopaedicsOne - The Orthopaedic Knowledge Network . Created Sep 19, 2011 
09:04. Last modified Oct 06, 2013 14:20 ver.7. Retrieved 2018-01-23, from https://www.orthopaedic-
sone.com/x/sYAaB. 
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Figure 3.2   
A reproduction of the anatomic study which led to the Oberlin transfer (Oberlin et al. 1994) p233 
 
 
Figure 3.3   
The original description of the Oberlin transfer (Oberlin et al. 1994) p234 
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Figure3.4   
 Intraoperative picture and diagram of the technique of double transfer from (Goubier & Teboul 2007) 
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3.2.2 Rehabilitation and recovery of function 
Following a nerve transfer; patients are immobilised for six weeks in a sling twenty-four hours a 
day. When this period of immobilisation has finished patients are then rehabilitated from the sec-
ondary joint stiffness (created by this immobilisation necessary to protect the nerve repair). There 
then follows a set protocol for rehabilitation of the arm and specifically the function of elbow 
flexion. This process utilises the concept of cerebral plasticity whereby the brain can relearn to 
use this re-assigned function. That is to say to correctly use the axons that used to command 
wrist flexion but that now bend the elbow. 
The return of innervation to the biceps and brachialis muscles occurs following the regrowth of 
the axons from the transferred fascicles from the nerve repair, down the de-innervated distal 
nerve stump to the muscle. Following this ingrowth, and the re-establishment of motor endplates, 
contraction is possible. In parallel with the efferent (out going messages) re-innervation there is 
also a cohort of afferent axons also re-growing. 
The arrival of the axons at their distal targets is difficult to assess and thus place a definitive time 
period on. The efferent fibres are only liable to contract when the patient has volition control over 
the transferred function and is liable, thus to to a clinical assessment lag (Kakinoki et al 2010) in 
assessing the differences between intercostal and Oberlin transfers to biceps noted that the time 
to MRC 1 function in the Oberlin group was 9.8 weeks and MRC grade 3 by 36.8 weeks.  
The afferent pathways were investigated by Lee et al (2015) in a study on the tender muscle sign 
(TMS). They studied 31 patients with a variety of differing nerve transfers in a retrospective review 
of prospectively collected data. They assessed the presence of a deep tenderness and noted that 
it preceded and predicted return of volitional contraction They noted that the TMS sign was pos-
itive 2-7 months prior to any palpable muscle contraction was evident.  
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4. 
An introduction to motor function, and its assess-
ment 
A review of the literature on the history and future of Motor Outcome 
assessment. 
Figure 5.1: 
Taken from Fig 14 of Aids to Examination of the peripheral nervous system, Medical research council memoran-
dum No 45 (superseding War Memorandum No7) Her Majesty’s publishers. 1976 
 
The following is an introduction to the discipline of clinical assessment of motor recovery pertinent 
to the measurement of outcomes following re-innervation.  
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4.1  
The clinical experience of nerve injury involves many aspects which are subjective in nature; not 
easily objectively gradable: One example is the experience of pain. It is a very personal experience 
and can in truth never be assessed by another. “Is it possible, in the final analysis, for one human 
being to achieve perfect understanding of another?” (Murakami 2011). But one can, as an ob-
server, recognise signs that a fellow human is in pain (Cowen et al. 2015) and indeed, this empa-
thetic assessment is frequently used to grade young children’s pain (Slater et al. 2008) and others 
who cannot comprehend or communicate their suffering (Herr et al. 2006).  
The objective assessment of movement seems to be, at first glance, a much more straightforward 
task. Movement is easily seen by an observer and can be graded. A simplistic assessment would 
presume that the observation of a movement is not so different to the subjective experience of a 
movement. Many movements are straightforward to initiate, requiring no conscious effort; that 
they occur almost without willing them. Yet even this assessment of observed or measured motor 
function has encountered challenges. 
The recovery of motor function following denervation (occurring naturally or after surgical inter-
vention) is a slow one; From a long period of flaccid paralysis to the first flickers of volitional 
contraction to a plateau of functional gain takes months. In objectively assessing development of 
this recovered muscle function, force has become the ‘headline figure’. Other aspects of force 
such as; sustainability and fatigue, control and proprioception, grade-ability of increase or release 
of force have been overlooked or ignored. Beyond this even the assessment of muscle force has 
become simplified. Force has been equated solely and synonymously with maximal voluntary 
contraction (MVC). Manual muscle testing (MMT) of MVC has been established by consensus 
over generations of clinicians as the uni-modal assessment of choice when assessing this im-
portant characteristic of neurologic disease.  
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There has been a recognition, present since early history (having been recorded over 3500 years 
ago in Genesis 32 (Hoenig 1997) of the importance of the assessment of muscular wasting, pa-
ralysis and weakness from nerve injury. There is a good review of this history in, a historical essay 
tracing the ‘history of scoring and assessment of neuromuscular weakness as part of daily neu-
rological practice’ written by Dyck (2005). 
The first modern record of a scale to try to assess weakness from neurologic dysfunction was 
published by Mitchell and Lewis (1886) in the United States, this collaboration between a cele-
brated American Civil war surgeon (Silas Weir Mitchell) and Neurologist (Morris J Lewis) sets the 
tone for the driving power of military experience and multidisciplinary collaboration which is seen 
continued unto the modern day. In their report (Mitchell & Lewis 1886) on 23 patients with ‘pos-
terior sclerosis’ of the spinal cord they were not only the first to describe how to elicit a tendon 
reflex but also they also were the first to describe an alpha numeric scoring system - scoring the 
ataxia from this upper motor neurone lesions as  
Class 1: normal  
Class 2: slight impairment,  
Class 3: great impairment, 
Class 4: paralysis  
With further reference to muscle reflexes (an assessment of the muscle control arc) scored as 0 
(absent) = (very slight) - (slight) N (normal) + (marked) and + + (very marked).  
The next recognised step forward came from the Mayo Clinic in Rochester where according to 
research by Dyck (2005) the work of Henry Plummer from 1910 at this clinic extended the use of 
a ordinal numerical scale and the use of + and - for muscle weakness. Their scale (still used in 
many American institutions) begins with 0 (normal) then-1 weak, to -4 (being absent). This scale 
did not appear in publication until 1956 (Bastron 1956). 
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Wilhelmine Wright writing in the Boston medical and surgical journal in 1912 (Wright 1912) re-
garding her experiences of Polio in Boston and in Berlin writes of her ‘rough method’ of classifying 
the muscles according to the amount of resistance they can overcome is the following :—  
1. Muscle capable of overcoming gravity and outside force—normal.   
2. Muscle capable of overcoming gravity alone—good.   
3. Muscle capable of overcoming friction of joint and table—fair.   
4. Muscle capable of overcoming friction  only when assisted—poor.   
5.  Muscle incapable of any contraction—bad.  
Robert Lovett a Professor of Orthopaedic Surgery in Boston Mass. USA, published his rather 
simplistic no- numerical rank scale in 1916  (Lovett 1916). 
Fair (able to move against gravity) and  
Good (able to move against resistance).  
 
In 1939 Kendall and Kendall (H. O. Kendall et al. 1971) when assessing the motor loss and recov-
ery in cases from the Polio epidemic they empirically graded a manual assessment equating fair 
with 50% strength and good with 80% strength.  
The assessment of manual muscle testing was advanced under the Chairmanship of the Medical 
Research Council committee 1941 of Brigadier Riddoch in the pamphlet “Aids to the investigation 
of peripheral nerve injuries (war memorandum no 7)” HMSO, London (subsequently revised in 
1943). The MRC scale was established as a post war tool for manual muscle testing (MMT) to 
grade the recovery of nerve injuries, (rather than as previous scales have been addressing dete-
riorating medical neurology).  
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Thus the improvement from paralysis the scale starts with 0 for no function and progress upwards 
to 5 for the measurement of peak Power.  
0 No contraction  
1 flicker or trace of contraction  
2 Active movement with gravity eliminated  
3 Active movement against gravity  
4 Active movement against gravity and resistance  
5 Normal power.  
This publication’s popularity and worldwide recognition is most probably due to its simplicity, and 
educational illustrations on how limb muscles should be tested (see picture 4.1). Various versions 
of the MRC report have subsequently been published that have aimed to improve the methods 
for muscle examination. The revision of this work in 1976 “MRC Memorandum No 45. (supersed-
ing War memorandum No7) Aids to the examination of the peripheral nervous system”, HMSO, 
London (Committee medical 1976) includes recognition that  
“Grades 4-, 4 and 4+ may be used to indicated movement against slight, moderate and 
strong resistance respectively” (Committee medical 1976) 
It is this scale that has held a pre-eminent position in muscle force assessment clinically and in 
research outcomes for the past three generations. The author has conducted a recent review 
[Chapter 5.5.1] of leading clinicians (n=18) across the world on their preference for recording 
muscle force and 100% used the MRC system. The MRC system has been central to international 
medical education for it is easy to understand and (until the introduction of the arbitrarily assessed 
graduations of slight, moderate and strong resistance with grade 4) highly reproducible and valid. 
The most recent (2010) edition of ‘Aids to the Investigation of Peripheral Nerve Injuries, Medical 
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Research Council: Nerve Injuries Research Committee’ starts with a historical review and appre-
ciation for its application over  the years (Compston 2010). 
In 1983 Kendall and McCreary (F. P. Kendall & MacCreary 1983) revisited the work of Kendall and 
Kendall in the 1940s within the  0-to-5 scale. They equated 4/5 strength with a level of force called 
‘good’ and suggested (with out clear justification) that this should be considered as representing 
80% of full strength. None of these estimations of force seemed to relate to the descriptions given 
in the MRC system. 
This clash of an empirical feeling of what ‘good’ and ‘fair’ outcomes are and how these lie within  
the agreed classifiable boundaries (MRC) sat poorly together. What was needed was a clarifica-
tion between what researchers and clinicians thought was good and fair and what the demon-
strable boundaries (as flawed as they were) demonstrated. This clarification came from MacAvoy 
in a robust cadaveric biomechanical analysis (MacAvoy & Green 2007) that 4% of a muscle’s 
possible range of force is required for function against gravity. From this work; MRC 4 can be 
equated to a statement that it is “at least 4% of full force”. Further if MRC 5 is taken as 95-100% 
then 91% of power range is contained within MRC grade 4 (MacAvoy & Green 2007). The follow-
ing graphic represents this distribution. 
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Figure 4.2. 
Graphic representation of distribution of percentage muscle force required to attain differing levels of MRC assessed Force. 
Based on MacAvoy & Green 2007. 
 
Despite being a cardinal feature of daily neurological practice (and long before MacAvoy’s study),  
it had been recognised that the MRC scale was not an ideal too, perhaps  due to this inequity of 
its categories (with Grades 1, 2 and 3 being too narrow, and 4 being too broad) being appreciated.  
This lead to many attempts to modify the scale (Brandsma et al., 1995; Dyck et al., 2005; Cuthbert 
and Goodheart, 2007; MacAvoy and Green, 2007; Merlini, 2010). Many adding sub divisions 4-, 
4, 4+, or starting to quantify within the grade of 4 the ability to lift certain given weights. These 
attempts however well intended still do not provide the ideal continuous scale for assessment of 
maximal muscle force. 
All of the scoring systems described (whether; (normal, good, or fair) (5, 4, or 3) or including + or 
– grades) are subjective descriptions of strength, not an objective measure. They are ordinal num-
bers: only the order of the numbers is meaningful, whereas the distance between two numbers 
	 39	
or grades does not lend itself to practical interpretation, and cannot be the basis for meaningful 
arithmetic operations (even though many publications quote non integer outcomes).  
Having assessed the validity of approach of MRC grading of manual muscle testing (MMT), it is 
important to know if the method of assessment is reproducible. The inter-tester and intra-tester 
reliability of MMT graded with the MRC system has been shown to be acceptable (Hislop & Mont-
gomery 2007). Another problem with this system is inherent inter-subject variability in muscle 
strength, this weakness makes it useful primarily for intra-subject changes in strength rather than 
inter-subject comparisons (James 2007). In addition, as James has pointed out “this system 
tempts the examiner to consider a muscle with a certain grade of strength as having the same 
degree of recovery as another muscle with the same grade, when in fact the amount of recovery 
necessary to enable the deltoid to be graded 3 may be considerably different than the amount of 
recovery necessary to enable a wrist extensor to be graded 3” (James 2007; MacAvoy & Green 
2007). 
It is now through necessary that if clinicians, in nerve surgery, are to pursue improvements in 
outcome for patients a scale more responsive to differences with in the MRC grade 4 range is 
required. This should be a continuous numerical scale where a force can be recorded as any 
value between 0 and the full power where there is an infinite rage of possibilities between these 
two outcomes. This will then allow statistical comparison of differing populations to assess if any 
specific intervention has been beneficial.  
With the advent of mechanical testing came the ability to measure muscle testing with accuracy 
using first mechanical and then more recently electronic means. The isokinetic dynamometer is a 
lab based device which offers a very high reliability and validity for a variety of bio-mechanical 
assessments. Isokinetic dynamometers, such as the Cybex (USA) (Rowell 1988), the Biodex (USA) 
(Valovich-McLeod et al. 2004), or the model D60107MK1 Penny and Giles transducers Christ-
church, Hampshire) (Quick et al. 2016) [Chapter six] can measure number of properties such as 
dynamic peak torque, peak torque angle, angle-specific torque, power, and energy used. Their 
use is, however, not applicable in the standard clinic environment and thus their utility is limited. 
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Thus the hand held dynamometer was developed and with with techniques to maximise its re-
producibility and reliability. The assessment of force with a hand held dynamometer have histor-
ically been shown to be valid in both adults and children (Bohannon 1995; Bohannon 1997).  
Standard hand held dynamometers (HHD) can be used for the maximum volitional contraction 
(MVC) assessment they are practical and inexpensive.  
“We conclude that a hand-held dynamometer and a fixed dynamometer yield comparable 
results in patients with neuromuscular disease, provided that testing is limited to muscle 
groups producing relatively low forces” (Brinkmann 1994)  
Reproducibility studies have shown a high intra-class correlation coefficient (0.91–0.97) and low 
SEm (standard error of measurement) (3%) in all muscle regions tested (Colombo et al. 2000) 
showing intra-class correlation coefficient of 0.96 for elbow flexion. 
Kilmer (Kilmer et al. 1997) agrees with a very similar reliability finding and stating Hand Held Dy-
namometry ‘appears to be a reliable method to measure maximal isometric strength in persons 
with neurogenic weakness, and may be useful to quickly and objectively evaluate strength in the 
clinical setting’.  
Wiles & Karni 1983 reporting the Queen’s Square experience states that  
“For most muscle and some peripheral nerve disorders it is change in strength which is 
the ultimate manifestation of improvement or deterioration in the underlying disease.” 
(Wiles & Karni 1983) 
This paper finds  
“In conclusion we find that several muscle groups in patients with peripheral neuromus-
cular disorders can be satisfactorily and reproducibly measured using the hand held my-
ometer ...and suggest that the technique is highly appropriate for routine clinical applica-
tion.” 
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Stark et al (2011) after undertaking a large systematic review on the comparison of HDD with 
isokinetic dynamometer conclude-  
“Compared with isokinetic devices this instrument [HDD] can be regarded as a reliable 
and valid instrument for muscle strength assessment in a clinical setting.” (Stark et al. 
2011) 
A frequently identified criticism of HDD is that when measuring subnormal strength in strong mus-
cle groups it can be that these will exceed the strength of the tester and thus be under estimated 
(Visser et al. 2003). Whilst this may introduce an error in theoretical application; the muscle and 
the population under study will uncommonly overcome the examiner.  
“Perhaps World War II surgeons using early techniques of nerve repair were gratified to 
achieve grade 3 strength in a previously paralyzed muscle, and the differences between 
grades 3, 4, and 5 did not concern them, because this level of recovery was usually not 
attained” 
“Modern techniques may achieve better results and engender higher expectations of a 
measurement system.” 
“Unless HHD is widely adopted or until a better grading system is developed and well 
validated, the MRC will continue to be used.” James 2007 
The argument is clear for the need, validity and reproducibility of HHD for measuring muscle force. 
The aim now, necessarily, must progress to consider other aspects of muscle re-innervation re-
covery other than peak volitional force. The patient’s experience is central to this exploration. The 
history of assessing outcomes has evolved from physician assessed to patient assessed out-
comes. This has been driven by a so called revolution in health care (Relman 1991) which works 
towards outcome measures that have validity to talk to improvement across a wide spectrum of 
influence (Swiontkowski et al. 1999): quality of life (de Putter et al. 2014), satisfaction (Hamilton et 
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al. 2013), function (Hudak et al. 1996), right down to to specific object orientated outcomes 
(Waljee et al. 2014).  
 
4.2  Summary 
The history of assessment of muscle function has been, almost without other focus, centred 
around the assessment of maximal volitional force. This focus has grown and developed over 
time until (in recognition of the flaws of a discrete system) the technologic advances have made 
continuous peak force assessment possible. 
 
Recognising other features of motor recovery function will provide more detail in assessing out-
comes and these methods will undoubtedly now become more and more the focus of assessing 
the outcomes of re-innervated muscle function.   
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5. 
A web based Delphi questionnaire to assess     
motor outcome assessment attitudes in a cohort of 
international experts. 
 
 Introduction  
The basis of designing outcome measures for any assessment of treatment to improve muscle 
function after nerve injury necessitates measures that are sensitive to change and a knowledge 
of what amount of change (of that measure) is identified as significant by the patient. It has been 
identified that “heterogeneous selection and measurement of outcomes in clinical trials further 
impairs the ability to synthesise results across studies in systematic reviews” (Clarke 2008). IN 
this manner ‘agreement towards the standardisation of outcomes for clinical trials has been pro-
posed as a solution to the problems of inappropriate and non-uniform outcome selection’.  
It is thus important to know what is the accepted standard and is what the attitudes are of ex-
perts in the field as to what measures could be undertaken to improve upon these standards. 
5.1 Research Questions 
• What is used in common practice to assess motor function? 
• What should the ideal clinical assessment of motor function look like?  
• From the discussion in modern outcomes science and clinical practice it appears it will likely 
have to be multifaceted and combine some aspect of subjective and objective assessment. 
What do leading clinicians think? 
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5.2 Aims 
The aims were to: 
• Characterise what the current opinion regarding motor assessment was across a group of 
clinical nerve injury experts.  
• Identify what assessment methods were used currently and what expert opinion regarded 
as the strengths and weakness of these current methods. 
• Identify if any maximal force assessments use any other measurement tool other than MRC 
grade. 
• Assess the experts’ opinions on what an MCID for re-innervated elbow flexion force would 
be. 
• Identify what the expectation were for outcomes in each experts’ practice from an Oberlin 
transfer and how this relates to the literature. 
• Identify which aspects beyond peak force were considered to be useful to assess and 
which are being collected. 
• Assess the degree to which Patient related outcomes were being deployed and which ones. 
• Attempt to gain consensus on what data should be collected in the future. 
5.3 Objectives 
1. Establish and contact a group of experts who would engage with a Delphi process. 
2. Design and administer an online questionnaire to assess expert opinion. 
3. Respond to the themes of the primary responses to further clarify the opinion of the 
panel to the future direction of motor assessment.  
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5.4 Methods  
A set of questions was designed by the author to invite responses towards the aims of the 
study. A combination of direct yes/no, multiple choice, open ended answers and Likert ques-
tions were used. See below for list of questions. 
A web based questionnaire was loaded with this questions and offered up to receive responses. 
(Figure 5.1 shows a screen grab of the on-line questionnaire) 
Experts were identified by invitations being extended to all delegates at the 22nd Sunderland So-
ciety group meeting in Frankfurt, Germany (December 4-6 2016) and the Anglo-Scandinavian 
nerve injury and plexus meeting (Stockholm, Sweden May 19-20 2017). At each meeting the au-
thor delivered a presentation on the above material (and the findings of chapter six) at two inter-
national meetings (subsequent discussion within the group at the Sunderland meeting was tran-
scribed and is attached as an appendix). The audience of international leading Attending Con-
sultant surgeons and leading therapist were asked to fill in an online survey hosted on Google 
Docs – (Google corp. Mountain View, California, United States). Across both meetings there 
were 70 delegates (15 delegates in Sweden and 55 in Frankfurt). The questionnaire received 18 
respondents all Attending/ Consultant surgeons from the US, Canada, Sweden, Netherlands, 
Finland, Norway, Germany, India, Scotland and England. 
N=18 respondents engaged with the first round.  The results are below in 5.5. The second round 
method is detailed in 5.6. 
	 46	
  
Figure 5.1: 
a screen grab from the Google forms data collection page 
 
The following questions were posed  
Q1. Do you routinely use the MRC (0-5) Muscle Power grading for muscle recovery after dener-
vation/renervation? 
Q2. Do you find the MRC Grading system for force: 
  very useful 
  quite useful 
  just something I do as a matter of course 
  nearly no use 
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  pointless 
  I only use it for research purposes 
Q3. What percentage of your elbow flexor restoration nerve transfers do you think attain MRC 
grade 4? 
Q4. What percentage attain less than MRC Grade 4? (0-3) 
Q5. What percentage of the outcomes do you think you would grade MRC Grade 5? 
Q6. What other methods of assessing muscle power do you use routinely? 
Q7. What force of elbow flexion (on average) do you think your patients attain from an Oberlin 
nerve transfer? 
  <1kg Force  5Kg Force 10Kg Force 
  1Kg Force  6Kg Force 11Kg Force 
  2Kg Force  7Kg Force 12Kg Force 
  3Kg Force  8Kg Force 13Kg Force 
  4Kg Force  9Kg Force 14Kg Force 
       15Kg Force 
       > 15Kg Force 
Q8. What percentage do you think this in relation to the normal side? 
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Q9. Given a population of Oberlin transfers which has a mean Force of 7Kgs what do you think 
would be the necessary increase in force to be clinically relevant? (the Minimal Clinical Im-
portant Difference). As represented by difference to the right shifted red curve below. 
 
 
Q10. Following on from this question what do you think the minimal assessable improvement in 
this cohort would be (the smallest difference we could reliably assess)? 
Q11. Which of the following factors do you consider useful in assessing muscle recovery from 
denervation? 
 - select one, non or many of the following: maximal contractile force, sustainability of 
force, fatigability of effort, grade-ability of recruitment of force, control of other joints around the 
assessed muscle (e.g. shoulder ER when assessing elbow flexion), co-contraction, propriocep-
tion, pain, sensory alteration. 
Q12. Do you find the results of any patient related outcomes (PROMs) useful in assessing your 
outcomes from nerve transfers? Yes/ no 
Q13. If you do use PROMS - which ones? [Free text] 
Following the first round the results were interpreted and the second round of questions was 
developed. 
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5.5  Results 
The answers were as follows 
5.5.1 Q1. Do you routinely use the MRC (0-5) Muscle Power grading for muscle recovery after 
denervation/renervation? (18 responses)  
A1. 100% yes. 
 
Figure 5.2:  
Pie chart of responses to question 1  
“Do you routinely use the MRC (05) Muscle power grading for muscle recovery after denerva-
tion/re-innervation?” 
 
The use of the MRC muscle grading system is universal across all the clinics and countries 
sampled. This (as discussed in chapter four) is a situation which is well understood by clinicians, 
it has become the universal method applied in clinical discussions and published literature. It is 
a well used tool where by its weaknesses are well known but it is still favoured despite these; it 
has stood the test of time. Its longevity universality has made it part of the lexicon of motor as-
sessment however it is this dominance that, it could be argued, is holding back development of 
novel tools of assessment.  
5.5.2    Q2. Do you find the MRC Grading system for power (18 responses). 
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A2.  Very useful (3) 17% 
Quite useful (11) 61 % 
Just something I do as a matter of course (1) 5% 
Nearly no use (1) 5% 
I only use it for research purposes (1) 5% 
Other (1) 5% 
“Expected by others, gives an impression easily understood by other doctors, 
but woefully unrelated to holistic function and heavily skewed towards minor in-
creases in non-functionally relevant strength”  
 
 
Figure 5.3: 
Pie chart of responses to question 2 “. Do you find the MRC Grading system for power:” 
 
5.5.3 Q3.What percentage of your elbow flexor restoration nerve transfers do you think attain 
MRC grade 4?(18 responses) 
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% attain 
MRC 
Grade 4 
90 85 80 75 70 65 60 55 50 45 40 
Re-
sponses 
2 2 6 0 6 1 0 0 0 0 1 
 
 
Figure 5.4 :  
Histogram chart of responses to question 3 “.What percentage of your elbow flexor restoration nerve transfers do you think 
attain MRC grade 4?” 
 
Thus 2/3rds of respondents believe over 80% of nerve transfers restore elbow flexion to MRC 
grade 4 and 89% believe over 70% of their case regain this level. 
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5.5.4 Q4. What percentage attain less than MRC Grade 4? (0-3) (9 responses) 
% attain 
> than 
MRC 
Grade 4 
0 5 10 15 20 25 30 35 40 45 50 55 60 
Re-
sponses 
0 1 1 2 8 1 4 0 0 0 0 0 1 
 
 
Figure 5.5: 
Histogram chart of responses to question 4 “What percentage attain less than MRC Grade 4? (0-3)” 
 
This is not the exact inverse that one would have expected from question three. It does show 
that the range of opinion is between 15-30 percent of nerve transfers that do not attain MRC 
grade IV (the ability to lift weight against gravity). 
 
5.5.5 Q5. What percentage of the outcomes do you think you would grade MRC Grade 
5? (9 responses). 
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A5. 
0% (13) 72% 
shouldn’t use it (1) 5% 
5% (2) 11% 
10% (1) 5% 
 
Figure 5.6 : 
 Bar chart of responses to question Q5. “What percentage of the outcomes do you think you would grade MRC Grade 5?” 
 
Over 2/3rds of experts are of the thought that re-innervated muscle never gains MRC grade V 
(normal) peak force and a further respondent was of the opinion that MRC V should not be (on 
principle of definition) assigned to a re-innervated muscle. 
If we were to define ‘normality’ to be 2SD beyond the mean this would mean from our figures 
(normal arms 20.65KgF SD6.85) then normal could be defined as attaining 7KgF and below but 
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it is clear that even though our respondents recognise that (Q7) a mean outcome for this popu-
lation is over this (7.11KgF) they do not consider this to be gradable as normal and thus per-
haps are subconsciously considering other aspects of a muscle’s function when they consider 
no one will attain a Grade 5 MRC (‘normal’). This thought is highlighted by one respondent; who 
states that it ‘should not’ be used, by which, the author presumes, they mean that even though 
peak power may reach a level considered in the range of normal, the recovery should not be la-
belled as normal for other reasons. 
 
5.5.6 Q6. What other methods of assessing muscle power do you use routinely? 
(15 responses- including multiple responses to this question). 
Pinch (2) 
Dynamometer (5) 
Calibration by weight lifted (discrete functional assessments) (5) 
Grip (3) 
Assessment of functional tasks (3) 
Pinch (2) 
Calibration by weight lifted in adults particularly (1) 
Active range of movement (1) 
Verbal assessment of fatigue (2) 
There were numerous other assessments of peak force; pinch, grip, calibration by weights lifted 
and dynamometer. These are all continuous measurements of force (other than weights lifted- a 
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discrete method of measurement). Only 3 respondents assessed any other feature of muscle 
function (2 cast a vote for: verbal assessment of fatigue and 1 for: active range). 
5.5.7 Q7. What force of elbow flexion (on average) do you think your patients attain from 
an Oberlin nerve transfer? (17 responses). 
A7. 
 
Figure 5.7 : 
 Bar chart of responses to question Q7. “What force of elbow flexion (on average) do you think your patients attain from an 
Oberlin nerve?” 
 
The mode response is 5Kg (mean for the distribution of these responses is 7.11KgF range 2-
10). 
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5.5.8 Q8. What percentage do you think this in relation to the normal side? 
(17responses) 1 answer – ‘no clue’. 
Percentage 
of normal 
side 
<10 10 20 30 40 50 60 70 80 90 100 
Responses 1 0 0 8 3 4 0 0 0 0 0 
 
A8. 
The mean here is 23% mode 20% of normal force. Thus extrapolated from the force that the re-
spondents gave as presumed mean (7.11KgF) this would give an estimate of the expected nor-
mal mean of 30KgF. 
 
5.5.9 Q9. Given a population of Oberlin transfers which has a mean Force of 7Kgs what 
do you think would be the necessary increase in force to be clinically relevant? (the Mini-
mal Clinical Important Difference) (13 responses). 
A9 
MCID 
(KgF) 
0.5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Re-
sponses 
1 1 5 0 0 2 0 1 0 0 1 0 0 1 0 0 
The author recognises the low rate of response to this questions (13/18). The question may be 
poorly worded or the concept a difficult one but the concept was defined in the lecture given by 
the author to each of the invited audiences. 
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These responses give a median response for MCID of 3.57KgF and mode response of 2Kg. 
Given the group defined the mean of outcomes as 7.11Kgs this is an MCID of 50%, taking the 
mode (2kgs) this is MCID of 29%. 
5.5.10 Q10. Following on from this question what do you think the minimal assessable im-
provement (MAI) in this cohort would be (the smallest difference we could reliably as-
sess)? 
(15 responses) of these 2 stated do not know. 
A10. 
MAI 0.5 1 2 3 4 5 6 
Responses 5 5 1 1 0 1 0 
 
Thus the range of expected MAI is 0.96Kgs with our respondents presuming an average mean 
outcome of 7.11KgF MAD being 14% of the mean. 
 
5.5.11 Q11. Which of the following factors do you consider useful in assessing muscle re-
covery from denervation (18 responses)? 
 A11. 
maximal contractile force (9) 
sustainability/ fatigability of force (5)  
proprioception (1) 
grade-ability of recruitment of force (0) 
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control of other joints around the assessed joint (0) 
sensory alteration (0) 
pain (0) 
co-contraction (0) 
other (3) 
“All of the above, but the link only permits selection of one. The relative significance of each var-
ies between muscle/joint movements” (1) 
“Range of movement, force, co-contraction “(1) 
“Most of the above” (1) 
 
Figure 5.8 :  
Bar chart of responses to question Q11. “Which if the following factors do you consider useful in assessing muscle recovery 
from denervation?” 
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The responses show that 50% consider the assessment of maximal contractile force being use-
ful. Sustainability has been rated as useful by 22% of respondents. The free text answers give 
further insight that a multifaceted assessment is most useful. 
There is an appreciation of need for a more global assessment of re-innervated muscle function. 
Factors such as fatigue and the ability to maintain contractile force, control the joints and effect 
proprioception are important as well as the standard assessment of maximal volitional force. 
 
5.5.12 Q12. Do you find the results of any patient related outcomes (PROMs) useful in as-
sessing your outcomes from nerve transfers? (14 responses) 
A12. 
Yes 11 
No 0 
Other (3) 
 “Unfortunately we don´t use it routinely, but YES”. 
 “Probably should use”  
“Yes, but we do not use it.” 
 
5.5.13 Q13. If you do use PROMS (patient related outcomes) - which ones? (11 respond-
ents some with multiple responses) 
A13. 
DASH (6) 
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Psychology (2) 
Quick Dash (1) 
ADL's (1) 
SF36 (2) 
Michigan Hand (1) 
PROMs (1) 
PROMs often assess function or quality of life. 
The Dash (The Disabilities of the Arm, Shoulder and Hand (DASH) Score is a validated study 
(Hudak et al. 1996) of upper limb function and is utilised widely for a functional assessment of 
upper limb global activity and is mentioned by ¾ of those who responded that they had identi-
fied PROM outcome measures to use. 
The short form 36 was developed as a global assessment of quality of life. It is validated in the 
UK populous (Hudak et al. 1996) and around the world. It assesses physical and mental well be-
ing and function. 
 
5.5.14 Q14. Thank you for your support in this project. Do you have any further comment 
to make? 
(5 response) 
A14. 
“Laudable intention, very complex topic though.” 
“MRC grade 5 represents normal power. This is never achieved after nerve repair.” 
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“We currently do not use PROMS on this population, but we are searching for PROMS that 
could be relevant for these patients. On obstetric brachial plexus palsy patients, we use Brief 
pain inventory, and plan to get the BPOM translated to Norwegian. We also plan to use the EQ-
5D on the obstetric population.” 
“Fatigability of effort is almost as important as maximal contractile force.” 
“Difficult questions Tom. We do not have the answers to all your questions but have tried to fill in 
the boxes as good as possible.” 
 
5.5.15 First stage conclusions: 
• This body of peers, active in the field of nerve injury treatment, demonstrate the spread 
of opinion around motor outcomes from nerve transfer.  
• They demonstrate that there has been widespread acceptance of the method of 
assessing maximal volition force as a motor outcome.  
• MRC grade is used universally however it is only considered very useful by 17%, the 
majority (61%) consider if quite useful and some consider it of little use. 
• Assessment of force within MRC grade 4 is used by 11/18 of the group. With 5/18 using 
a continuous assessment of force (HHD) and 6/18 using discrete weights. 
•  The group considers that the mean expected outcome from an Oberlin nerve transfer is 
7.11KgF which they consider would as a mean represent 23% of normal. 
This data shows that the Delphi group considers maximal volitional force (MVF) as an entry level 
motor assessment. Perhaps best considered as a threshold assessment in recovery and that 
following the ability to attain some useful level of force other features should be assessed along 
with it. (It makes no sense to assess sustainability if there is no force to sustain and no point in 
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assessing features of a function which has no application). To further characterise the agree-
ment on the relative importance of these differing recognised aspects of re-innervated motor 
pattern further questions were asked of the group. 
 
5.6 Second stage method 
The same clinicians, that responded to the first round, were contacted again by email. They 
were thanked for their engagement and given the raw anonymised data of the first round find-
ings. They were again asked to complete an online questionnaire; The following questions were 
designed by the author to identify the group’s opinion on best practice. 
Second round Questions: 
Do you agree to the following statements (1 - not at all to 5 - completely agree). 
• Peak force assessment is an essential part of assessing re-innervated muscle 
function 
• An assessment of fatigability would be useful as part of assessing re-innervated 
muscle function 
• An assessment of grade-ability of recruitment of force would be useful as part of 
assessing re-innervated muscle function 
• An assessment of muscular pain would be useful as part of assessing re-inner-
vated muscle function 
• An assessment of afferent (proprioception, muscle pinned function, etc) function 
would be useful as part of assessing re-innervated muscle function 
• As a global patient-reported outcome (PRO) would you consider PGIC (see below) 
would be useful as part of assessing the outcome of a nerve transfer. 
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Patient related global impression of change (PGIC) is a simple assessment where-by (at a 
set time) post operatively the patient is asked what their impression of change from that 
operation has been:  
   
 
 
The above questions were again presented via Google forms online.  
 
5.7 Second round data 
From the invited group of 18, n=10 second round answers were received. 
They were as follows. 
 
5.7.1 Q1. Peak force assessment is an essential part of assessing re-innervated muscle 
function (1-not at all to  5- completely agree) 
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Score 1 2 3 4 5 
# of re-
sponses 
0 0 2 4 4 
Score 4.2/5 
There is agreement to strong agreement here (with no disagreement)- Peak force is con-
sidered an essential part of assessing re-innervated muscle function. 
 
5.7.2 Q2. An assessment of fatigue-ability would be useful as part of assessing re-inner-
vated muscle function (1-not at all to  5- completely agree) 
Score 1 2 3 4 5 
# of re-
sponses 
0 0 0 5 5 
Score 4.5/5 
Greater agreement here with a tighter spread. All respondents either 4/5 or 5/5 agreed 
that an assessment of fatigability would be a useful part of assessing re-innervated mus-
cle function. 
 
5.7.3 Q3. An assessment of grade-ability of recruitment of force would be useful as part 
of assessing re-innervated muscle function (1-not at all to  5- completely agree) 
Score 1 2 3 4 5 
# of re-
sponses 
0 0 4 4 2 
Score 3.8/5 
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Agreement, but less strong than for peak force and fatigue seen for assessing grade-abil-
ity of recruitment of force. 
 
5.7.4 Q4. An assessment of muscular pain would be useful as part of assessing re-inner-
vated muscle function (1-not at all to  5- completely agree) 
Score 1 2 3 4 5 
# of re-
sponses 
0 4 3 3 0 
Score 2.9/5 
A balance of mild agreement and disagreement here for muscular pain being useful. 
 
5.7.5 Q5. An assessment of afferent (proprioception, muscle pinned function, etc) func-
tion would be useful as part of assessing re-innervated muscle function 
Score 1 2 3 4 5 
# of re-
sponses 
0 3 3 2 2 
Score 3.3/5 
 
5.7.6 Q6. As a global Patient reported outcome (PRO) would you consider PGIC (see be-
low) would be useful as part of assessing the outcome of a nerve transfer. 
Score 1 2 3 4 5 
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# of re-
sponses 
0 2 0 5 4 
Score 4.4/5 
 
5.7.7  Summary 
Thus in rank order of agreement on what should make up an assessment of function of re-inner-
vated muscle function: 
Fatigue, Patient reported outcome, Peak Force all attained greater than 4/5 Likert agreement. 
With assessment of recruitment, proprioception and pain being less than 4/5 agreement. 
 
5.8  Discussion 
As part of this review of muscle function assessment a group of expert views were sampled 
from larger expert groups and questioned for their view on what and how motor function should 
be assessed following nerve transfers. Through the two stage Delphi there has been an attempt 
to come to a consensus on how to assess re-innervated muscle function. The Delphi technique 
is a widely used and accepted method for gathering data from respondents within their domain 
of expertise. The technique is designed as a group communication process which aims to 
achieve a convergence of opinion on a specific issue. Participants in a Delphi study do not inter-
act directly with each other, so situations where the group is dominated by the views of certain 
individuals can be avoided.  
Delphi groups have been used widely in clinical medicine and surgery to inform scoping exer-
cises for research questions (Schneider 2016), gain consensus for treatment recommendations 
(Van Vliet et al 2016) and to identify which parameters to measure in clinical trials (Sinha 2011). 
There has been discussion (Powell 2003) of the merits and pitfalls of this method of harnessing 
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the opinions of an often diverse group of experts on practice-related problems. Particularly 
challenging is the level of evidence it is considered to provide inhabiting, as it does, the ground 
between opinion-based and evidence-based research (Powell 2003). 
To place this work in nerve injury within the context of the current body of knowledge we re-
viewed the English literature using the search string “Dephi” AND “nerve injury” OR “nerve”; 
There were only two published full studies on nerve injury using a Delphi approach in clinical as-
pects of nerve injury. One poster reference was also identified. 
Scmid & Coppieters 2011 invited 50 experts to discuss ‘double crush’ nerve pathology and gar-
nered 17 responders of whom 16 complete their 3 stage process towards delineating the mech-
anism(s) underlying the pathology. In a Delphi study on sensory therapy Jerosch-Herold 2011) 
invited the opinions of 70 hand therapists and of the 10 responders, 7 responded to all three 
rounds. A poster presentation by Dy et al (Dy et al 2017) assessed which portions of a nerve de-
compression operation were deemed to be critical by a three stage Delphi with 10 respondents 
they did not explicitly identify the method used to identify the group nor did they characterise 
their experience. 
The first round of this Delhi process demonstrated that the MRC grade was universally de-
ployed [A1] to assess peak force and that this was the top outcome assessed [A6]. There is 
however a section of responders [A2] who see the MRC grade as insufficient or inadequate: 
only 17% rated the MRC grade very useful with 22% rating the score as not useful (“nearly no 
use”, “just something I do as a matter of course” or “woefully unrelated to holistic function”). 
Having exposed the lack of support for a wider utility for the MRC grade it is still true that of the 
factors considered useful in assessing motor function [A11] peak contractile force represents 
the majority of responses (50%). Thus the author assesses that the Delphi group whilst deeming 
peak force important see MRC grade assessment as inadequate for this role. The validity and 
utility of a continuous measure of force in motor assessment has been supported widely in the 
literature [Quick 2016]. This is shown [A6] in the current support for continuous measurements 
of force (pinch measurement, dynamometry, grip assessment).  
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Moving assessment beyond that of peak force; there is a wider appreciation of motor assess-
ment apparent [A11] with sustainability of force, fatigue, proprioception and range of movement 
all featuring in responses. There were no positive responses for grade-ability of force being a 
useful aspect of assessment however.  
Interestingly the Delphi group strongly favour assessment of the efferent functions of re-inner-
vated muscle – the only afferent assessment selected, as being potentially useful in clinical as-
sessment, is that of proprioception (with only one response). There were no respondents who 
selected pain or sensory alteration as important. Contrast this with the findings from the data on 
the subjective patient experience in chapter nine. There is evidence of a disconnection here be-
tween the professionals’ impression of what it is important to assess and the patients’ voice on 
this matter. 
Moving to subjective assessments and PROMs, following the increasing popularity of such 
methods worldwide (Weldring & Smith 2011) the Delphi group showed that these were used by 
14 of the respondents (all of those that replied to Q13). Of these, two used a quality of life out-
come (QoL) the Short form 36 (SF36). The others used functional assessments. The Disability of 
the arm shoulder and hand (DASH) or a validated shortened version of this. One stated they de-
ployed an assessment of activities of daily living (ADL). This was an area where 90% (n=9/10) of 
respondents in round 2 agreed to a Likert level of 4/5 or 5/5 that a specific subjective outcome 
of change (PGIC) assessment would be useful. 
The second round again demonstrated the importance to the expert group of peak force with 
80% agreeing 4/5 or 5/5 that it is an essential part of assessment of a re-innervated muscle. 
100% agreed (at a 4 or 5/5 level) that an assessment of fatigue-ability would be useful as part of 
assessing re-innervated muscle function. Grade-ability of function as an important outcome at-
tracted only 60% agreeing 4 or 5/5 (the others showing neither agreement nor disagreement). 
On muscular pain assessment there was even less support (30% with 4 or 5/5) with 40% disa-
greeing. Support was at similar proportions for assessing the afferent pathways. 
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This is novel data and there is no specific literature with which to compare it. It is shown how-
ever that this sample of international experts sees that peak force should be seen as part (and 
not the part of the assessment which met with most agreement on its importance either) of clini-
cal studies on this area of muscle re-innervation. Historically such studies have focused on peak 
force to the exclusion of any other assessment (Figure 7.9). 
 
5.8 Limitations 
A significant limitation of this study is the potential for selection bias: The specialists were ap-
proached to engaged via two international meetings the catchment was over 70 such special-
ists. The Delphi group we questioned was made up of 18 respondees; self-selected from from a 
larger group to whom the invited was extended. Groups of this size are however common in 
Delphi processes.  Murphy et al (1998) reports that reliability is compromised by fewer than six 
participants, whereas groups in excess of 12 do not increase reliability of judgments thus the 
sample size itself is not in question but the method of selection is open to bias. The concern 
therefore is posseted that the responses may not be representative of the larger community. 
The author intends to mitigate this assertion by publishing these data for peer review and to 
prompt wider discussion. The group was noted to be internationally heterogeneous with re-
sponses from across a number of differing countries. There is implicit response bias in a group 
like this but to recruit those not engaged in this area would lead to a low response rate. Even 
this self selecting group shows a drop off between stage one and two (18-10). It could however 
be considered; that given the open invite, the Delphi group were a self selecting group of those 
interested and engaged with the subject of motor assessment (the free comments support this 
assertion) and thus not representative of the wider community. It is not possible to assess how 
the sample size and drop off has influenced the results and the intention to publish the work for 
wider consumption and discussion will inform this and allow future projects to benefit from this 
input. There is no other literature regarding the consensus in this area that this data will attract 
interest and comment.  
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The assumptions the author draws regarding the pervading practice across those in practice 
are valid only if the practice of the experts is seen to be representative of that of their peers. The 
utility of a Delphi process allows opinion to be canvassed. The validity of using such a process 
to survey practice may not hold as individual practices (rather than the underlying intellectual 
process or reasoning which Delphi process were set up survey), may have regional reasons why 
they do not align. A formal site by site survey would be the most appropriate manner to estab-
lish the practices in use but would be impractical to establish in any manner other than a pro-
cess similar to this. The questions though would be posed as a survey of clinic site or unit prac-
tice rather than a question on individual practice. 
 
5.8   Conclusions 
As set out in the aims; this study has demonstrated the opinions of working expert clinicians in 
the field on the subject of re-innervated muscle assessment. 
Maximal volitional force remains the clinicians’ primary outcome measure. The assessment 
methods used currently are mainly the MRC grade. The current state of muscle re-innervation 
assessment is that MRC grades of force are used as the universal outcome measure. Although 
most recognise this has shortfalls (with only 17% grading as a very useful tool). 
Experts expect 7.1KgF peak force from their Oberlin transfers; This is representative of what the 
published literature states. (Bhandari 2011, Carlsen 2011, Martins 2013, Quick 2016). 
There has been some consensus reached through this process on what data should be col-
lected in the future, peak force is considered to be one of the most important reported outcome 
but there is a recognition that fatigue and patient related outcomes should form part of any as-
sessment. 
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6. 
A quantitative assessment of the functional         
recovery through nerve transfer reconstruction of      
elbow flexion in patients with a brachial plexus 
injury  
 
Published after registration as:  
TJ Quick, AK Singh, M Fox, M Sinisi, A MacQuillan. Bone Joint J 2016;98-B:1517-203 
6.1 Abstract 
Introduction: Assessment of the efferent function of motor function is essential both to as-
sessing the outcome of nerve injury treatment but also to inform research towards a better un-
derstanding of muscle re-innervation (to allow development of better treatments). The current 
standard is to assess the peak contractile force via the Medical Research Council (MRC) as-
sessment. The MRC assessment is applied universally by experts in the field (chapter five), with 
83% of these considering it is less than very useful. As a discrete, rank assessment tool the 
MRC force assessment does not provide sufficient information to fulfil all of these roles. This 
study set out to use a continuous measure of recovered muscle force to characterise a popula-
tion of patients who had undergone nerve transfer.  The intention is that such a population of 
                                                
3 Published paper included as an appendix, inclusion of an amended text is  made with the full agreement of all 
authors, who’s contributions were; support of data collection (A Singh) and comments on the final text (M Fox, 
M Sinisi, A MacQuillan). The concept, justification, design and delivery of the study were the authors own work. 
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nerve transfer re-innervated elbow flexion function patients may form the basis of future study 
as a research population (chapter four, chapter ten).  
Methods: Twenty-six patients (range 16-66 years) from a cohort of fifty-two eligible patients at-
tended review examination. Inclusion criteria were that the patient was at a point greater than 
two years after having undergone a nerve transfer procedure for elbow flexion, between 2006-
2012. Their elbow flexion strength outcome was measured in am clinical outpatient environment 
with a static dynamometer. 
Results: These data showed 81% of nerve transfers gained elbow flexion strength of MRC 
grade 4 and would by standard assessment thus all be indiscernible by traditional assessment 
(chapter 3,4). We examined the spread of results within the MRC range and showed the average 
force outcome was 7.2Kgf (range 3-15.5Kgf), standard deviation of 3.3 and variance 10.8.  
Conclusion: This study establishes the dynamometer as a viable tool for assessing peak force 
outcomes following elbow re-innervation in a standard clinical set-up. It is suggested, as the 
HHD equipment is inexpensive that this method should be widely adopted to further inform the 
traditional MRC grade attained in around 80% of patients in outcome studies of re-innervated 
muscle. 
 
6.2 Introduction 
Brachial Plexus injuries are a rare (Midha 1996) and severely debilitating condition. The majority 
of cases are young men involved in motorbike accidents (Midha 1996). This injury results in 
physical disability, psychological distress and also has significant socioeconomic implications; 
A significant proportion of patients are not able to make a return to their previous level of activ-
ity (Choi 1997). Thee has been over the past few decades an increase in knowledge and under-
standing of the pathology and physiology following nerve injury through basic science and ani-
mal experimentation . This knowledge base has driven a change in approach in dealing with 
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nerve injuries, and changed it from ‘wait and watch’ to more aggressive approach of ‘early inter-
vention’. This evolution of treatment  is still clinically contentious but has a growing evidence 
base demonstrating improved outcomes, in terms of global functionality and quality of life 
(Kretschmer et al. 2009, Bengtson et al. 2008, Kato 2006, Leechavengvongs et al. 1998, Htut et 
al. 2016, Oberlin et al. 1994, Teboul, Kakkar, Ameur, Beaulieu, et al. 2004, Tung et al. 2004). It is 
the intention of this paper to support this move. Demonstrating that more adept, senstivie ad 
scientific  outcome measures will allow study not just of the model used in this paper but all 
other motor outcomes. 
Surgical intervention such as nerve repair and/or nerve transfer gives the best chance for re-
gaining maximum function after severe brachial plexus injuries (Kretschmer et al. 2009, 
Bengtson et al. 2008, Kato 2006, Leechavengvongs et al. 1998, Htut et al. 2016, Oberlin et al. 
1994, Teboul, Kakkar, Ameur, Beaulieu, et al. 2004, Tung et al. 2004). One of the aims of surgi-
cal planning in this situation is restoration of elbow flexion (Htut et al. 2016, Oberlin et al. 1994, 
Teboul, Kakkar, Ameur, Beaulieu, et al. 2004, Tung et al. 2004, Carlsen et al. 2009, Shin et al. 
2005). Carlsen (2011) showed that in the laboratory setting it is possible to apply the use of a 
hand held dynanmometer  (HHD) to assess peak contractile force, in order to popularise this ap-
proach it is necessary to demonstrate its efficacy in the clinical environment. 
The era of proof of concept of nerve transfers has now passed; it now falls to this generation to 
improve upon the work of those before us. In order to asses an improvement in outcomes it is 
(after clear criticism of discrete measures of force) now necessary to adopt a continuous scale 
to measure the range of force created by the re-innervation procedure. Through this approach it 
will be possible to demonstrate small differences and thus to finesse surgical technique and to 
use this controlled model (chapter four) as a method of study of nerve regeneration. 
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6.3 Aims & Objectives 
6.3.1 Aims: 
1. Characterise and describe (mean, SD) the population of peak force outcomes using KgF  
2. Popularise the utility and validity of HHD assessment of force in assessing re-innervated 
muscle.  
3. This data will inform planned future studies into improving nerve regeneration outcomes. 
 
6.3.2 Objectives: 
1. Identify a Cohort of Oberlin transfer patients with documented MRC grade 4 recovery of 
elbow flexion greater than 2 years post operation. 
2. Utilise this population to study the peak force generated with maximal effort. 
3. Assess this force with a Hand held dynamometer to produce continuous data. 
 
6.4 Material & Methods 
6.4.1. Data Collection 
The project was approved after institutional PEP (project evaluation review process) and REC 
(Research Ethical Committee) approval. A retrospective review of the RNOH’s peripheral nerve 
injury unit’s database was performed. Patients were included who underwent nerve transfer for 
returning elbow flexion from May 2006 to May 2012 and had a follow-up of at least 2 years 
post-procedure. Fifty-two such patients who had ulnar and median nerve fascicle transferred to 
biceps (+/- brachialis) were identified, and they were invited to a follow-up clinic. Twenty-six pa-
tients attended the follow up appointment. The low percentage is typical of other follow up 
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studies in trauma series and may also reflect the wide  geographic (national) referral base of the 
clinical unit with long distances perhaps also contributing to an unwillingness to return to be as-
sessed at 2 years or greater post intervention. 
A dynamometer (model D60107MK1 Penny and Giles Transducers, Christchurch, Hampshire) 
was used for measuring quantitatively the strength in re-innervated biceps (Fig 6.1). The instru-
ment was calibrated at the RNOH Biomechanical Institute. Patients were seated on a chair, with 
the elbow flexed at right angle and forearm rested on the table. The force plate of the dyna-
mometer was placed at a fixed point, 10 cm proximal to distal wrist crease, and the examiner 
applied a force to maintain an isometric contraction of the subject. The effort was maintained 
for 3 seconds with strong verbal encouragement and the peak force was recorded. The read-
ings, which were in Kilogram force (KgF), were recorded in three different positions, namely in 
full forearm supination, neutral and full pronation. (Figure 6.2) 
 
 Figure 6.1:  
Hand held dynamometer (model D60107MK1 Penny and Giles Transducers, Christchurch, Hampshire) 
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At the clinical research review, patients were assessed by a disinterested observer for returned 
elbow flexion force. The assessment was carried out in a standard clinic room with no specialist 
equipment other than the dynamometer. The measurement of elbow flexion was performed in 
three positions of forearm rotation (full supination, neutral and pronation). These measurements 
were repeated twice. These readings were then averaged, as it was observed that the patients 
varied in their strength in different forearm positions and sometimes could not attempt any el-
bow flexion in a particular position.  The other arm was used as control. The regained strength 
of injured extremity in elbow flexion was compared to the contralateral side and expressed as a 
percentage. 
 
 
Figure 6.2: 
 Hand held dynamometer in use with three differing positions of measurement. 
  
Synchronous brachioradialis and or triceps muscle activity during elbow flexion were clinically 
assessed with visual inspection and palpation. The clinical notes were reviewed to determine 
their documented historic progress, in terms of MRC grade, at six, twelve and twenty-four 
months follow-up. 
Patients were seated on a chair, with the elbow bent at right angles and forearm resting on the 
table. The force plate of the dynamometer was placed at a specific, but arbitrary point, 10cms 
proximal to the distal wrist crease, and the examiner applied a restistive force through it. The 
force generated by the patient to overcome this resistance was noted. The readings were taken 
in three different positions, namely in forearm supination, neutral and pronation (Fig 6.2). There 
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were two observers who obtained two sets of readings on each individual patient. The other 
arm was used as a control.  
6.4.2 Patients  
Twenty-six patients and their case notes were reviewed for this study. During this assessment, 
patients were assessed for synchronous brachioradialis and triceps muscle activity during el-
bow flexion. There were twenty-three patients who had a single and three who had a double 
transfer. 
6.4.3 Study Demographics 
The group studied was made up of twenty three male and three female patients, with a mean 
age at the time of operation of 37.3 years (16 to 66). Their median time between the index injury 
and the Oberlin procedure was 18.7 weeks (one day to 64.1 weeks). A total of 21 patients un-
derwent quantitative assessment for the strength of their re-innervated biceps muscle as they 
had attained the ability to flex the elbow against resistance. 
6.4.4 Injury Demographics 
There were fifteen patients with left-sided and eleven with right- sided brachial plexus injuries. 
Of these, twelve were on the dominant side and fourteen on the non-dominant side. A total of 
twenty four had sustained the injury in a road traffic incident, of whom seventeen were riding a 
motorcycle. One patient sustained an injury playing rugby, and one had an iatrogenic injury at 
the time of an intrascalene block. The strength of elbow flexion improved gradually post-opera-
tively with the first flickering movement noticed at around six months.  
6.4.5 Statistical Analysis  
Statistical analysis was performed using SPSS software package (version19). A two-tailed p-
value was determined, for these two continuous data sets with statistical significance set at 
p<0.05.  
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6.5 Results 
6.5.1 Force outcome 
At a mean follow-up of 56 months (28 to 101) the mean strength of flexion of the elbow was 7.2 
Kgf (3 to 15.5; SD 3.3). When compared with the contralateral arm was a  mean of 34.7% (me-
dian 33%, interquartile range 11.9% to 66.5%). Figure 6.2 shows the values for the strength of 
flexion of the elbow obtained for the group with MRC grade 4. Eighty percent of this cohort  
(21/26) undergoing nerve transfer gained MRC grade 4 strength of flexion. Within this group of 
twent-one cases the spread of data withn the grade MRC 4 was a mean of 7.2 Kgf (3 to 15.5; 
SD 3.3). This equates to between one-eighth to two-thirds increase in strength, and an average 
of up to one-third of normal.  
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Num-
ber 
Pt.  
Age @ 
Injury 
(years) Injury Level 
Donor 
nerve 
Recipient 
nerve 
MRC 
Grade 
Peak readings on Affected 
side for each position 
(S/N/P) KgF 
Mean reading -Af-
fected side 
[(S+N+P)/3] KgF 
Peak readings on Normal 
side for each position 
(S/N/P) KgF 
Mean reading -Nor-
mal side 
[(S+N+P)/3] KgF 
%Elbow 
Strength 
1 SP 15 C5-6  U B 4 17/9.6/8.5 11.7 22/19.9/17.3 19.7 59.4 
2 DB 18 C5-6  U B 4 11.9/9.3/7.9 9.7 21.1/17.8/19.8 19.6 49.2 
3 BP 23 C5-6  M B 4 4.0/3.3/6.5 4.6 26/21/28.7 25.2 18.3 
4 TH 29 C5-6 M B 4 6.5/6.1/7.2 6.6 18.6/20.6/20.8 20 33 
5 KC 35 C5-6  U B 4 5.8/8.1/6.3 6.7 23/17/24.7 21.6 31 
6 MH 46 C5-6  M B 4 7.9/6.2/7.9 7.3 17/23.8/16.1 19 38.4 
7 SP 46 C5-6  U B 4 5.4/5.3/6.6 5.8 28.2/31.1/22.9 27.4 21.2 
8 CB 35 C5-6  U+M B&B 4 4/2.8/7.2 4.7 22/18.5/18.5 19.7 23.9 
9 SB 41 C5-6 M B 4 8.4/3.1/6.4 6 21.1/21.4/22.8 21.8 27.5 
10 IB 41 C5-6  U+M B&B 4 8.9/7.2/7.7 7.9 19.8/15.1/14.5 16.5 47.8 
11 CM 43 C5-6 U B 3 Nil Nil 28.1/22.4/17.5 22.7 Nil 
12 DB 35 C5-6  M B 3 Nil Nil 19.2/17.5/ 18.3 18.3 Nil 
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13 BA 47 C5-6  U B 1 Nil Nil 16.3/20.2/16.5 17.7 Nil 
 14 SA 17 C5-6 U B 4 4.8/2.2/3.5 3.5 18.2/12.9/11.2 14.1 24.1 
 15 NA 34 C5-6 U B 4 12.7/5.4/10.5 9.4 18.2/20.5/20.6 19.8 47.5 
 16 SW 21 C5-6 U B 4 12.2/13.2/14.7 13.4 28.5/29.5/25 27.7 48.4 
17 RR 64 C6 U B 4 4.8/5.0/5.1 5 11.8/10.8/11.2 11.3 44.2 
18 AW 42 C5 -7  U B 4 4.5/4.4/6.0 5 23.2/ 20.9/ 19.1 21 23.8 
19 DC 30 C5 -7  U B 4 8.2/ nil/ nil 8.2 20.1/27.5/25.4 24.3 33.7 
20 LC 19 C5 -7 M B 4 3.1/2.3/3.6 3 26.9/26.1/22.8 25.3 11.9 
21 GM 44 C5 -7 U B 4 4.0/3.0l/5.6 4.2 19/14.2/19.8 17.7 23.7 
22 PJ 41 C5 -7 U B 4 3/4.9/5.3 4.4 22/21.2/19.3 20.8 21.1 
23 FG 66 C5 -7 M B 0 Nil Nil 16.4/15.2/15.8 15.8 Nil 
24 RA 52 C5 -7  U B 3 Nil Nil 17.6/ 18.2/ 17.1 17.6 Nil 
25 KP 53 Infraclavicular  U B&B 4 8.6/5.4/9.3 7.8 25.8/24/17 22.3 35 
26 TB 33 Infraclavicular  U B 4 16.9/15.4/14.2 15.5 26.3/22.0/21.4 23.3 66.5 
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Figure 6.2  
Table summary of injury pattern and outcome following Oberlin procedure. 
U: Ulnar, M: Median, B: Biceps, B&B: Biceps & Brachialis, S: Supination, N: Neutral, P: Pronation Taken from Quick et al 2016 with permission of all authors.
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Synchronous contractions of brachioradialis were noted in every case during attempted elbow 
flexion. This was greatly reduced when elbow flexion was attempted in the position of full supi-
nation we were unable to quantify the contribution of this change. Triceps co-contraction were 
demonstrable in two cases.  
 
 
Figure 6.3:  
Force curve depicting MRC Grade 4 subset distribution. Mean 7.2 KgF (3 to 15.5; SD 3.3).                                 
(Best fit line as calculated by SPSS software) 
 
Thus it was observed that more than 80% of patients undergoing nerve transfer, will gain an el-
bow flexion strength of MRC grade 4, This is in keeping with other reported case series (figure 
7.9 ) placing these data as commensurate with other groups. The strength of this study is to fur-
ther assess this group of MRC 4 outcomes. Measuring they have, on average, recovered an el-
bow flexion power of 7.2 KgF equating to a force which is an average of one-third of the other 
arm’s strength. 
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6.6 Discussion 
The standard assessment of outcomes from nerve transfers have universally been expressed via 
MRC grade. The move from this technique has started to occur, driven first in this field by a dis-
cussion of how to discern a difference between differing surgical techniques for nerve transfer.. 
Carlsen (2011) presented his findings of a retrospective study using a sophisticated bimechanic 
laborataory set up, comparing (6) single versus (16) double nerve transfer.. The study was inade-
quately powered to show a difference. The data revield elbow flexion strength was 8.94+/-
5.92Nm and 12.54+/-11.76Nm respectively single  and double (Carlsen et al. 2011). Martins 
(2013) followed this study with a slightly larger prosepective cohort (18 single 19 double) over 
5years; Having performed a (one presumes a post hoc) power analysis and assessing 84 pa-
tients were necessary to show a difference he proceeded with a single surgeon single site study 
assessing his own outcomes and showing 4.14 ±3.27KgF (single) and 5.6±2.41KgF.  
  
In this study, of the twenty-six patients twenty-one attained a MRC grade 4 power which when 
quantitatively assessed with the dynamometer showed mean elbow flexion strength of 7.2+/- 
3.3kgF. This is close to the values 8.94+/-5.92 Nm, obtained in a biomechanical laboratory set-
up by Carslen (2011). Also, the mean percentage elbow strength compared to contralateral side 
in this study was 34.7%+/-14.4%, again not hugely different from this study. The data does not  
allow us to perform any sensible comparison of these data (between single versus double nerve 
transfer) due to the significant difference in numbers between the groups (23 vs 3). This study 
was not deisgned to show any such difference.  There were six cases in this study that under-
went nerve transfer within two weeks of their injuries (after exploration and identification of avul-
sion lesions at the site of injury in the supraclvicular brachial plexus). These six cases all 
achieved a MRC grade 4 at a two year period 
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This is the first study looking at the medium term outcome; 2 years post procedure, for the UK 
population. This study presents an example of how in a practical manner a continuous quantita-
tive measurement for regained elbow strength can be carried out in a standard clinical environ-
ment and it is hoped the data and descriptive technique will popularise the use of HHD in as-
sessing continuous peak force assessment. Such a process allows the clinician and patient to 
compare the reading from previous follow-ups to record recovery increasing engagement with 
rehabilitation. It also avoids the use of the epithetic MRC descriptors 4-, 4+, 4++ which are not 
validated sensitive or reactive measures. The values obtained during this assessment are similar 
to those obtained under biomechanical laboratory conditions (Carslen 2011). This supports and 
validates the feasibility of use of HHD as a measurement tool in clinics in future.  
 
The following limitation of the study deign are acknowledged: Elbow flexion peak force should 
have ideally been measured as a torque (Nm as in Carlsen 2001) this would have required a cal-
culation of how force was applied across a moment arm formed by the distance between the of 
centre of rotation of the elbow (he trans-epicondylar axis) and the centre of gravity of forearm 
(where the resistance was applied) which would be different in each arm (due to variation in the 
mass distribution within in the forearm). This is only possible in a formal biomechanical labora-
tory (as asessed in Carlsen 2011). The use of KgF was therefor the only possible assessment 
and was undertaken to demonstrate that this technique can be widely applied in a standard clin-
ical setting. Equally an assumption that the mid-point of forearm was the centre of gravity for 
measurements would have introduced error for a related reason. Hence, arbitrarily, a fixed point 
of 10cms proximal to the wrist crease, was selected as the point for application of force. Sec-
ondly, this study was not designed to (and was thus underpowered for) comparison of other is-
sues of interest; such as difference in outcome of early versus late surgery, or single versus dou-
ble nerve transfers. Thirdly it is accepted, that as with any clinical assessment tool, there are in-
ter and intra-observer variations. These have been well documented (Tuttle 1913, Feiss 1912). 
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This deficiency of the study is acknowledged,  but it is noted  that these data are similar to the 
only other previously published series of continuously assessed outcomes (Carlsen et al. 2011, 
Martins 2013).  
There is  importance given by the research group to a recognition that peak force generation is a 
simplistic assessment of motor re-innervation outcome. There is, thus, a future challenge to 
identify methods to assess factors that our patients find confound their recovery, fatigability, 
tremor, lack of proprioception, co-contraction to identify but a few. The challenges implicit in the 
heterogeneity of human nerve injury and its outcomes are recognised. An exploration of the con-
tribution of individual variability (age, nature of injury, distance from nerve transfer to target or-
gan, time since injury, co-morbidities, gender etc.) will be informed through use of these meas-
urements in comparative studies of the future. 
To conclude, this study  has characterised the left-shifted (from a normal population) population 
of re-innervated elbow flexion function: showing a Mean of 7.2 kgf (3 to 15.5; ± 3.3) at a mean of 
56 months (28- 101 months) post operatively.  The utility of a continuous quantitative measure-
ment of outcome from muscle renervation has been demonstrated and will give patients an ap-
preciation of their likely future recovery and holds the potential for playing a key role in future re-
search for nerve injury recovery.  
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7. 
Validation of a consensus-based minimal clinically 
important difference (MCID) threshold in nerve 
transfer muscle re-animation, using an objective 
functional patient reported external anchor, an 
assessment of standard error of measurement, a 
Distributional Assessment and a Delphi group    
exercise.  
 
7.1 Overview and Summary  
7.1.1 Background context:  
The minimal clinically important difference (MCID) is defined as ‘the smallest change in an out-
come that a patient would perceive as meaningful. The Initiative on Methods, Measurement and 
Assessment in Clinical Trials (IMMPACT) group (2010) proposed defining the MCID as a 30% 
improvement in self-reported pain or function. However, this MCID threshold has not been vali-
dated against an objective physical measure.  
Nerve transfer muscle re-animation is a treatment option for use when a nerve injury renders a 
muscle denervated and thus paralysed. The characteristics of the maximal elbow flexion force 
generated by individuals within a group with renervated biceps muscle have been demonstrated 
(Chapter six, Quick 2016) but there is no current method to manipulate the biologic response 
shown to improve on the results of this surgery. No drug efficacious to improve such outcomes.  
Identifying such a method to biologically improve nerve repair and nerve regeneration generally 
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is thought attractive. It is not known what the MCID would be for any such an intervention to im-
prove outcome; what magnitude of effect would be noticed by patients. This is a significant gap 
in the knowledge necessary to progress such work. 
 
7.1.2 Summary Aim: 
To establish a valid range for MCID force of elbow flexion following muscle re-innervation nerve 
transfer surgery. Thus supporting a move towards an objective, measurable threshold that is pa-
tient-centred when aiming to improve motor outcomes. 
7.1.3 Summary Objectives:  
To use a range of accepted approaches to calculate MCID: 
• Firstly, to utilise an ‘anchor method’: i.e. compare subjective, self-report measures of func-
tion with an objective measure of, the power generated from nerve transfer. 
• Bring together an expert panel and explore the question through a Delphi exercise. 
• Assess the spread of published results from nerve transfer operations to inform a ‘distribu-
tion method’ analysis of MCID. 
• Analyse the likely standard error of measurement implicit in measuring elbow flexion force 
and consider this as a proxy for MCID via ‘SEM method’ 
• Finally, to assess a purely statistical method using a p value of 0.05 to calculate from pub-
lished data a level of significant change.  
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7.1.4 Summary of Study Design:  
A multiple point analysis of MCID was undertaken across a number of domains looking at what 
the additional force (KgF) generated by elbow flexion would have to be to reach a minimum clini-
cally important (meaningful) improvement. This study draws on data from an assessment of 
force in Oberlin nerve transfer outcomes (Chapter10). 
7.1.5 Summary of Patient Sample:  
The anchor population was a sample of 12 patients selected from the PNI Unit data base having 
developed elbow flexion from an Oberlin nerve transfer and being greater than 24months from 
that surgery (as presented in Chapter 10). This cohort was examined by two observers (both in-
dependent therapists). The inter and intra observer assessments of these data has been used to 
inform the standard error or measurement calculation. The anchor based assessment relates to 
results of the MICD question (Chapter 6) taken from the same sample of patients. As detailed in 
Methods (7.1.17) Ethical approval was gained from the NHS ethical board after IRAS application.  
 REC reference:  16/LO/0623 
 IRAS project ID:   202847  
7.1.6 Summary of Outcome Measures:  
A survey of expectation of function was applied to all in the study to assess the actual or retro-
spective intention of post operative recovery. Questionnaires were completed by all post-opera-
tive patients to assess their impression of change following the surgery to re-innervate their el-
bow. 
7.1.7 Summary of Methods:    
MICD is a reported quantity with a great deal of uncertainty around its calculation. It is certainly 
a heterogeneous concept: At least 9 methods have been described as valid in calculating MCID 
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(Wright et al. 2012). In general, methodological approaches can be classified into two broad 
groups: anchor-based and distribution-based. Previous authors have outlined the strengths and 
weaknesses associated with these two methods; however, a single standardised methodology 
for calculating MCID has yet to be determined (Copay et al. 2007).  
In this study a patient anchor assessment was gained from a retrospective sample of 13 patients 
who had recovered elbow flexion force following nerve transfer surgery. A Delphi assessment of 
18 invited international experts in the field of nerve surgery provide their impression on MCID for 
motor recovery.  Distribution-based approaches include a meta-analysis of a review of all pub-
lished outcome series in the English language. Medline and PubMed and Google scholar were 
searched for publications including the search strings “outcome” AND “nerve transfer”, “bi-
ceps”, “elbow flexion” any publications not published in English were thus excluded 46 papers 
were identified. These papers were searched for outcomes quoted and a further 8 papers were 
identified from the bibliography searches. 56 papers were then searched for continuous out-
comes measures and then further reduced to those that related to Oberlin nerve transfers. A cal-
culation of the accepted errors of measurement and an assessment of Minimal detectable 
change are also included.  
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7.1.8 Summary of Results:  
Method Percentage improvement  
(taking the reference popula-
tion as Quick 2016 7.2 Kgf 
(SD 3.3). 
MCID elbow flexion force for 
Oberlin transfer 
 
IMMPACT 30% 2.16Kg 
Patient anchor 90% 6.52Kg 
Delphi 72% 5.16Kg 
SEM 1SEM: 9-11%  650g-792g 
Distribution method 21% 1.54KgF 
statistical p= 00.5 70% 4.9 KgF 
Figure 7.1: 
Table demonstrating the multiple assessments of MCID calculated via differing methods and expressed as a 
force (KgF) and as a percentage change based on the published series Quick et al 2016. (Chapter 6) 
 
7.1.9 Summary of Conclusions:  
These data demonstrate a wide range of MCID values (figure 7.1) for MCID in the motor assess-
ment of maximal volitional force assessment of re-innervated muscle (0.650Kg to 6.5 KgF). Such 
a spread of values is often reported in publications undertaking similar methodologies. The aim 
of MCID studies is to provide a unique threshold value, whereas, ironically, the different methods 
by necessity produce a range of MCID values. The range of an order of magnitude reflects this 
diversity of method.  
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7.2 Introduction 
Surgery to address nerve injury has been accepted world wide as beneficial in selected cases to 
improve upon natural history. The proof of concept of the various methods deployed, (neuroly-
sis, nerve repair, nerve grafting and nerve transfer) has been reached. The next stage necessi-
tates a focus on the indications and to identify other methods to improve outcome. Advancing 
the state of the art is difficult due to indistinct classification systems (related to the huge varia-
tion in the injuries seen and the difficulties implicit in predicting outcome), outcome measures 
and standardising surgical treatments.  
Nerve injury can affect some or all of the modalities of nerve function- movement, sensation, 
sweating, proprioception, pain etc. There are a number of validated measures used to assess 
these factors. Many of these measures are subjectively assessed and can vary widely due to ex-
ternal factors- (stress, physiology, temperature, analgesia etc.) The assessment of motor out-
come has undergone an evolution in clinical assessment recently and is now regularly measured 
as a continuously assessed variable of maximal effort force. Peak force generate-able by maxi-
mal effort is standardisable and for certain muscle groups (elbow flexors) and easily and repro-
ducibly assessable. Our previous published data (Chapter six, Quick et al. 2016) have shown a 
mean outcome of 7.2Kg of force (KgF) at a mean of 56 months (28- 101 months) with a SD of 
3.3 KgF. This model has been chosen for study as the nerve transfer can be considered a 
‘standardised nerve injury’. The outcome from the nerve transfer is solely due to the repair and 
recovery is purely motor. The outcome is obvious to the patient and thus can be considered and 
discussed as an isolated outcome. We intend to use this model to assess the likely MCID of any 
intervention to improve upon the current level of force recovery following re-innervation. This im-
provement could be a systemic drug, a surgical technique improvement, a novel rehabilitation 
technique or local drug delivery at the point of nerve repair or transfer. For each of these an 
MCID in each facet of recovery (pain, sensation, sweating, proprioception) would be necessary 
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to detect any meaningful change - we only consider the return of motor function as assessed by 
the traditional peak force in this study. 
 
7.3 Background 
Jaeschke (1989) first defined minimal clinically important difference (MCID) as being “the small-
est difference in score in the domain of interest which patients perceive as beneficial and which 
would mandate, in the absence of troublesome side effects and excessive cost, a change in the 
patient’s management”.  Variations and applications of this concept have varied (Beaton et al. 
2002; Chung et al. 2017) but the concept of a threshold level of change in a given outcome 
which when crossed is seen by patients or clinicians as demonstrating an appreciable difference 
(Gatchel et al. 2013). The Initiative on Methods, Measurement, and Pain Assessment in Clinical 
Trials (IMMPACT) (Haythornthwaite 2010) group recommended that the MCID be defined as a 
30% change in self-reported pain or function (Dworkin et al. 2005; Haythornthwaite 2010). How-
ever, this was a consensus decision based on a review of studies that used different methodolo-
gies. Subsequently, several other recommendations have been made, using both anchor-based 
and distribution-based MCID approaches (Gatchel & Mayer 2010; Copay et al. 2007; Chung et 
al. 2017).  In order to apply these methods to investigate the parameters in the assessment of 
muscle re-innervation the following study was undertaken:  
 
7.4 Study Design 
In the taxonomy of MCID it is difficult to develop a single method that offers validation across all 
aspects of assessment. MCID is often taken as an absolute value but we would support a more 
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nuanced view of the metric. We thus designed four parallel methods to assess the same out-
come measure. (the outcome measure in question was an objective assessment of a continuous 
metric; elbow flexion force (KgF) in renervated elbow flexors). 
A questionnaire has been used to capture subjects’ views on what level of extra force would 
represent a MCID to them. Following this; a phenomenological assessment of patient lived ex-
perience of nerve transfer recovery of elbow flexion (detailed in chapter eight) was undertaken  
and free text anchor statements to assess patient cohort expectation are also provided.  
Previously published data has been used of the outcome of nerve renervation results to analyse 
the MCID on a population basis (Quick 2016). Data taken from the previously presented Delphi 
group (chapter 5) where discussion on outcome measurement was held at two international 
meetings, following a presentation of the subject area and agreement made between the group.  
Finally, and most pragmatically; the standard error of measurement (SEm) was calculated 
(through a recognised method; Jacobson 1992, Rai 2015). This represents the minimal effect 
that could realistically be measured with the methods in use currently.  
 
7.4.1 Anchor based approach  
An anchor statement or questionnaire is a method to record a meaningful external ‘anchor’ 
which relates to the patients’ experience. It is a self valid statement either a direct statement of 
outcome ( “I would want a two minute improvement in my walking distance,” or “be able to per-
form that task 10 minutes quicker”) or indirect such as a global impression of change. This can 
be used to delineate indirectly the MCID by cross-referencing the specific outcome point where 
there is a perceived population positive global impression of change. Thus we questioned a co-
hort of patients who had all had recovered the ability to lift weight following nerve transfer sur-
gery. “What increase in force do you think that you would need to gain in order to notice the dif-
ference”.  
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Participant Gen-
der 
Age Affected 
side  
Dominance 
D-dominant 
ND-nonDom 
Injury Op 
date 
HHD 
(Kgf) 
Affected Non Af-
fected 
1 GP M 47 L ND Avulsion C5/6 27/08/1
4 
14.03 19.18 
2 LJ M 27 L ND AvulsionC5  
RuptureC6 
02/10/1
5 
16.27 29.62 
3 SM M 27 L ND UT neuroma 23/01/1
5 
8.92 10.01 
4 CW F 69 L ND UT neuroma 17/09/1
0 
6.33 15.63 
5 MH M 52 L ND UT neuroma 30/09/1
1 
6.83 9.9 
6 PA M 44 L ND AvulsionC5  
neuromaC6  
23/05/1
4 
9.57 25.61 
7 SB M 51 R D Avulsion C5/6 15/06/0
9 
12.3 28.97 
8 SP F 47 R D Tumour 
upper trunk 
06/07/9
8 
3.12 19.76 
9 TH M 36 R D Avulsion C5/6 27/08/1
0 
5.36 19.02 
10 TB M 53 R D Muscular cu-
taneous nerve 
humeral # 
23/08/9
6 
10.38 28.71 
11 MM M 43 L D Avulsion 
C5/6/7 +/-8 
17/10/1
4 
4.65 9.9 
12 AW M 50 L ND Avulsion 
C5/6/7 
09/09/0
9 
7.2 30.45 
 
Figure 7.2:  
Table of Patient demographics. The study cohort was n=12 subjects 
 (M10 F 2) mean age 45.5 (27-69) years. 
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OUTCOMES MEASURES:  
This cohort of self-reported MCID was gathered using the anchor question: 
“What increase in force do you think that you would need to gain in order to notice the differ-
ence?”  
This was assessed with a possible range of answers: 
• 50gs (approx. the weight of a chocolate bar) 
• 100gs (approx. the weight of a tube of toothpaste) 
• 300ga (approx. the weight of a small tin of beans) 
• 500gs (approx. the weight of a 1/2litre bottle of water) 
• 1Kg (approx. the weight of a litre bottle of water) 
• 2Kg (approx. the weight of 4 pints of milk) 
• 3Kg (approx. the weight of a 3 litre tin of paint) 
• 5Kg (approx. the weight of a vacuum cleaner) 
• 10Kg (approx. the weight of a lawnmower) 
• 15Kg (approx. the weight of 12 bottles of wine) 
• greater than 15Kg 
• ADD “OTHER" 
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Figure 7.3: 
 Representation of spread of responses to a question of MCID. 
 
Mean 6.53 KgF SD (6.419) N=12 
MODE 15 KgF 
RESULTS:  
Descriptive Statistics N Minimum Maximum Mean  Std. Deviation 
MCID   12 .30Kg  15.00Kg 6.52Kg  6.418 
Figure 7.4:  
Results of anchored patient assessment of MCID 
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There is a very large spread of numbers here and as shown by the histogram even the mode re-
sponses was split between two responses of 15 Kgs and 2kgs. To investigate this further we re-
directed our focus to the current situation not a hypothetical improvement- We undertook com-
parison between the response to the question “what difference has this operation made to you” 
and the force recorded for 12 patients who attended for assessment of their force.  
The force of elbow flexion (KgF) following 
elbow flexion nerve transfer operation  
What difference has this operation 
made to you 
Likert response 0- none  5- a huge dif-
ference. 
16.270 5 
9.57 5 
8.92 5 
7.730 5 
6.33 5 
4.650 5 
12.3 4 
10.38 4 
7.20 4 
6.83 4 
5.36 4 
3.12 0 
Figure 7.5:  
Results of subjective assessment of impression of impact (difference to patient) as measured by a Likert scale of 
returned force of elbow flexion (in KgF). 
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Further assessing the means of the groups who assessed 4/5 and 5/5 impression of change we 
find 5/5 (n=6 Mean 8.91KgF, SD 4.0) and 4/5 group (n=5 Mean 8.41KgF SD 2.8). A two tailed 
comparison of these two populations shows no significant difference between them. 
Anchor-based methods have been criticised for the effect of recall bias on long-term respon-
siveness (Norman 1997, Stratford 1997) and it has been shown that retrospective report of 
change is reflective of the patient’s current health status.  
We further illustrate the disparity between groups in this analysis with selected significant 
phrases taken from a phenomenological analysis of a group discussion (n=5) on the patient ex-
perience of muscle re-innervation (Chapter 9) 
“just to move it was a reasonable outcome” 
“any function is better than none so the force is kind of just the starting point “ 
 
7.4.2  Delphi 
7.4.2.1 Method: 
Subjects: The author attended two international nerve injury meetings (Sunderland meeting 
Frankfurt September 2016 and the Scandinavian- UK Brachial Plexus meeting Stockholm May 
2017) where this project was presented via a 3 minute presentation and a 7 minute question and 
answer session. An invite was extended to the assembled audience during this presentation to 
complete an online poll- 18 responders provided 12 answers to MCID.  
To the request for an estimation of MCID there were three incomplete answers - 2 said they did 
not understand the question, one misunderstood the question (the response was; that to im-
prove function they would do a Stendler flexoplasty- an operation to move the origin of the 
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flexor muscles of the forearm to effect an increase in elbow flexion vector to the pull of these 
muscles) and one answered that a MCID would be 50% of the patient’s current function. 
 
DELPHI MCID- given a population with a mean force of 7Kg and a SD of 3.5 what is the 
minimal additional force that would be necessary for a patient to notice a clinically rele-
vant improvement?  
n=12 
KGf 0.5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
N 1 1 4 2 0 1 0 1 0 0 1 0 0 1 0 0 
Figure 7.6:  
Table of Delphi responses of MCID for returned elbow flexion 
 
         N Minimum Maximum Mean  Std. Deviation 
MCID Delphi  12 .50Kg  13.00Kg 5.16Kg  3.921 
Figure 7.7:  
Distribution of data from Figure 7.5 
 
This result from a Delphi assessment of many international expert Brachial plexus surgeons-  all 
of whom regularly perform nerve transfers for elbow flexion and clinically assess their own re-
sults. There is a much tighter distribution than we presented in the patient MCID. This represents 
then a common understanding of the area.  
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7.4.2.2 Conclusion:  
The Delphi group provide a mean of 5.16Kg which is very similar to the Patient group 6.52 KgF. 
This is at odds with Goldsmith’s heuristic approach (Goldsmith et al. 1993)  where it was argued 
that clinical experts would want to see more change in an individual’s score before they confi-
dently consider an important change to have occurred than in a group of patients’ scores. There 
is considerable agreement between the two groups (subjective and objective assessment here). 
However this simplifies the very different distribution of these data. In comparing the distribution 
of responses from the patients and the experts there is a narrower spread of MCIDs identified by 
the experts (Patient SD- 6.42. Delphi SD- 3.92). 
7.4.2.3 Discussion of Delphi Data:  
This difference between the spread of results may reflect the fact that the Delphi group utilise 
force outcome assessment regularly (and have considered this concept prior to the study and 
have an innate preconception of what an MCID is in their own practice). It may also reflects 
weaknesses in the question design and/or method.  These concepts have not been explored in 
the literature previously and so it is difficult to place these data in the context of others.  
In that the subjective and objective means are similar and that motor assessment of peak power 
is often used as an objective assessment; it is suggested that this MCID is valid for these ob-
servers. 
 
7.4.3 MCID (signal) versus the SEm measurement error (noise)  
An assessment of an important change can only be useful if it is greater than the measurement 
error (Standard error of meausment SEm) is the error implicit in the system. The system can be 
considered as having two major compartments- the assessment and the assessed quantity. The 
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assessed quality first of all. We do not know the variation of the force from one moment to the 
next, is there day to day and moment to moment variation? Then does the assessment vary 
from time to time with a stable metric- this is the Intra-class correlation. 
The intra-class correlation ( ICC) and Standard Error of measurement (SEm) are related, (Strat-
ford & Goldsmith 1997) but they convey different information about the reliability of a measure. 
The standard error of measurement (SEm) estimates how repeated measures of a person on the 
same instrument tend to be distributed around his or her “true” score. The true score is always 
an unknown because no measure can be constructed that provides a perfect reflection of the 
true score (Stratford & Goldsmith 1997).  In trying to assess the MCID we must acknowledge 
that if it is smaller than the SEm then it will be drowned out in this variation. The signal will not 
be detectable due to the noise. Thus it is argued that the SEm can be used as a minimum level 
for the MCID. 
 
INTER RATER AS-
SESSMENT 
Observer A  
mean (SD) 
Observer B  
mean (SD) 
Pearson 
Correlation 
Over 3 assessments 7.72 (3.70) 7.65 (3.50) 0.941** (.000) 
Figure 7.8:  
Inter-rater assessment of the mean of 3 assessments by two observers’ (A and B) assessment of elbow flexion 
force following Oberlin using HHD. 
 ** significant value p=<0.05 
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INTRA-RATER 
ASSESSMENT 
Observer A1 
Mean (SD) 
Observer A2 
Mean (SD) 
Observer A3 
Mean (SD) 
Kappa correla-
tion R= 
Oberlin 7.47 (3.33) 7.61 (3.56) 7.87 (3.69) A1-A2: 0.967** 
(0.000) 
A1-A3: 0.958** 
(0.000) 
A2-A3:0.971** 
(0.000) 
Figure 7.9:  
Intra-rater assessment; Mean and SDs of 3 assessments (A1, A2, A3) by a single observer (A) Correlation of 
comparison between A1-2 A103 and A2-3 is demonstrated with Kappa R  
**significant value p=<0.05 
 
First to assess the SEm we must take the information from inter and intra rater observer varia-
tion of elbow flexion strength.  When assessing the variation of repetitive assessments with in-
ter-observer (R=0.941 Rho) and intra-observer (R=0.958) assessments of peak force there is lit-
tle noise here.  
7.4.3.1 Methods for SEM method 
Using the data from a study (presented in Chapter 10) on assessing force in Oberlin re-inner-
vated elbow flexion. The Standard error of measurement (SEm) in turn, can be calculated from 
an analysis of a variance table (intra-class correlation or ICC) of repeated measures in stable pa-
tients, may be estimated by the following formula: SD times the square root of [2 × (1 − R)] 
where R is the test-retest reliability coefficient (Jacobson 1992, Rai 2015). It should be noted 
that the original Jacobson formula did not include the factor of square root of 2 (= 1.41) (Rai 
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2015). The R value for HHD assessment of peak force Oberlin transfer outcome is tabulated in 
Figure 7.9 [data from chapter 10 study]. 
7.4.3.2 Calculation 
Taking the SEM as calculated in relation to the Inter-class correlation  
 
There is thus  the following spread: 
using the data from 2 observers assessing peak force of an affected limb post Oberlin transfer 
(figure 7.8) (data again from from Chapter 10) three times there is an ICC of 0.941. 
 
 
 with the population mean being 7.685KgF (Quick et al. 2016) 
then SEm% = 11% 
Using assessment by one observer assessing three peak contractions of a normal limb 
  
 
 Kg with the population mean at 20KG  
then the SEm% = 18%. 
 
 
SEM = SD * ( 1 − ICC )
SEM = SD * ( 1 − ICC )
SEM = 3.634 * ( 1 − 0.941)
SEM = 0.896
SEM = SD * ( 1 − ICC )
SEM = 6.833 * ( 1 − 0.958)
SEM = 1.411
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7.4.4 SEm in the literature 
The literature provides SEm for hand held dynamometers as follows; Brogårdh et al 2015) noted 
in testing 28 patients with polio weakness of the upper limb using a Biodex System 3 PRO dyna-
mometer (Biodex Medical Systems, Inc, Shirley, NY) the SEM% ranged from 12-16% in measur-
ing isometric elbow flexion. Ekstrand (Ekstrand et al. 2015) using the same equipment in 2015 
measured 45 patients post stroke and found SEm% 5.6-7.6% for elbow isometric flexion con-
traction. Most recently Liu in 2016 (Liu et al. 2016) in a study looking at improving the reliability 
of hand held dynamometers (using the HBO HHD Yueqing Haibao Instrument Co. Ltd., Zhejiang 
Province, China) noted a SEm% in isometric elbow flexion at 90 degrees of 9.8%.  
Thus the theoretical calculated SEm is in the same range as that seen experimentally from this 
data. 
 
7.5 Distribution based approach  
Distribution-based approaches to determining MCID scores are based on the statistical charac-
teristics of published sample populations (and in turn on statistically significant changes in rela-
tion to the probability that the change has occurred by chance). One advantage of distribution 
based methods is the ability to account for change beyond some level of random variation. Con-
versely, a weakness of distribution-based methods is that there are few agreed upon bench-
marks for establishing clinically significant improvement (MCID)- a circular argument for our pur-
poses.  
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It is also important to recognise that distribution based methods do not address the question of 
the individual patient’s perspective of MICD which is distinctly different from statistical signifi-
cance across a population. Thus this method will produce an MCID which is applicable only In 
certain situations – studying population change for example. 
 
7.5.1 Method 
In order to demonstrate the spread of published outcomes using a continuous measure a litera-
ture search An electronic search of three databases was undertaken (performed on October 18, 
2017,) including Medline (1946-present), EMBASE (1974-present), and the Cochrane Central 
Register of Controlled Trials. The search strategy used the following MeSH terms: “brachial 
plexus”, “nerve transfer”, and “wounds and injuries”. Studies were initially screened for inclusion 
based upon titles and abstracts. If eligible, the full-text article was obtained and a final decision 
on inclusion was made. The bibliographies of included studies were also checked for additional 
citations. Inclusion criteria were studies evaluating intra- or extra-plexal nerve transfers to the 
musculocutaneous nerve or its distal branches to biceps and/or brachialis to restore elbow flex-
ion in patients with traumatic brachial plexus palsy. Minimum follow-up had to be twelve months 
and surgery had to be performed within one year of injury. The primary outcome of interest was 
a continuous measure of elbow flexion strength, such as kilogram force (Kgf). If this was not re-
ported, we recorded the absence of such data, but included the study if it measured our sec-
ondary outcomes of interest, including the MRC grade and elbow range of motion (ROM). Out-
come data from eligible studies were extracted from the latest follow-up in all studies. Exclusion 
criteria included obstetrical brachial plexus birth palsies, paediatric patients, nerve transfers re-
quiring an intervening nerve graft, cadaveric or non-human studies, isolated case reports, litera-
ture reviews, technique descriptions, expert opinions, and non-English articles. Studies were 
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also excluded if individual data for elbow flexion neurotization could not be extracted from the 
article. 
After performing the above searches 46 papers were identified. These papers were searched for 
outcomes quoted and a further 8 papers were identified from the bibliographies within these 
publications. All 46 papers reported MRC grade outcomes. The table below shows the studies 
that quoted a continuous measure of force. In order to arrive at a weighted summated average 
of the results published in the highlighted papers (highlighted in grey in figure 7.11) the following 
calculation was followed based on research methodology advisory publications (Bravata and Ol-
kin 2001, Wan et al 2014). 
 
Thus the following weighting of means was applied: 
Mean of total group reported = (n1*X1+n2*X2)/(n1+n2) 
Having made these assumptions, the following equation was used:  
n1= No. of observations in 'paper 1' 
n2= No. of observations in ‘paper 1' 
X1= mean of results in ‘paper 1’. 
X2=mean of results in ‘paper 2’. 
 
The following equation was to assess combined group variance:  
Variance of total group = n1*(S12+d12)+n2*(S22+d22)/(n1+n2) 
n1= No. of observations in ‘paper 1' 
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n2= No. of observations in ‘paper 1' 
X1= mean of ‘paper 1’. 
X2=mean of ‘paper 2’. 
S12= variance of ‘paper 1’. 
S22= variance of ‘paper 2’. 
d1 = X1-mean of total group  
 d2 = X2-mean of total group 
 
The resultant weighted population mean and SD have been used to calculate a figure for MCID 
in a number of ways by Wright et al (2012). Wright in reviewing the literature describes a distribu-
tion based approach where the MCID is defined as follows. 
 
Where X is set 1 for small effect, 1.96 for moderate or 2.77 for large effect. The calcuation 
performed below utilises the figure of 2.77 (but also quotes the range of outcomes rom 1-2.77).   
Wright (2012) also decribes an aproach where 0.05 x SD is used quoting  arguments that an 
effect size of 5% is often consdiered a moderate effect. This approach is also calucated below. 
 
 
 
 
108 
7.5.2 Results 
Paper number of 
patients 
Donor Force recorded 
Minami 1987 17 ICN - 
Kawai 1988 24 ICN - 
Nagano 1989 146 ICN - 
Nagano 1992 64 ICN - 
Chuang 1993 66 ICN 2.5kgF 
Thomeer 1993 9 ICN - 
Malessy 1993 7 ICN - 
Oberlin 1994 4 Ulnar - 
Krakauer 1994 8 ICN - 
Ruch 1995 17 ICN - 
Songcharoen 1995 21 ICN - 
Ogino 1995 10 ICN - 
Leechavengvong 
1998 
32 Ulnar 2.7±1.8kgF 
Brandt 1993 4 MP - 
Malessy 1998 25 ICN - 
Waikakul 1999 75 ICN - 
Okinaga 1999 5 (vasc) ICN - 
 6 (contr) ICN - 
El-Gammal 2002 20 ICN - 
Novak 2002 6 TDN - 
Sungpet 2003 36 Ulnar 1.8kgF 
Xu 2002 15 Phrenic - 
Sungpet 2003b 5 Median 2.5kgF 
Chalidapong 2004 19 ICN - 
Bertelli 2004 12 Ulnar - 
Bertelli 2004 10 Ulnar - 
Teboul 2004 32 Ulnar 2.6±2.5kgF 
Mackinnon 2005 6 Ulnar/Med - 
Liverneaux 2006 10 Ulnar/Med 3.7±2KgF 
Nath 2006 40 Median - 
Leechavengvongs 
2006 
15 Ulnar 2.6±2KgF 
Goubier 2007 5 Ulnar/Med 6KgF 
Stockinger 2008 1 Med pec - 
Venkatramani 2008 15 Ulnar - 
Bhandari 2008 23 Ulnar - 
Zyaei 2010 10 Ulnar - 
Coulet 2010 17 ICN 3.1±1.7KgF 
 23 Ulnar 4.5±2.5KgF 
Bertelli 2010 7 Ulnar 5.2±1.4KgF 
Kakinoki 2010 8 Ulnar - 
 8 ICN - 
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Bhandari 2011 26 Ulnar/Med 5.7±1.3KgF 
 21 Ulnar/Med 5.8±1.5KgF 
Ray 2011 29 Ulnar/Med - 
Carlsen 2011 23 Ulnar 8.94±5.92Nm 
 32 Ulnar/Med 12.54±11.76Nm 
Estrella 2011 9 Ulnar/Med 2.7±1.6 KgF 
Suzuki 2011 8 Ulnar - 
Dolan 2011 12 Ulnar - 
 9 Ulnar/Med - 
Naito 2012 4 Ulnar - 
Socolovsky 2012 18 Ulnar 4.4±2.5KgF 
Martins 2013 20 Ulnar 4.14±3.27KgF 
 20 Ulnar/Med 5.6±2.41KgF 
Soldado 2014 5 TDN - 
Cho 2013 8 Ulnar - 
 15 Median - 
Schreiber 2014 21 (normal 
EMG) 
Ulnar - 
 6 (affected 
EMG) 
Ulnar - 
Xiao 2014 30 ICN - 
Socolovsky 2014 40 Ulnar 5.8KgF 
Cho 2015 19 ICN - 
Yi-Jung Tsai 2015a 16 ulnar nerve 4.3±2.7KgF 
Yi-Jung Tsai 2015b C5-C6 (9) ulnar nerve - 
 C5-C7 (9) ulnar nerve - 
Quick 2016 26 Ulnar 7.2±3.3KgF 
Frueh 2017 6 ulnar nerve - 
Figure 7.9: 
results of a literature review of papers reporting results for re-innervation of elbow flexion. Those highlighted in 
gray are assessment of Oberlin transfers which quoted a continuous measure of elbow flexion force. An elec-
tronic search of three databases was performed on October 18, 2017, including Medline (1946-present), EM-
BASE (1974-present), and the Cochrane CentralRegister of Controlled Trials. The search strategy used the fol-
lowing MeSH terms:“brachial plexus”, “nerve transfer”, and “wounds and injuries”. Inclusion criteria were studies 
evaluating intra- or extra-plexal nerve transfers to the musculocutaneous nerve or its distal branches to biceps 
and/or brachialis to restoreelbow flexion in patients with traumatic brachial plexus palsy. Exclusion criteria in-
cluded obstetrical brachial plexus birth palsies, pediatric patients, nerve transfers requiring an intervening nerve 
graft, cadaveric or non-human studies, isolated case reports, literature reviews, technique descriptions, expert 
opinions, and non-English articles. Studies were also excluded if individual data for elbow flexionneurotization 
could not be extracted from the article. 
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Figure 7.10:  
Free body diagram of force vectors around the elbow; from (Lucas et al. 2011) 
 
The following papers were selected as they reported continuous force outcomes (figure 7.8).  
(Chuang et al. 1993, Leechavengvongs et al. 1998, Sungpet et al. 2003Tebul 2004, Liverneaux et 
al. 2006, Leechavengvongs et al. 2006, Coulet et al. 2010, Bertelli & Ghizoni 2010, Bhandari 
2011, Carlsen 2011, Estrella 2011, Scolovsky 2012, 2014,  Martiins 2013, Tsai 2015)  
The papers reporting ICN transfers were further excluded to arrive at a meta-analysis on the out-
comes for Oberlin (or double) Oberlin transfers (figure 7.10) 
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One paper (Carlsen et al. 2011) reported force  in Nm; this was converted to Kg Meters 
(1Nm=0.10187KgMeters) then as per the biomechanical analysis in (Lucas et al. 2011) [Figure 
7.10]. Then divided by 4, then multiplied by 35.5, to approximate the force likely to be measured 
at the radial styloid (assuming all elbow flexion function is via biceps). The subsequently derived 
data (8.09KgF and 11.27KgF) were both noted to be  significant outliers. In that small changes in 
the multiplication value in the calculation is likely to produce a significantly different values for 
the mean these synthesised results were excluded from further analysis (figure 7.10). 
Chuang 1993 66 ICN 2.5kg 
Leechavengvong 
1998 
32 Ulnar 2.7±1.8kg 
Sungpet 2003 36 Ulnar 1.8kg 
 5 Median 2.5kg 
Teboul 2004 32 Ulnar 2.6±2.5kg 
Liverneaux 2006 10 Ulnar/Med 3.7±2kg 
Leechavengvongs 
2006 
15 Ulnar 2.6±2kg 
Goubier 2007 5 Ulnar/Med 6kg 
Coulet 2010 17 ICN 3.1±1.7kg 
 23 Ulnar 4.5±2.5kg 
Bertelli 2010 7 Ulnar 5.2±1.4kg 
Bhandari 2011 26 Ulnar/Med 5.7±1.3kg 
 21 Ulnar/Med 5.8±1.5kg 
Carlsen 2011 23 Ulnar 8.94±5.92Nm 0.912 
KgM 
8.09 KgF 
 32 Ulnar/Med 12.54±11.76Nm 1.27KgM 11.27 KgF 
Estrella 2011 9 Ulnar/Med 2.7±1.6 kg 
Socolovsky 2012 18 Ulnar 4.4±2.5kg 
Martins 2013 20 Ulnar 4.14±3.27kg 
 20 Ulnar/Med 5.6±2.41kg 
Socolovsky 2014 40 Ulnar 5.8kg 
Yi-Jung Tsai 2015a 16 ulnar nerve 4.3±2.7kg 
Quick 2016 26 Ulnar 7.2±3.3kg 
Figure 7.11:  
Tabulation of those identified as reporting continuous measures of force for elbow flexion. Papers included in the 
analysis in the text are highlighted in grey. Those excluded (in white): Chuang 1993 & Coulet 2010 excluded from 
the analysis of Oberlin as they were ICN transfers. Carlsen 2011 also excluded as the reported values were in 
Nm (shown in the table is an attempt at conversion towards KgF as discussed in the text.) 
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In order to arrive at a weighted summated average of the results published in the highlighted pa-
pers (highlighted in grey in figure 7.11)  the following calculation was followed based on research 
methodology advisory publications as supported by Bravata and Olkin (2001) and  Wan et al 
(2014). 
Thus the following weighting of means was applied- 
Mean of total group reported = (n1*X1+n2*X2)/(n1+n2) 
Having made these assumptions the following equation was used:  
n1= No. of observations in 'paper 1' 
n2= No. of observations in ‘paper 1' 
X1= mean of results in ‘paper 1’. 
X2=mean of results in ‘paper 2’. 
 
(32*2.7) + (36*1.8) + (5*2.5) + (32*2.6) + (10*3.7) + (15*2.6) + (5*6) + (23*4.5) + (7*5.2) + (26*5.7) + 
(21*5.8) + (9*2.7) + (18*4.4) + (20*4.14) + (20*5.6) + (40*5.8) + (16*4.3) + (26*7.2) = 
 
Mean = 86.4 + 64.8 + 12.5 + 83.2 + 37 + 39 + 30 + 103.5 + 36.4 + 148.2 + 121.8 + 24.3 + 79.2 + 
82.8 + 112 + 232 +68.8 + 187.2 = 1549.1 / 361 
Mean outcome from reported papers for elbow flexion following Oberlin outcome = 
4.29KgF 
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To arrive at a weighted summated SD of these reports the following assumptions were made 
(Wan et al 2014) 
• The quoted +/- ranges were 2SD ranges (thus they were halved and then squared to 
create the variance) 
• Those without ranges quoted were assumed to have a SD of the average for the group. 
 
Having made these assumptions a similar process was undertaken to calculate the weighted 
spread of the results. 
For this, the following equation was used :  
Variance of total group = n1*(S12+d12)+n2*(S22+d22)/(n1+n2) 
n1= No. of observations in ‘paper 1' 
n2= No. of observations in ‘paper 1' 
X1= mean of ‘paper 1’. 
X2=mean of ‘paper 2’. 
S12= variance of ‘paper 1’. 
S22= variance of ‘paper 2’. 
 d1 = X1-mean of total group 
 d2 = X2-mean of total group 
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32 (0.81 +4.29) + 36 (0.81 +4.29) + 32 (1.56 +4.29) + 10 (1 + 4.29 ) + 15 (1 + 4.29) + 23 (1.56 + 
4.29) + 7 (0.49 + 4.29) + 26 (0.4225 + 4.29) + 21 (0.5625 + 4.29) + 9 (1.8225 + 4.29) + 18 (1.5625 
+ 4.29) + 20 (2.67 + 4.29) + 20 ( 1.452 + 4.29) + 16 (1.8225 + 4.29) + 26 (2.7225 + 4.29)  / 311 
 
163.2 + 183.6 + 187.2 + 52.9 + 79.35 + 134.55 + 33.46 + 122.525 + 101.9025 + 55.0125 + 
105.345 + 139.2 + 114.84 + 97.8 + 182.325 / 311 =  
1747.21/331= 5.27  
Thus SD = Square root of 5.27 = 2.2956 
SD = 2.3 
 
Thus the average outcome from reported papers for elbow flexion following Ober-
lin outcome is  4.29KgF +/- 4.59Kg (range of 0 - 8.88KgF) 
 
 
In order to calculate MCID from this calculated weighted population data the following 
calculations have been applied:  
 
 
Where X is set at 1 for a small effect and 1.96 for moderate and 2.77 for a large effect and the 
test–retest intra-class correlation coefficient (ICC) of stable patients is used for r. The larger ef-
fect size has been  
Thus: 
 MCID = 2.77 x 2.3 [Sq Root(1-0.941) 
MCID = 2.77 x 2.3(0.243)  
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MCID as related to the spread of data in the published series is: 
MCID = 1.54KgF 
(If the effect size had been deemed small and the X set at 1 the MCID would = 0.56KgF) 
 
Statistical method (MCID = 0.5SD) 
It has been argued in published work (Wright 2012) that a figure for MCID could be 5% of 
the SD of the population Standard deviation.  
 
the change here being the development of force of elbow flexion ie = mean force 
MCID=  0.5 (2.3) 4.29KgF 
MCID as calculated as p= 0.5 is: 
MCID = 4.9KgF 
7.6 Conclusions 
The stated aim in this study was to establish a valid range for MCID in force of elbow flexion fol-
lowing muscle re-innervation nerve transfer surgery. Thus supporting a move towards an objec-
tive, measurable threshold that is patient-centred when aiming to improve motor outcomes. It 
has been shown (in Table 7.1) that a range of MCIDs may be applicable, from 0.65KgF-6.5KgF. 
This is a variation of an order of magnitude. This relates from a 10% change (as calculated from 
SEm to a 90% difference as assessed by patients. Such a spread of values is often reported in 
publications undertaking similar methodologies.  
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The figures quoted relate to population figures; they are suitable for application in trial design (al-
lowing a power analysis to be properly calculated) or to support QUALY information. They do 
not relate to the impact of the operation of re-innervation of muscle following nerve injury in indi-
viduals. An individual MCID will be unrelated to the methods used in this study (other than the 
anchor question – but this again is a summation of a large range of individual responses). 
There is no literature specifically relating to this area previously published and as such its rela-
tionship with other data cannot be directly explored. These data are applicable to any study as-
sessing any improvement in outcome from an Oberlin nerve transfer as they inform the discus-
sion as to what the minimal change any study should be powered to demonstrate. 
Methods such as these demonstrated in this chapter should be applied with a recognition of the 
need to identify not just the success of realising a reliable change but combine this with a crite-
rion for clinical significance. “Better” is defined by MCID; the realm of how much ‘better’ should 
be calculated using one of these methods-  an anchor-based approach, a meaningful percent 
change criterion, or statistical criteria for clinical significance. In this way change is identified 
correctly as reliable and clinically significant. 
 
7.7 Discussion  
In using SEm% to calculate a MCID Wyrwich (2004) noted that to attaining a 1.96 or 2.77  SEm 
threshold for classifying important improvements in abnormal individuals (Jacobson et al. 1999), 
while others consistently advocate that 1 SEm is the crucial minimum threshold for demonstrat-
ing individual change (Schaie & Willis 1986). If we look at our calculated SEm from our study 
then we note that a range 2.77-3.9Kg as a MCID (calculated as 1.96-2.77 x SEm) provides on 
our study population mean range of 27-53%. 
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It is not uncommon that such a variation in MCID is found even in one study Terwee et al. (2010) 
found five different MCID scores, ranging from 24.2 to 18.9 points (with 95% of the values lying 
between 214.9 and 13.8) for the WOMAC physical function subscale when using five different 
MCID methods much in the same way as this paper. One possible explanation is that different 
MCID methods result in different MCID scores due to the multiple reported conceptual and 
methodological differences   
Whilst the SEm method has been supported by many experienced authors in this area it is sig-
nificantly challenged in this area of technological advancement as with improvement in technol-
ogy it is likely that internal standard errors of measurement decrease and thus the SEm will devi-
ate from any historic values. 
The aim of MCID studies is to provide a unique threshold value, whereas, ironically, the different 
methods by necessity produce a range of MCID values. Anchor-based methods will produce dif-
ferent MCID depending on the criterion scale and the arbitrary selection or grouping of scale lev-
els. Conceptually, a minimal difference is a difference between two adjacent levels on a scale, 
such as ‘‘unchanged’’ and ‘‘slightly better.’’ MCID would then depend on the number of levels 
on a scale: the larger the number of levels, the smaller the difference between two adjacent lev-
els, and the smaller the MCID. Ostelo et al. (2008) supported this premise when the authors re-
ported a wide range of MCID scores on commonly used back pain outcome measures. In this 
study, the reported MCID score for the Oswestry disability index reportedly ranged from 2.0 to 
8.6 points on a 100-point scale. 
It is interesting to consider the potential  uses that an MCID value would to be put to: All of the 
methods used in this study produce a population MCID other than the anchor question. From 
this data the MCID may properly be deployed to inform the calculation of a power assessment in 
study design or assess efficacy of an intervention for assessment of health economics (QUALY 
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calculation etc). However it speaks little to the experience of any particular individual. For the in-
dividual the range of MCIDs is reflected in the raw data of the subjective study (from 0.3Kg – 
15Kg). Thus it is important to recognise the method utilised to arrive at any MCID prior to apply-
ing to any specific use. 
The definition of MCID requires some further thought when the intervention is surgical. We ac-
cept Jaeschke’s definition (1989) for MCID but feel the addition of the concept of minimal clinical 
acceptable difference (MCAD) is also important. The ratio MCID: MCAD would reflect the per-
ceived inherent risk of the intervention under discussion. If it were a physical therapy inervention 
then MCID and MCAD would near a 1:1 relationship. If it were to be a life essential intervention 
(organ transplant for example) then the ratio would drop hugely with the difference in symptoms 
thought to be noticeable would be tempered by what the patient was willing to risk to gain any 
improvement. In this field of study the MCID for nerve transfer surgery and augmentation of that 
outcome with drug therapy may be similar but MCAD for each would be different. (MCAD= per-
ceived risk vs perceived benefit of MCID.) 
To progress this project it is intended to prospectively collect data as patients renervate their bi-
ceps and thus follow the subjective peak force from not being able to lift the arm to being able 
to lift weight and link this with subjective scores of satisfaction and assessment of impact per-
centage scoring. We intend to compare this peak power change (as patients improve over time) 
with the receiver operating characteristic curve (ROC) to determine the change in score of the 
patient reported outcome (PRO) with the smallest difference between sensitivity and specificity 
to identify MCID. The area under the curve (AUC) represents the ability of the chosen MCID 
value to correctly discriminate improved and non-improved patients, with AUC values approach-
ing 1.0 representing excellent discrimination. This methodology will allow a more dynamic as-
sessment of the range for individual’s rate than the population scores we have assessed here 
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between what threshold is clinically important for a cohort. It could be that the peak force as-
sessment is not a valid tool to assess outcome; that is not seen by patients as directly repre-
senting a clinical difference. 
Further the implication of heath economics to the landscape of outcome assessment is key to 
the political environment we all practice thus we offer a quantification of MCID to QALY value. 
The interplay of the involvement of these has never been addressed as far as can be seen from 
a literature review. 
Whilst the information on MCID for maximal volitional contraction is likely to be helpful in design-
ing future trials, the greatest benefit from this process to the author has been to realise the com-
plexity of the patient experience in nerve injury recovery. The truth of assessing recovery from 
nerve injury is that recovery of full motor function can be useless to the patient if there is debili-
tating allodynia or parasthesia. Motor power assessment without an assessment of propriocep-
tion and fatigability and control can be meaningless. To this end we have set out to build a 
stream of research towards combining the objective assessments with a global subjective expe-
rience of recovery from nerve injury. We can then start to build a picture of which interventions 
benefit which aspects of nerve injury, what percentage improvement can be expected and at 
what risk to which population. It will also provide a view of the true benefit of our interventions 
against which we can grade improvements in the treatment available. i.e. if a new drug or proce-
dure is used what level of improvement is gained. Furthermore, the minimum quantum of im-
provement that is noticed or valued by individual patients is not known. 
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8. 
Does recovery of peak force correlate 
with patients’ perception of outcome? 
Subjective assessment of successful re-innervation leading to return of elbow flex-
ion. 
 
8.1.1 Overview  
Oberlin et al (1994) described a nerve transfer to renervate elbow flexion and thus improve arm 
function. It is performed with the aim of returning sufficient elbow flexion force to lift weight. Tra-
ditionally, surgical success is measured by the return of power and assessed by Maximal Peak 
Force (MPF) but is this outcome, in isolation, significant to patients?  
This study has been designed to explore whether peak power is a parameter that is meaningful 
to the patient. Patient satisfaction with outcome is often complicated and can include aspects 
such as: what an individual anticipated to achieve and what has made a difference to their day 
to day function.  
To the authors’ knowledge there has been no published data on subjective assessment and in 
particular, the patient’s opinion of their outcome following an Oberlin procedure.  
8.1.2 Method 
Study participants were recruited from the hospital database and comprised of 18 patients who 
were at least 24 months post double Oberlin transfer. The study received institutional ethical ap-
proval and informed consent was given by all participants.  
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A mixed methods approach was adopted whereby the cohort underwent a quantitative assess-
ment (maximal peak force (KgF) and completed a subjective questionnaire regarding the pa-
tient’s view of their individual recovery.  
This study set out with the null hypothesis (H0) that patient satisfaction with outcome would be 
directly related to the level of recovery of elbow flexion force (as measured by peak power). 
Ethical approval was gained from the NHS ethical board after IRAS application.  
 
8.1.3 Results 
Despite Maximal Peak Force (MPF) being the most commonly assessed outcome following 
nerve transfer surgery is shown to not be a responsive or representative outcome measure to 
reflect the patient experience of muscle re-innervation. There was no significant correlation be-
tween the commonly used outcome measure of peak power and the patient’s perception of the 
impact on their life (R 0.488 with a non-significant level of evidence p= 0.108).   
Patients significantly under-estimate the outcome of surgery as assessed by a comparison of 
the subjective assessment and objective measurement of elbow flexion peak force. There is sig-
nificant correlation between the patients’ assessment of their current function and expectation 
attainment. Whereas, objectively measured force was strongly correlated with patients’ assess-
ment of difference (r=0.619 P=0,006). 
Patient satisfaction levels were universally high with 100% of respondents reporting that they 
would both recommend the operation to others and undergo the same procedure if they were 
back in the same situation. As all patients had regained power of elbow flexion as was the aim of 
the operation this is not surprising. Of the cohort 11/16 (61%) rated the impact as having had 
made a huge difference to them.  
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It is thus demonstrated that patients do notice the difference of having greater peak force but do 
not translate that into their assessment of impact. 
8.1.4 Conclusion 
Satisfaction with this nerve transfer operation to renervate elbow flexion shows no correlation 
with how much force (KgF) against gravity the biceps muscle can provide. When correlation was 
sought between a range of subjective assessment questions and force outcome there was some 
degree of face validity when using peak force as an outcome measure. However, this study be-
gins to provide some evidence to support the necessity of a multimodal assessment to reflect a 
complicated picture of motor recovery. There is no related literature in the field of nerve injury on 
which to reflect. 
 
8.2 Introduction 
Loss of active elbow flexion creates a considerable deficit in function. Activities such as hand to 
mouth for feeding and hand to midline to allow for independent dressing are commonly reported 
functional goals. Nerve injuries to the upper trunk, lateral cord and musculocutaneous nerve can 
all result in the loss of active biceps contraction.  
 
8.3 Measurements of surgical outcome 
Traditionally, clinicians have used maximal peak force (measured by MRC grade) as a primary 
outcome measure. Hand Held Dynamometry (HHD) has been identified as a method to give a 
valid and continuous numerical value to force outcome assessment. A previous study within our 
institute examined the maximal force outcomes following Oberlin Transfer using HHD (Quick et 
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al. 2016). The benefits of ease of use and utility within a clinical environment were also high-
lighted. The results produced a continuous metric of KgF normally distributed around 7.2KgF for 
this patient group (Quick et al., 2016). Data was consistent with a previous study which  reported 
strength to be around 1/3 that of the uninjured contralateral limb (Carlsen et al. 2011). HHD 
therefore seems to be a useful method to measure peak force outcome within this cohort.  
Within the clinic environment it is common for many postoperative patients to report pain, fa-
tigue and difficulty placing the arm to be limiting factors to their everyday life. Anecdotally the 
weight they can lift in a single maximal contraction is seldom raised as an issue. Nevertheless, in 
the literature it is peak force that is almost universally used to assess outcome of muscle rener-
vation procedures. 
The World Health Organisation (WHO) developed the International Classification of Functioning, 
Disability and Health (ICF) as a framework for measuring health and disability at both individual 
and population levels (WHO, 2001). In this framework both muscle function and the person’s 
perceptions are considered alongside their ability to participate in everyday activities. This re-
flects the change in modern day healthcare where patient perceptions and satisfaction are con-
sidered with equal status to a clinician’s “objective” outcome. Recent analysis of outcome fol-
lowing nerve injury has endorsed the use of patient-reported outcomes and functional assess-
ments (Novak et al. 2009, Ahmed-Labib et al. 2007, Kitajima et al. 2006).  A literature search on 
subjective and patient reported outcome measures (PROMs) of Oberlin transfer or nerve transfer 
produced no results. This represents a significant void in the literature.  
Information regarding patient reported outcome in Oberlin transfer could provide a framework 
for clinicians to better tailor their assessment towards patient experience. Furthermore, the as-
sessment of patient experience may thus provide information on how to improve patient satis-
faction with their care. 
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8.4: Aims, objectives & Methodology 
8.4.1 Study question: 
− Is there a positive correlation between an individual’s reported satisfaction with their out-
come and the amount of elbow flexion strength that is regained following renervation 
surgery? 
8.4.2 Aims:  
1. Identify a cohort of Oberlin transfer patients with documented MRC grade 4 recovery of 
elbow flexion at greater than 2 years post-operatively. 
2. Design and administer a questionnaire to assess patient perception, expectation and 
satisfaction with surgical outcome. 
3. Carry out a standardised peak force assessment using HHD for comparison with the 
subjective findings from the questionnaire. 
8.4.3 Objectives:  
1. To use a mixed methods format to gain information on the impression patients had of 
their outcome.  
2. To collect patients’ assessment of their own peak power and whether they thought they 
had attained their original expectation of outcome. 
3. To assess if patient satisfaction correlated with the degree of muscle strength of elbow 
flexion or attainment of preoperative expectation. 
4. To assess a cohort of patients to assess whether difference within attainment of peak 
power outcome is reflected in satisfaction  
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8.5 Hypotheses 
Null Hypothesis (H0): Patient assessment of satisfaction in their outcome is directly related to 
their recovery of force (as measured by Maximal Peak Force).  
Primary Hypothesis (H1): Patient assessment of satisfaction in their outcome is not directly re-
lated to their recovery of force (as measured by Maximal Volitional Force).  
 
8.6 Materials and Methods 
Ethical approval was gained from the NHS ethical board after IRAS application.  
 REC reference:  16/LO/0623 
 IRAS project ID:   202847  
 
The hospital database was examined to identify patients who were at a point greater than 24 
months following Oberlin nerve transfer. These individuals were then further reviewed against 
the inclusion and exclusion criteria which included documented recovery of a minimum of MRC 
grade IV within their medical records (full criteria is outlined in Table 8.1). Sixty-two patients were 
identified as being eligible to participate in the study. All participants were contacted by post 
with a letter to invite them to complete an online questionnaire and to attend a clinical review. If 
no response was received after one month a second invitation letter was sent. A total of 18 pa-
tients were recruited in the study; of these 12 participants attended for a force outcome assess-
ment. 
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Inclusion Exclusion 
Oberlin/double Oberlin transfer – treated with 
standard post-operaive regimen 
>24 months post surgery 
Documented activity of elbow flexion of grade 
4 MRC or above from clinical notes 
Adult 18+ 
Oberlin transfer <24months post surgery 
Oberlin transfer >24 months post surgery 
with MRC <3  
Oberlin transfer >24 months post surgery 
proceeded to free functioning muscle trans-
fer 
Child (0 -18 years) 
Figure 8.1: 
 Inclusion / Exclusion criteria. 
The time period of 24 months post surgery was chosen by consensus agreement between the 
researchers as a suitable period for full motor recovery to have occurred. Clinically, after this 
time, there is very little evidence of further renervation. All patients underwent a standard regi-
men of post operative rehabilitation; an initial immobilisation period of 6 weeks followed by a 
milestone driven process of passive mobilisation, active movement and strengthening when 
signs of renervation returned.  
A mixed methods approach was adopted whereby a subjective qualitative questionnaire focus-
sing on satisfaction and participant’s opinions relating to their motor recovery was compared to 
an objective quantitative maximal force outcome measured using a HHD (Biometrics Ltd, 
Cwmfelinfach Wales). 
 
8.6.1 Stage 1. Subjective data collection 
The qualitative questionnaire was designed by the researchers (TQ, HB and KJ) utilising a mixed 
approach of discrete, framework supported and Likert questions to pose questions around the 
concepts of interest (impression of current function, expectation of function, minimal accepted 
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expectation of function, impression of change and impact of change). These were then devel-
oped into an online ‘Google forms’ survey (Google Inc. Mountain View, California, United States). 
The questionnaire commenced with an animated video of an isolated elbow flexion motion to fo-
cus the mind of the responder. Additional text was provided to direct respondents to solely con-
sider elbow flexion as they answered the questions. In order to gather as much information as 
possible tick box, Likert scales and free text entry functions were utilised.  
 
 
Figure 8.2:  
 Screen grab from Google Forms assessment tool questionnaire. 
 
The questionnaire focused on various elements of recovery to explore different dimensions of 
patient experience. The themes included patient/participants’ assessment of their current force 
of elbow flexion, a percentage assessment of their overall elbow function, their hopes preopera-
tively, their minimum expectation and their impression of change following the renervation and 
the impact this change has had. Finally, standard frequently used questions, such as those in 
128 
the Friends and Family test (NHS England 2014), guided questions towards the subjects’ per-
ception and finally satisfaction of their outcome (for example; would they recommend the sur-
gery to others? and would they chose to have the surgery again?). 
 
8.6.2 Stage 2. Objective Quantitative data 
In order to anchor the answers to the questionnaire 12 of the 18 patients (67%) agreed to attend 
an assessment of their maximal peak force MPF. This assessment was carried out by 2 experi-
enced therapists (HB and KJ). The assessment protocol utilises a HHD (Biometrics Ltd, Cwmfe-
linfach Wales) and is described in a previous publication (Quick et al. 2016).  During this assess-
ment; participants were asked to relate and disclose the maximal weight in kilograms that they 
believe that they can lift using their biceps muscle (i.e. elbow flexion). These were related to eve-
ryday objects (such as: 2kgs is approximately a four-pint bottle of milk and 5kgs approximately 
the weight of a vacuum cleaner). The validity of the test is shown by inter-observer R= 0.958 and 
intra-observer reliability R=0.941 of the test is documented in figures 7.8 and 7.9. 
 
 
 
 
 
 
.  
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 Question: Question focus:  Quantification 
Q1 How much are you currently able to 
bend your elbow? 
Current function/ Subjective 
assessment 
Discrete; statements de-
scribing MRC  
Q2 Before surgery I would have realistically 
hoped to… 
 
Pre operative Expectation/ 
Hope 
Discrete; statements de-
scribing MRC 
 Q2b ..be able to lift the following with oper-
ated arm alone. 
Discrete KgF with anchor 
statements 
Q3 Before surgery I would have agreed to 
go ahead only if I could have realistically 
expected to… 
Minimum Expectation Discrete; statements de-
scribing MRC 
 Q4 A normal elbow is one which is pain-
free, has full range of movement, normal 
strength and allows you to do what you 
feel your elbow should allow you to do 
this is scored at 100% (10/10). 0/10 is 
no function. How would you score your 
elbow? 
 
 
SPONEA 
Percentage assessed  
function with definition of 
range 
Q5 How much do you think that your elbow 
function has improved since your sur-
gery? 
Impression of Change/ Im-
provement 
Likert scale with each 
point defined  0-6  
Q6 What difference has this operation made 
to you? 
Impression of Impact/Differ-
ence 
Likert scale with end 
points defined  0-6 
Q7 Would you recommend this operation to 
somebody else (who has had the same 
injury as you) to improve their ability to 
bend their elbow? 
 
Satisfaction 
 
Binary Y/N 
Q8 With your current knowledge, if we were 
to take you back in time to before the 
operation would you say yes to the offer 
of an operation to gain movement in 
your elbow? 
 
Satisfaction 
 
Binary Y/N 
Figure 8.3.  
Summary of focus of subjective asessment tool questions. 
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8.7   Results: 
18 patients (15 Male and 3 Female) consented to participate in stage one of the study (qualita-
tive questionnaire). Of these, 12 (10 males and 2 females) proceeded to stage two (quantitative 
muscle force assessment). The mean age of the participants was 45 years (27- 69 years old). 
Right hand dominance (RHD) was reported in 16 participants with the remaining 2 being left 
handed (LHD). Injured dominant side 10, non-dominant 8 (dominant 5, non-dominant 7) The 
days since injury at time of assessment were an average of 2704.17 (range 642-7227). Full re-
sults and demographics are presented in Figure 8.4. 
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Participant Gender Age Injured 
side 
Injured 
side 
Injury Op date Peak   
Force 
(Kgf) 
SPONEA 
(/10) 
1  M 47 L ND Avulsion C5/6 27/08/14 7.73 7 
2  M 27 L ND Avulsion C5  
Rupture C6 
02/10/15 16.27 7 
3  M 27 L ND UT neuroma 23/01/15 8.92 5 
4  F 69 L ND UT neuroma 17/09/10 6.33 5 
5  M 52 L ND UT neuroma 30/09/11 6.83 5 
6  M 44 L ND C5 Avulsion 
C6 neuroma 
23/05/14 9.57 1 
7  M 51 R D Avulsion C5/6 15/06/09 12.3 4 
8  F 47 R D Tumour 
upper trunk 
06/07/98 3.12 1 
9  M 36 R D Avulsion C5/6 27/08/10 5.36 4 
10 M 53 R D MCN Rupture 
Humeral frac-
ture 
23/08/96 10.38 5 
11  M 43 L D Avulsion C5/6/7 
+/-8 
17/10/14 4.65 3 
12  M 50 L ND Avulsion C5/6/7 09/09/09 7.21 5 
13  M 41 R D Avulsion C 5/6 01/09/14  6 
14  M 51 L ND Avulsion C5/6/7 11/02/15  0 
15  M 29 R D Avulsion C5/6 31/01/14  2 
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16 M 26 L D Avulsion C5/6 
Rupture C7/8 
05/03/08  5 
17  F 45 R D MCN iatrogenic  20/11/15  6 
18  M 59 R D MCN Rupture 
Humeral frac-
ture 
15/04/15  7 
Figure 8.4: 
Research Subjects demographics & information (first n-=12 have force data) In the text the numbers quoted first 
(and highlighted in bold) are the group of n=12 who both completed the questionnaire and underwent an objec-
tive assessment of their peak force. 
 
 
 Stage 1. Subjective Outcomes. 
8.7.1 Q1. How much are you currently able to bend your elbow. 
All subjects by selection criteria had recovered MRC grade 4.  
 
Figure  8.5 
.Bar chart representing answers to Q1. “How much are you currently able to bend your elbow?” 
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Current force assessment n=18 MRC 
Equivalent (/5) 
No. 
(/18) 
I am unable to bend my elbow unless I use another part of my body to 
bend it 
1 or 2 1 
I am able to bend my elbow a bit by itself but would not be able to lift 
any weight 
3 3 
I am able to bend my elbow by itself and would be able to lift some 
weight 
4 11 
My elbow can bend to what I consider to be just less than full power 5 3 
Figure  8.6: 
Tabulated results for  Q1. How much are you currently able to bend your elbow? 
 
Commentary on Q1: 14/18 (78%) identified that the restoration of innervation to the elbow flex-
ors has allowed them to lift some weight. This corresponds with at least MRC grade IV classifi-
cation. 4/18 (22%) report that the return of power is insufficient to lift a weight.   
8.7.2 Q2a. Before surgery I would have realistically hoped to... 
 
Figure 8.7: 
Bar chat representation for results for Q2a. Before surgery I would have realistically hoped to … 
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Before surgery I would have realistically hoped to…(Ex-
pectation) 
MRC Equiva-
lent (/5) 
No.(/18) 
Be unable to bend my elbow unless I use another part of 
my body to bend it 
1 – 2 3 
Be able to bend my elbow a bit by itself but would not be 
able to lift any weight 
3 3 
Be able to bend my elbow by itself and able to lift some 
weight 
4 10 
Be able to bend my elbow to what I consider to be just 
less than full power 
5 2 
Figure 8.8: 
 Tabulated representation for results for Q2. Before surgery I would have realistically hoped to … 
 
Q2b. Before surgery I would have realistically hoped to lift the following with the operated 
arm alone.  
Before surgery I would have realistically hoped to lift the following with 
the operated arm alone  
(Expectation) 
MRC 
Equiva-
lent (/5) 
No. 
(/18) 
50gs (approx. the weight of a chocolate bar) 4 1 
100gs (approx. the weight of a tube of tooth paste) 4 0 
300gs (approx. the weight of a small tin of beans) 4 1 
500gs (approx the weight of a small bottle of water) 4 2 
1kg (approx the weight of a litre bottle of water) 4 2 
2kgs (approx the weight of a 4 pint bottle of milk) 4 4 
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3kgs (approx the weight of 3 litre tin of paint) 4 0 
5kgs (approx the weight of a vacuum cleaner) 4 1 
10kgs (approx the weight of a lawn mower ) 4/5? 2 
15kgs (approx the weight of 12 bottles of wine ) 5 2 
Figure 8.9: 
Tabulated representation for results for Qb2. Before surgery I would have realistically hoped to … (n=1 “Depends 
on how much I have trained the muscles” n=1 did not answer                                                                                
n=1 “I can lift a heavy weight but not using biceps”  
 
Table 8.10: 
 Bar chat representation for results for Q2b. Before surgery I would have realistically hoped to … 
 
Commentary on Q2a and b:  
The findings from Q2a MRC questions show that 3/18 (17%) patients hoped to achieve the 
equivalent of MRC grade V (normal or just less than normal – accepting 95-100% being near 
normal and classically classified as MRC 5/5). 11/18 (61%) expected MRC 4/5 power, 3/18 
(17%) hoped for MRC 3/5 and finally, 1/12 (8%) expected MRC 2/5 or less. 
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In Q2b a level of internal dissonance is demonstrated as 15 patients stated they would have 
MRC 4+ power. (n=3 either did not answer or stated they didn’t use biceps to lift a heavy weight 
or they stated “it depends on how much I have trained the muscle”. This distribution tri-modal 
and has an overall mean resonance as 4 KgF the mode is 2kgF.  
 
8.7.3 Q3. Before surgery I would have agreed to go ahead only if I could have realistically 
expected to… 
 
Figure 8.11: 
Bar Chart representation for results for Q3. Before surgery I would have agreed to go ahead only if I could have 
realistically expected to. 
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I would only have gone ahead with surgery if I could have realistically 
 expected  to... n=18 
MRC 
Equiv-
alent 
(/5) 
No. 
(/18) 
Be unable to bend my elbow unless I use another part of my body to bend it. 0  1 
Be unable to bend my elbow unless I use another part of my body to bend it 
BUT be able to feel the muscle responding as if it wanted to work. 
1 – 2 1 
Be able to bend my elbow a bit by itself but would not be able to lift any 
weight 
3 4 
Be able to bend my elbow by itself and would be able to lift some weight 4 12 
Be able to bend my elbow at full power 5 0 
Figure 8.12: 
Tabulated results for Q3. Before surgery I would have agreed to go ahead only if I could have  
realistically expected to… 
 
Commentary on Q3: 
This question aimed to assess a minimal expectation level (what the patient expected as a mini-
mum) in order to give consent to surgery. 12/18 (67%) expected as a minimum to achieve MRC 
grade IV recovery. This is well within the boundaries of any series of Oberlin outcome results. It 
represents a real and attainable expectation. 
It is interesting that 2/18 (11%) would have been happy with no visible functional improvement 
and 6/18 (23%) would have been happy to proceed if they could have as a minimum expected 
no functional improvement.  
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Review of Q1, Q2 & Q3: 
MRC Grade Cohort Actual* 
Outcome 
(Clinically as-
sessed) 
Cohort self As-
sessed 
Present Out-
come 
Cohort Realistic 
Expectation of 
Outcome 
Cohort Mini-
mum Expecta-
tion of Out-
come 
0/5 - - - - 
1/5 - - - 1 
2/5 - 1 3 1 
3/5 - 3 3 4 
4/5 18 11 10 12 
5/5 - 3 2 - 
Figure 8.13: 
Tabulated results for Q1, Q2& Q3. To demonstrate the number of the cohort in each category of MRC force (* 
this cohort was purposefully selected to be MRC grade 4) 
 
Figure 8.14: 
Tabulated results to demonstrate the percentage of the cohort for each category with function (MRC>/=4) (* this 
cohort was selected to be MRC grade 4) (**expectation of an MRC 4+ outcome following Oberlin transfer in non 
selected standard population) 
 
MRC GRADE 
>/ =4/5 
    
Population** 
actual 
Cohort actual* Cohort as-
sessed 
Cohort ex-
pected 
Cohort mini-
mum  
80% 100% 78% 67% 67% 
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Table 8.13 demonstrates the shifting distribution of where the cohort currently believes them-
selves to be (despite a purposeful sample of MRC grade IV being selected for the study). The ta-
ble shows where the cohort had hoped they would be (expectation of outcome) and the spread 
of expectations which they would have considered as a minimum to consent to surgery. Table 
8.14 displays these same concepts as a percentage of the cohort at or above MRC 4 (a com-
monly quoted outcome in the literature).   
In summary, when Qs 1,2 and 3 are reviewed in relation to one another the following can be as-
serted:  
The (retrospectively assessed) expectation or hope of the procedure was for 78% greater than, 
or equal to MRC grade IV. This is in line with published rates of outcome from Oberlin procedure 
and thus represents a realistic expectation.  
However only 14/18 (78%) stated that they thought they had attained MRC grade IV despite be-
ing purposely included in the study based on a documented clinical record of grade IV being 
achieved. 
This suggests that the remaining 22% did not achieve their expected level of strength or force (a 
Negative Expectation Attainment). It may therefore be surmised that subjective impression of 
change is less than the objective observer may think.  
Two thirds of participants expected as a minimum to attain their expectation: The minimum ex-
pectation assessment relates 12/18 hoping for function (elbow flexion >/=MRC IV) and expecta-
tion relates the same figure 12/18 hoping to gain at least some function to lift weight.  
• Interestingly 2/12 patients’ minimum expectation was no functional return whereas 3 
stated they expected they would get no functional return. i.e. 2 subjects were happy to 
go ahead with surgery even if they got no function and one was happy to go ahead only 
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if they could as a minimum expect a flicker of activity but actually realistically expected 
to get no function.  
However, 33% predicted they would not achieve their expectation of the benefit of the operation 
(a negative predicted personal experience: NPPE). 
Objective Anchor comparison with Q2b 
12 participants attended for stage 2 (objective force assessment) the force they generated in ob-
jective testing was compared with what they predicted the maximal weight that they could lift 
with their affected arm. 
Actual current function: (Objective force assessment data) 
n=12:(7.73/16.27/8.92/6.33/6.83/9.57/12.30/3.12/5.36/10.38/4.65/7.2 KgF) mean 78.22 
(range3.12-16.27 ) SD 3.59  
Patient assessed current function (Subjective assessment anchor question)  “At 2 years 
post nerve transfer surgery I am able to lift”: 
The same n=12: (2/15/2/0/0.5/2/depends/10/0.5/0/1/2) Kg mean 3.5 (range0-15 SD 4.94) 
These are two differing groups with differing means:  
A paired samples analysis n=10 (2 predicted values missing thus excluded) shows a difference 
of -4.1Kg between the mean (predicted being lower than actual) with a 95 CI between -7.1 and -
1.1) t-3.044 and significance (2 tailed) of 0.014. That is to say; the average subjective assess-
ment of our patients was to attain a lesser outcome than demonstrated they could lift, or we can 
say there was an average over-attainment or a positive expectation mismatch.  
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Figure 8.15: 
a paired data analysis of Expectation mismatch- blue circles are the value the patients prediction (subjective as-
sessment) and in Green the actual or (objectively) observed KgF of elbow flexion 
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8.7.4 Q4. A normal elbow is one which is pain-free, has full range of movement, normal 
strength and allows you to do what you feel your elbow should allow you to do this is 
scored at 100% (10/10). 0/10 is no function. How would you score your elbow? [SPONEA] 
N=18 
 
Figure 8.16: 
 Bar Chart  results to demonstrate the SPONEA outcome. 
 
N=18 mode 5 mean 4.3 (range0-8) SD 2.14 
Figure 8.17: 
Tabulation of reponses to the SPONEA question. 
SPONEA 
A normal elbow is one which is pain-free, has full range of movement, normal 
strength and allows you to do what you feel your elbow should allow you to do 
this is scored at 100% 
% 10 20 30 40 50 60 70 80 90 100 
N 1 2 1 1 2 6 2 3 0 0 
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Commentary on Q4:  
When the subjective SPONEA is compared with the MPF scores there is a definite relationship 
between the two as demonstrated by a Pearson’s correlation of 0.604 with a two tailed signifi-
cance of 0.008. 
 
Figure 8.18:  
Funnel Scatter plot of SPONEA against Objectively assessed peak force with a linear best fit surrounded by 95% 
CI. 
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8.7.5 Q5. How much do you think that your elbow function has improved since your sur-
gery? 
1. No change (or condition has got worse). 
2. Almost the same, hardly any change at all. 
3. A little better, but no noticeable improvement in my function. 
4. Somewhat better, but the change has made no noticeable improvement in my function. 
5. Moderately better with a slight but noticeable change in my function. 
6. Better with a definite improvement that has made a real and worthwhile difference in my func-
tion. 
7.  A great deal better with a considerable improvement that has made all the difference in my 
function. 
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Figure  8.19:  
Bar chart results to demonstrate impression of change since surgery. Plot of overall satisfaction Likert Scale no 
better (1) – a great deal better (7)- mode = 5 mean= 4.78 
 
Figure 8.20: 
 Tabulated results to Q5.  
 
Commentary on Q5: 
 The mode of 5 represents another facet of the patient experience – “moderately better with a 
slight but noticeable change” and with 12/18 rating the change as noticeable or better. 
 
 
 
Q5. How much do you think that your elbow function has improved since your surgery? 
0- No change 
1- Almost the same hardly any change at all.  
2- A little better, but no noticeable improvement in my function. 
3- Somewhat better, but the change has made no noticeable improvement in my 
function. 
4- Moderately better with a slight but noticeable change in my function. 
5- Better with a definite improvement that has made a real and worthwhile differ-
ence in my function. 
6- A great deal better with a considerable improvement that has made all the differ-
ence in my function 
change 0 1 2 3 4 5 6 
n 0 1 0 2 3 7 5 
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8.7.6 Q6a.what difference has this made from 0 (no difference) - 5 (a huge difference)  
 
Figure 8.21:  
Bar chart results to Q6. Demonstrating the subjective impact of the re-innervation  
(0)- no difference to (5) a huge difference 
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Figure 8.22:  
Bar chart results to demonstrate distribution of difference made 5: huge difference to 0: no difference. N=18 
Mean 4.22/5, Mode 5/5 SD 1.309. 
 
Characterisation of groups by assessment of impact     
     N  Mean Std. Deviation Std. Error Mean 
force of those with impact 5/5  8  9.9600  4.44762 1.81573 
force of those with less than 5/5 8  7.4150  3.43892 1.40393 
Comparison of groups by assessment of impact 
     t n    Sig 2t   Mean Diff    95% CI 
force of those with impact 5/5  5.485 8 p=.003*    9.96000       5.2925-14.6275 
force of those with less than 5/5 5.282 8 p=.003*     7.41500    3.8061-11.0239 
Figure 8.23:  
Comparison of groups by assessment of impact. Two groups were created those who deemed the impact 5/5 (a 
huge difference and those who did not; the peak Force they developed were compared in KgF. 
 
 
Q6 what difference has this made from 0 (no difference) - 5 (a huge difference) 
0- No change 
5- A huge difference  
Difference 0 1 2 3 4 5 
N 1 1 0 0 6 10 
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Free text entry following question on degree of impact of recovery.  
“Can move my arm where as before it was useless.” 
“Can still do my job as a heavy plant engineer” 
“Because my arm was completely useless before the surgery yes I would like it to be bet-
ter and continue to try to improve it!” 
“I went from a totally non functional arm to Semi-functional.” 
“My arm was totally dead. The ability to move the elbow and hold or lift light items is a 
great comfort. It also offers some worthwhile useful functions when cooking, dressing or 
carrying things.” 
“I had no function in my arm and limited movement. No I have some and it is getting 
stronger” 
“No difference at all really, but to be fair it was a long time ago and it was a long shot to 
get my elbow moving again!” 
“Prior to my operation I had very limited use of my arm. I can not be sure that the opera-
tion has been the sole reason for progress, I do believe 'other' muscles compensate.”  
“Although not perfect, to one that doesn't know, it all looks and operates quite normal 
though my arm tires very quickly.” 
“Before the operation I had no movement at all in my left arm and now I have quite a bit 
of muscle contraction. So I think that it has definitely made a huge difference.” 
“Prior to my op, I had no biceps / triceps function - now both work to a reasonable / use-
ful level” 
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“Living through the progress” 
“Prior to operation the whole left arm from shoulder to hand did not have any function. 
along with tendon transfers & nerve surgery this operation has transformed my daily liv-
ing.” 
“As a PE teacher and a right arm injury the flex ion of my arm is essential to work.” 
“Before was unable to move now I have full movement with not many restrictions in what 
I can do. I would recommend it to anyone” 
These qualitative data provides texture to the qualitative subjective experience where the impact 
is rated as a Mean 4.22/5, Mode 5/5 SD 1.309. 
Commentary on Q6a and b: 
There is significant population difference when the means of those individuals who stated the 
operation has made a 5/5 huge difference (n=6, 9.96 KgF) with those who graded it as less than 
this (n=6, 7.42 KgF). However, 16/18 of the respondents graded the impact as 4/5 or greater 
therefore this difference is less clinically relevant. The respondent who graded the impact as 0/5 
scored an MPF of 3.12KgF. The overall satisfaction with the impact is 4.78/5 satisfaction. Over 
50% (10/18) scored 5/5. The majority (11/12) reported a 4/5 or 5/5 difference.  
 
8.7.7 Q7. Would you recommend it to another with the same problem? 
18/18 (100%) responded Yes 
8.7.8 Q8. Given the chance would you undergo the same treatment again?  
18/18 (100%) responded Yes 
150 
8.7.9    Stage 2. Quantitative Outcomes. 
Patient’s re-innervated force outcomes (as measured with a continuous measure of Kilogram 
Force; KgF, with a HHD) were normally distributed (mean = 8.2KgF SD = 3.6). 
 
 
 
Figure 8.23: 
 Histogram of the spread of objectively assessed force (KgF) as measured with a HHD. Line of best fit depicting 
MRC Grade 4 subset distribution. Mean 7.2 kgf (3 to 15.5; SD 3.3). (Best fit line as calculated by SPSS software)  
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Figure 8.24:  
Table demonstrating multi input bi-variate analysis of two tailed significance of Pearsons correlation 
 
When subjective outcomes are compared to Maximal Peak Force (MPF) there is poor correlation 
between the majority of the qualitative data and the quantitative outcome. However, there was a 
link between two of the subjective assessments and peak force, but neither had a very strong 
correlation (r= 0.631 and 0.694) Figure 8.24. 
• Improvement/impression of change (Q5) had a correlation of 0.694 at a significance level 
of 0.12  
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• The SPONEA (Q4) correlated to a similar level (0.631) with a higher significance of 0.028. 
The strongest correlations within the collective of subjective assessments were between:  
• Hope (Q2.) showed a correlation of 0.59 (at a sig of 0.01) with minimal expectation 
• The SPONEA Q4 correlated with several measures as well as the peak objective 
force: 
• Current function: 0.604 at the 0.008 level.  
• Assessment of improvement (Q5.): (0.519 sig 0.27)  
• Impression of impact/difference (Q6.): (0.560 sig 0.16)  
• Assessment of Improvement (Q5) and the assessment of the difference this made 
(Q6) correlate to 0.889 (with a significance of 0.000) 
• Expectation mismatch (*EM) (Q123) and current function; (0.817 sig 0.004) but, as 
EM is a derivative of current function, (current function – expectation = EM) this may 
be likely a product of the relationship rather than demonstrate a causal relationship.  
The findings therefore enable us to reject the null hypothesis. The results demonstrate that satis-
faction with nerve transfer surgery for elbow reanimation is unrelated to the peak force attain-
ment. 
This study demonstrates that the patient related impact of restoring active elbow flexion is unre-
lated to the amount of force restored. However, the subjective satisfaction for Oberlin nerve 
transfer is high across the range in force (8.22Kg SD 3.595).  
There is a disparity seen between the standard objective outcome assessment of muscle func-
tion (as assessed by clinicians) compared to the objective experience and patient’s perception 
of the strength and use of their arm. Peak force is not a responsive or representative outcome 
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measure to reflect the patient experience of muscle re-innervation. This reinforces that the ob-
jective assessment of peak force is not reflective of the breadth of subjective factors that influ-
ence a patient’s perception of their outcome. However, the study does indicate that maximal 
peak force does show some correlation with the patient’s impression of change and some im-
provement in function. Patients do not appear to relate peak power in an unrelated or unquali-
fied way to their outcome 
 
8.8 Discussion 
This study aimed to evaluate the patient’s perspective of their return of muscle function follow-
ing Oberlin nerve transfer. To the authors’ knowledge this is the first study to do this. The stand-
ard outcome for this operation has been peak force and these data suggest this is a poor meas-
ure of outcome with little validity to patient experience.  
Patient reported outcomes are growing in popularity and the strengths and weaknesses of these 
are well discussed. In designing this battery of questions a multidimensional approach was used 
in order to try to be as reflective of the many layers and aspects of patient experience as possi-
ble. Health Transition Questions (HTQs) do this by directly asking patients to assess whether 
they consider their health or functioning to have changed in comparison with a previous time 
point, often pre intervention, pre surgical intervention. Particularly when short measures are em-
ployed or single global questions are grouped with HTQs that probe experiences of adverse 
events or side effects. For example, to assess the accuracy and sensitivity of measures de-
signed to specifically probe PROs in Orthopaedic surgery, treatment satisfaction questions have 
been posed alongside direct HTQs as an external anchor (Dawson et al. 2008; 2014). 
In a recent review (Lloyd et al. 2014) suggest that there are a number of benefits associated with 
combining a simple set of questions to elicit patients’ assessments of the outcomes of hospital 
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treatment. Most importantly, it directly identifies outcomes relevant to the individual patient, 
which can differ between patients and also from what clinicians believe to be important to meas-
ure. The results of surveys using this type of question may feed into improvements in clinical 
practice more easily. There is also evidence in the literature that asking patients to assess the 
outcome of their treatment has face validity. Indeed, Jaeschke et al. (1989) concluded that in the 
absence of a gold standard measure external global ratings represent a credible meaning of 
change in a new measure.  This is shown in the widespread use of such questions, particularly 
transition questions as external anchors to assess the performance of other PROMs. This meth-
odology allows identification of outcomes relevant to the patient. Dawson et al. (2010) found that 
patient satisfaction with surgery poorly correlated with clinician ratings at follow up, and there-
fore provided more evidence of the difference between patients’ and clinicians’ perceptions of 
which aspect of outcome to rate as important  (Jenkinson et al. 2002; Wright et al. 1994). 
In designing the questions for our data collection tool we utilised a spread of question type, 
methodology and subject areas. We combined closely defined parameter questions and Likert 
methods; to bring together investigations on subjective measures of expectation, attainment, 
function and satisfaction. It has been shown that, questions that interrogate patients as to the 
extent to which an intervention has helped improve their health, or that explore the direct experi-
ence of treatment may be less subject to bias than satisfaction questions (Pathak 1981) Likert-
type satisfaction rating scales provide a high degree of precision (Fitzpatrick et al. 1998). It is 
also known that in order to to avoid the problems of using a single global measure which is likely 
to reflect numerous features of the treatment received, and be closely related to the quality of 
the care received- satisfaction and assessment of the outcomes of treatment should be meas-
ured multi-dimensionally (Cleary & McNeil 1988). In addition, multi-item scales generally yield 
more score variability, and higher reliability and validity score than single items measures (Ware 
et al. 1978). 
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In selecting our anchor objective assessment we rely on our previous work which identified the 
use of a hand held dynamometer (HHD) as reliable method to measure peak force of elbow 
strength in this cohort (Quick et al. 2016, Maricq et al. 2014). A previously published pilot study 
outlined the protocol for use and discusses its weakness (Quick et al. 2016).  
A cohort of patients was identified who met the inclusion criteria. They had undergone nerve 
transfer surgery and successfully gained reanimated elbow flexion to MRC grade IV at 24 
months post operatively. A mixed-methods approach was adopted as it seemed best suited to 
provide a holistic overview and gain the maximum amount of information to answer the research 
question. 
Stage 1 of the study utilised a structured questionnaire to provide insight into patient experi-
ence, expectations and satisfaction levels with surgical outcome. Several aspects of the qualita-
tive information were of particular interest: 
 Firstly, in asking patients to assess their current function (when they had been selected as being 
able to lift some weight) only 14/18 (78%) identified that the restoration of innervation to the el-
bow flexors has allowed them to lift some weight (this corresponds with at least MRC grade IV 
classification). Thus; 4/18 (22%) failed to recognise the functional ability of their renervated mus-
cle.  
 A literature review to identify experience in assessing subjectively rated force (in PubMEd and 
Google Scholar) for the strings ("Muscle strength" AND "subjective assessment") and ("Muscle 
power" AND  "subjective assessment")  ("Muscle power" AND "patients assessment") ("Muscle 
force" AND "experience") ("Muscle assessment" AND  "experience") ("Muscle assessment" AND 
"subjective" AND "objective") identified no pertinent studies.   
The authors’ discussions with colleagues identified a systematic review on shoulder outcome 
named “Patient reports of the outcomes of treatment: a structured review of approaches’ by 
Lloyd ( 2014) highlighted, as one of its themes, force assessment in shoulder outcomes. From 
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here two studies were identified which showed assessment of force (Smith et al. 2006; Yang et 
al. 2015)  
Yang (Yang et al. 2015) identified one hundred and  twenty consecutive patients at their 1-year 
postoperative visit after shoulder arthroplasty and captured patient assessed, home-based 
questionnaire. Within this study the patients lifted bags filled with water up to a mean weight of 
2.72Kg. This test was designed to test range of motion under differing loads not peak force.  
Smith (Smith et al. 2006) assessed that “physicians rated … strength as being closer to normal 
[in comparison with the subjective assessment]”. This study was an assessment of a consecu-
tive series of 68 patients encounters who were at the point of assessment at an average of 51 
months following shoulder surgery (range 6 months – 22 years). The assessment was framed as 
a rating of ‘the overall strength of the shoulder” and was graded with a 10 point Likert scale (with 
non linear ‘advisory statements’) such at  from normal was 1,  Good- 3,  Fair- 4.5 , Poor 6.5, very 
poor – 8 and Paralysis – 10.  
 
 
They had patients complete this assessment by colouring in a circle and a similar assessment 
was preformed by the treating surgeon or one of the junior medical staff. The two groups graded 
the force – physicians 3.75 +/-  2.3 and the patients 4.43 +/- 2.3. The mean difference is as-
sessed as being -0.68 with the 95% intervals as being -1.12 and -.025). 
This does appear to be an area of research which will require more attention. It is however im-
portant not just to assess what the disparity is between subjective and objective assessment of 
force (as shown in graph x) but to investigate why. These data have shown an overall pessimistic 
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assessment of elbow flexion assessment both in terms of global MRC (anchored statement 
scale) and the KgF (anchored statement scale). This may represent a lack of internal validity of 
the measure- that the cohort do not fully understand how to assess their elbow flexion force, but 
it is considered that it more likely represents that muscle peak force is not a quantity which rep-
resents patient experience. 
When patients were asked to disclose their realistic expectation of surgery (Q2) 78% reported an 
expected outcome of MRC >/= 4/5. As previously discussed, the published data regarding the 
outcome of Oberlin transfer in terms of peak force is considered to be MRC grade IV in an aver-
age of 80% of cases (Sedain et al. 2011; Goubier & Teboul 2007; Ray et al. 2011). This suggests 
that the expectations of patients with regards to their likely outcome are being well met.  Fur-
thermore, it may act as an indicator that patients have been appropriately informed during the 
consent process with realistic outcomes portrayed. It is interesting to note that patient expecta-
tions are closely associated with their ratings of satisfaction with medical care (Kravitz 2016; Wil-
liams et al. 1995) and it may be an effect of treatment in a specialist centre that the patient co-
hort receives multimodal education and a common message to prepare expectations. 
The inclusion criteria of the study purposely selected individuals who had documented recovery 
of at least grade IV elbow flexion. Conversely, 4/18 (22%) participants reported that the return of 
power was insufficient for them to lift weight. Furthermore, one respondent reported that they 
were unable to bend their elbow without assistance. This demonstrates some conflict with the 
clinical documented outcome of grade IV MRC. There is the possibility that these outliers may 
have misunderstood the nature of the question. Equally their answers display the potential mis-
match between clinical assessment of force and patient perception of outcome. In order to as-
sess the demonstrated variance between the predicted and observed force for the Q3b it is 
noted that there have strangely been few studies to assess patient’s assessment of their own 
force as above. Several questions highlighted that it is not just the recovery of elbow flexion 
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force that is important to the patient. This is illustrated keenly in the free text responses only two 
patients use the word ‘elbow’ the vast majority refer to their ‘arm’ as a wider assessment.  
 
Question 4 focussed on the SPONEA which was an adaptation of the SPONSA. The SPONSA – 
the Validation of the Stanmore percentage of normal shoulder assessment is a validated out-
come measure (Noorani et al. 2012) for shoulder function now widely used  (George, Malal et al. 
2014, Torrance et al. 2017). Our modification is asking the same question “A normal shoulder is 
one which is pain-free, with a full range of movement, normal strength and stability, and allows 
you to do what you feel your shoulder, if normal, should allow you to do. A normal shoulder is 
scored as 100 percent, while a completely useless shoulder is scored as 0 percent. Overall 
where would you rate your shoulder between 0 and 100 percent, at this present time” but re-
placing the word shoulder for elbow. This a novel subjective measure of elbow function intro-
duced specifically for this study and whilst it takes face validity from the SPONSA it is not yet 
formally fully validated. However, the SPONEA was able to demonstrate a significant correlation 
with Maximal Peak Force (two tailed significance p= 0.008) suggesting that it may have some 
clinical utility as an assessment tool. This is not a surprise though as integral to the question is a 
concept of ‘normal strength’ and thus it would be expected to be reactive to differences in the 
force of elbow flexion. Further studies are required to validate its use but this may be a valid tool  
to assess outcomes for the Oberlin. 
Most patients reported that the surgery had made a worthwhile or huge difference to their life 
with 16/18 (89%) rating it as providing a 4/5 or 5/5 difference to their lives. Patient satisfaction is 
perhaps the most important criterion of success. This concept  is well recognised in the service 
industries, though remains something of a nebulous concept in clinical care (Hamilton et al. 
2013). Patient reported outcomes measures (PROM) difference reporting for many orthopaedic 
musculoskeletal procedures have high ratings and varicose vein and breast reduction surgery. 
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In a large cohort (n=4709) of prospectively followed cohort with 95% take up Hamilton (Hamilton 
et al. 2013) patients were also asked to rate their overall satisfaction with their operated hip or 
knee on a four-point scale (very satisfied, satisfied, unsure or dissatisfied). Data on satisfaction 
with five specific facets of surgical outcome were obtained with the following questions, an-
swered on a six-point scale (excellently, very well, well, fairly, poorly, don’t know): (1) ‘How well 
did the surgery relieve the pain in your affected joint?’; (2) ‘How well did the surgery increase 
your ability to perform regular activities?’; (3) ‘How well did the surgery allow you to perform 
heavy work or sport activities?’; (4) ‘How well did the surgery meet your expectations?’ We then 
asked our patients to indicate their satisfaction with the care they received at the hospital with 
the question (5) ‘rate your overall hospital experience’ using the response scale; excellent, very 
good, good, fair, poor or unknown. We also asked further two questions that enquired as to the 
patient’s attitude towards further surgery: (1) ‘Would you have this operation again if it were re-
quired on another joint?’ and (2) ‘Would you recommend this operation to someone else?’ (Pos-
sible responses: definitely yes, possibly yes, probably not, certainly not or not sure) Overall pa-
tient satisfaction was predicted by: (1) meeting preoperative expectations (OR 2.62 (95% CI 2.24 
to 3.07)), (2) satisfaction with pain relief (2.40 (2.00 to 2.87)), (3) satisfaction with the hospital ex-
perience (1.7 (1.45 to 1.91)), (4) 12 months (1.08 (1.05 to 1.10)) and (5) preoperative (0.95 (0.93 to 
0.97)) Oxford scores. These five factors contributed to a model able to correctly predict 97% of 
the variation in overall patient satisfaction response. 
The two final questions focussed on satisfaction in the context of whether the patient would un-
dergo the same procedure again and whether they would recommend it to someone else. 100% 
of respondents said yes to both. The answers to these questions demonstrate the subjective im-
pression of the impact of the surgery. When reviewed alongside the free text answers to Ques-
tion 6 the strong positive results can be visualised. Several participants’ report that their arm 
was “useless” prior to surgery and many comments also focus on a return to “function” or 
“semi-function” within the arm. Furthermore one participant reported that they get comfort from 
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being able to grasp and lift light items. It may be surmised that in cases of life changing injury, 
satisfaction or impression of change tools may not be sensitive to the multidimensional and bio-
psychosocial effects of injury and therefore struggle to guide improvements in outcome meas-
urement Stage 2 of the study was to compare the most commonly used current assessment 
technique (of maximal peak force) correlated with the information gained in stage 1. The results 
again correlated with other literature (Quick et al. 2016; Carlsen et al. 2011)  with an average of 
8.2KgF (SD 3.6). When compared to the findings of Stage 1 and when considered in relation to 
the research question maximal peak force does demonstrate some face validity to the patient as 
an outcome measure; but only as part of a much more complicated picture. The findings of this 
study indicate that patients determine the impact of an intervention by how much they feel they 
are able to do.  When the answers from the questions regarding what difference the surgery had 
made to their lives were compared to actual force outcome there was no significant correlation 
(0.488 with a non-significant level of evidence p= 0.108).  
 
8.9  Study limitations 
There are various limitations within this study. Firstly, assessment of self reported function was 
solely focussed on motor recovery. Although recognised as important considerations for holistic 
management; Features such as Quality of life (QoL), pain and body image were not incorpo-
rated. This streamlined the study and reduced the scope of the commentary limiting the possi-
bility of the full breadth of subjective experience from being expressed. 
The retrospective nature of the study is not ideal; it was conceived as a pilot to inform the de-
sign of future prospective data capture studies. A 30% (18/62) follow up rate undoubtedly raises 
concerns of outcome bias however this response rate for trauma patient follow up is quite usual 
and representative of a typical trauma population (Leukhardt et al. 2010; Crandall et al. 2014). 
Commonly cited difficulties when arranging long term follow up with this cohort typically refer to 
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patients who are young, mobile and wish to return to normal life. Future studies may be advised 
to establish prospective data collection methods to enhance follow up rates.  
Patients were given the opportunity to remain anonymous or disclose their identity when com-
pleting the questionnaire. All participants chose to discard anonymity. In order to avoid any fur-
ther bias the researchers ensured that any treating clinicians were absent during the data collec-
tion process and that the entry of data was not overseen. 
Finally, this study adapted the wording from the SPONSA (a validated shoulder assessment) to 
create an elbow specific SPONEA. Although the SPONSA has been shown to be a legitimate 
measure for use with shoulder patients. It has not yet been assessed if it will have the same va-
lidity when modified for different joints (Noorani et al. 2012). However, the findings of this study 
suggest that the SPONEA may be a useful indicator of patient reported outcome for elbow rean-
imation. Considering the results of this investigation, future studies to validate the use of the 
SPONEA are recommended.   
 
8.10 Conclusion  
In summary, muscle is a complex organ and its functions beyond strength alone should be con-
sidered during assessment of outcome following a denervated period. Proprioception, functional 
co- contraction and mechanisms of smooth and controllable recruit-ability are some of a myriad 
of aspects of muscle renervated function which have been identified as limiting factors to recov-
ery post injury. Asking the patient’s opinions with regards to outcomes will enable clinicians to 
specifically measure valid improvements that exceed the minimal clinically important difference 
for that outcome. If we are to, quite acceptably, used peak power to inform studies on outcome 
it should be with one eye to the other dimensions of muscle function and global patient function. 
The results of this study have provided insight into the spectrum of motor outcomes. Ongoing 
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studies of a qualitative nature such as focus group discussions are recommended to further di-
rect care.  
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9. 
The lived experience of motor recovery  
of elbow flexion via nerve transfer. 
A phenomenological analysis of a group discussion around the experiential learn-
ing from living through motor recovery. 
	
9.1 Introduction 
Nerve injuries to the upper trunk, lateral cord and musculocutaneous nerve can all result in the 
loss of active biceps contraction. Surgeries such as nerve repair, grafting or nerve transfer are 
often required to allow axonal regrowth into the de-innervated muscle. Loss of active elbow flex-
ion creates a considerable deficit in function. Activities such as hand to mouth for feeding and 
hand to the midline to allow for independent dressing are commonly reported functional goals. 
Despite best efforts from both the surgical and therapeutic teams these injuries often result in 
long-term functional disabilities which affect all aspects of daily living. 
 
To date, no research has focused solely on the qualitative lived experience of motor recovery 
following a nerve injury. The purpose of this study was to give an account through the voice of 
patients’ who have successfully undergone nerve transfer surgery to re-innervate elbow flexors. 
It is hoped that the thoughts and feelings of these patients can facilitate medical professionals to 
better understand these life-changing injuries; leading to improvements in patient care. 
 
The aim of the research was to explore the opinions of those who have suffered a nerve injury 
with successful re-innervation of elbow flexion following an Oberlin nerve transfer. Phenomeno-
logical analysis of focus group discussion was identified as a suitable method to fulfil this aim 
and capture the participants’ lived experience.  
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Traditionally health research has put great emphasis on quantitative studies which focus on out-
come of injury to determine the efficacy and effectiveness of interventions.  
This is most likely born from the much quoted pyramid hierarchy of “best evidence” being fo-
cused towards Randomised controlled trials (RCTs) and systematic reviews (SR) (Evans 2003). 
Success is typically judged on elements such as isolated return of strength to a muscle; rather 
than the wider aspects of how that enables the person to participate in life with regards to family 
roles, employment and hobbies. Therefore, these closed traditional methodologically quantita-
tive outcome studies do not provide information to explore the themes of how to assess or im-
prove the experience of patients living with brachial plexus injuries. 
 
Modern healthcare is increasingly recognising the need to move away from a traditional medical 
approach and focus towards a bio-psychosocial approach. In essence putting the patients ex-
perience as the focus of all that we do. The World Health Organisation (WHO) developed the In-
ternational Classification of Functioning, Disability and Health (ICF) as a framework for measur-
ing health and disability at both an individual and population level (WHO, 2001). In this frame-
work both the muscle function and the person’s perceptions are considered alongside their abil-
ity to participate in everyday activities. This reflects the recent changes in healthcare where pa-
tient perceptions and satisfaction are considered with equal status to a clinician’s “objective” 
outcome. Recent analysis of outcome following nerve injury has endorsed the use of patient-re-
ported outcomes and functional assessments (Novak et al. 2009; Ahmed-Labib et al. 2007; 
Kitajima et al. 2006).  
Choi et al. (Choi et al. 1997) used a quantitative questionnaire survey to evaluate surgical treat-
ment for brachial plexus injury (BPI). The main outcome measures were overall life satisfaction, 
employment, and functional outcome.  In spite of the devastating nature of their injuries, their 
patient population reported a good quality of life and employment within the first year following 
injury. Davidson (Davidson 2009) compared upper limb amputees and patients with upper limb 
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injuries using the Disability of the Arm, Shoulder and Hand (DASH) questionnaire. She found pa-
tients with a BPI demonstrated significantly higher levels of disability compared to patients with 
unilateral upper limb amputations. However, the study was unable to provide information re-
garding the person’s perceptions of their disability. This study postulated that the definitive na-
ture of an amputation which differs from the somewhat unknown prognosis following BPI may 
lead to delayed acceptance, and altered views of long term disability. 
More recently Kitajima et al. (2006) conducted a quality of life (QoL) study for patients who had 
suffered a BPI. They found little correlation between SF-36 scores and clinical evaluation of joint 
function. This led them to conclude that a region or site-specific questionnaire is required to bet-
ter evaluate the outcomes of BPI. In summary, these studies suggest that questionnaire based 
surveys can offer some information with regards to how a patient is living with an injury. How-
ever, they are restricted in the capacity of what they provide. The main limitations are that they 
generate a defined set of data relating to the direct questions asked rather than providing a 
deeper understanding of the impact of a nerve injury. They do though offer pieces of this puzzle 
for analysis. 
 
Further challenges in assessing this group of patients is the heterogeneity of the traumatic  inju-
ries and the multi-factorial impact. There is no such thing as a typical traumatic brachial plexus 
injury (TBPI). For each person with a brachial plexus injury (BPI), the associated injuries, events 
surrounding the injury, recovery, and life experiences are individual. 
 
Qualitative research aims to understand human experience. Whereby, a person-centred and ho-
listic approach interprets and makes sense of phenomena in terms of the meanings people bring 
to them (Greenhalgh & Taylor 1997).  In light of the limitations identified by quantitative studies in 
BPI; this paradigm is appears particularly well suited to understanding the patient’s own experi-
ences and puts them at the centre of the study. There have been two previous studies focussing 
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on the lived experience of brachial plexus injuries. Wellington (Wellington 2010) used semi-struc-
tured interviews focussing on QoL issues following BPI. Her study centred around four subjec-
tive experiences that the participants had identified as being significant following their BPI: em-
ployment, pain, body image and sexuality/emotions.  Further to this McDonald and Pettigrew  
(McDonald & Pettigrew 2014) interviewed patients and used a phenomenological approach to 
examine the core concepts of the lived experiences of people with this injury.  Quality of life, 
motor function, activities of daily living and societal roles were noted to be key concepts.  
 
Previous research by the author (Chapter 8) has shown that patient satisfaction and impression 
of benefit following re-innervation of elbow flexors has only a small effect on, and low correlation 
with the peak force generated (correlation of 0.694 at a significance level of 0.12). As peak 
power is the main (and often the only) outcome measure used by clinicians to assess this type of 
procedure.  The intention of this research is to direct and inform future research aims towards 
outcomes that are meaningful to the patient experience. 
 
To date, no research has focused solely on the qualitative lived experience of motor recovery 
following a nerve injury. The purpose of this study was to give an account through the voice of 
patients’ who have successfully undergone nerve transfer surgery to re-innervate elbow flexion. 
It is hoped that the thoughts, feelings and experiences of these patients can allow researchers 
and therapists to learn from the ‘lived experiences’ to better direct their care and understanding 
towards these life changing injuries. 
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9.2 Design & Methodology 
 
Mason (Mason 2017) considers qualitative research to be: 
 
 “a highly rewarding activity because it engages us with things that matter, in ways that matter” 
 
This study was designed and reported in accordance with the COREQ guidelines (COn-
solidated criteria for REporting Qualitative research).  A checklist is provided as an appendix 
(Tong et al. 2007). 
 
9.2.1 Overall Approach and rationale 
The aims of the research were to explore the opinions of those who have a lived experience of a 
nerve injury with the successful return of power to elbow flexion following an Oberlin nerve 
transfer. In order to complete this aim a qualitative methodology was identified as an ideal 
method to capture participants’ lived experience.  
 
A broad range of qualitative methodologies exist. The four most commonly used methodologies 
include Grounded Theory, Phenomenology, Ethnography and Narrative research (Creswell & 
Poth 2016; Petty, Thomson & Stew 2012a). The methodology selected should depend upon 
what the research aims to gain from the participants.  
 
The purpose of this study was to focus on the patient’s voice; to ascertain what the motor 
recovery of their biceps meant to them. The information gained was intended to reflect as many 
people’s views as possible; so as to be transferrable to other patient’s in a similar position but 
still maintain the essence of what each individual had said. This directed the study deisgn away 
from a grounded theory of qualitative study and towards a phenomenological approach. The 
focus of Phenomenology is to understanding the unique lived experience of individuals by 
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exploring the meaning of a phenomenon. Interpretation and analysis of the data enables the 
researcher to uncover a description of the ‘essence’ of the phenomenon also described as “the 
universal meaning for individuals” (Petty, Thomson & Stew 2012a; Petty, Thomson & Stew 
2012b).  
 
9.3 Patient-Participants  
 
Patients under the care of the Royal National Orthopaedic Hospital Nerve Injury Unit were as-
sessed for the inclusion criteria: Participants had: a diagnosis of Traumatic brachial plexus injury 
and had undergone a nerve transfer to reanimate a denervated elbow flexor muscle, who had 
follow up of over 24 months post surgery. (All participants were over 2 years post operation to 
allow a suitable time to have elapsed for the experience of motor recovery to be present and the 
key features of their lived experience to still be memorable). Selection inclusion criteria: the pa-
tients had to be over 18 years of age; speak fluent English; and be able to participate verbally 
with the process. Participants were excluded from the study if they had: birth-related BPI; were 
less than 24 months post nerve transfer; had impaired cognitive functioning; or had difficulties in 
verbal communication. This yielded a cohort of 68 patients. Patients were approached and in-
vited via letter to be involved in the research. (with consent to do so from our institutions re-
search ethics board) via written letter and a single follow up phone call for non-responders. 
This project was approved by a national research and ethics board:  
REC ref 16/LO/0623 
IRAS project 202847 
 
A group of 23 patients was recruited in this manner to engage in a qualitative research project to 
quantify their renervated motor function. Of this group all were invited to participate in a group 
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discussion on the experience of motor recovery. Subsequently a group of 6 patients of varied 
backgrounds and times from injury to surgery (see Figure 9.1) consented to attend.  
 
 
Identifier Age Time since injury Gender 
GP 47 42 months M 
JT 46 29 months F 
PA 45 45 months M 
LJ 28 29 months M 
TB 54 260 months M 
SB 37 28 months M 
Figure 9.1: 
 Patient participant demographics 
 
 
9.4 Data gathering methods 
 
A research team was established with the author and two therapy colleagues; an OT (KJ) and a 
Physiotherapist (HB). The details of this team are included in the section on researchers below 
The research team worked together in this area to develop a robust methodology towards to the 
aim of establishing a lived experience of muscle re-innervated from nerve transfer process as 
collaborative, emphasising that the participants were the “primary experts” 
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The discussion group was thus established and was chaired by one health care professional (KJ) 
who had been uninvolved in the clinical care of the 6 participants and had no previous relation-
ship with the individuals. The discussion was observed by another therapist (HB) whose role it 
was to passively observe the interaction of the group to enhance analysis. 
 
The author and lead researcher (TQ) excluded himself from the group discussion as he was the 
treating surgeon for a number of the patient participants and reporting bias was feared in his 
presence.   A multidirectional digital voice recorder was used to record the hour long process 
which was held on NHS property in a non-clinical area. The audio file was later typed to create a 
transcript for use during the analysis. Once received, the transcript was reviewed by KJ and HB 
and corrections made to certify verbatim. 
 
9.5 Data analysis methods 
 
The intention of the study was to gain an insight into the “textured life-world” of patients and 
their evolving values as they grapple with disability (Greenfield & Jensen 2010). 
Two researchers (HB and TQ) analysed the data. TQ; being the external observer, and HB; im-
mersed in the group. HB was able to refer to the nuances and observed preferences of the 
group which may not be inferred from the transcript and audio file alone.  
Both the recorded audio file and the transcript were repeatedly reviewed, as were the notes and 
commentary written by HB during the group session. The researchers individually coded the dis-
cussion and highlighting the significant statements from the transcript. This method of data anal-
ysis is endorsed by Colaizzi (1978) as a method of maintaining the voice of the participants 
throughout. Following this, the researchers then met to discuss their individual impressions. 
Their professional backgrounds and roles within healthcare were declared as part of an effort to-
wards conscious reflexivity. Following this; agreement and disagreements regarding the signifi-
cant statements were discussed. The ideal of maintaining the ‘patient voice’ in the subsequent 
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analysis was always conformed to. Phenomenological processes, using a framework content 
type analysis were used in a step wise, manner to arrive at a ‘structure of understanding’.  
 
An independent fourth researcher (AG) who was naive to the subject area but who has experi-
ence in qualitative research methodology was asked to review the process, codes and themes in 
order to assist with transferability and accuracy.  
 
9.6 Researchers  
 
• Tom Quick (TQ) MA(Cantab) MB FRCS(TR&Orth) FHEA is a Consultant Peripheral Nerve 
Surgeon at the Royal National Orthopaedic Hospital (RNOH) and Director of the 
Peripheral Nerve Injury Research Unit (PNIRU). His sole clinical focus is the treatment 
and reconstruction of nerve injury, mainly brachial plexus injuries in children, adolescents 
and adults. 
 
• Hazel Brown (HB) MSc, BSc, Dip Orth is a Highly Specialised Physiotherapist treating 
adult and paediatric nerve injured patients at the RNOH. She has a wide experience of 
qualitative and quantitative research methodologies and outcome assessment validation. 
 
• Kathryn Johnson (KJ) Dip Phys is a Clinical Specialist Occupational Therapist who has 
worked with nerve injury patients for over 10 years. She has a wide experience of service 
development and patient advocacy. 
 
• Anthony Gilbert (AG) MRes, BSc is the Therapies Research Coordinator and Orthopaedic 
Physiotherapist at the RNOH. Anthony has significant clinical and academic experience 
in designing and delivering qualitative research methodologies.  
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All researchers have received Good clinical practice (GCP) certification from the National 
Institute of Health Research (NIHR) and maintain good standing with their professional bodies. 
 
9.7 Reflexivity  
 
Reflexivity is the important process of stating and recognising the continuum of research 
identity, voice and biases, within phenomenology. Thus in order to ensure this analysis was well 
grounded within its reflexivity: The two researchers involved in the analysis (HB and TQ) 
expressly and formally reflected their own identity, sense of voice, perspectives, assumptions, 
and sensitivities (as set out p.96 Marshall & Rossman 2011). Furthermore, the two analysing 
researchers undertook a group activity to identify the expressed subjective and objective 
differences between their two expressions of self.  
 
9.8 Ethics 
 
Ethical approval was granted by our institutional ethics board to convene the group discussion 
and to record and analyse the discussion as part of a wider project to explore patient assessed 
outcomes in renovated muscle. All participants were assured that their participation was 
voluntary and could be withdrawn at any point and any decision to enter or leave the trial would 
not change or affect the care they received.  
 
9.9 Data Collection  
 
This discussion was held on NHS Hospital property and was chaired by a senior therapist who 
had no previous engagement with the patients (KJ) and observed by another senior independent 
therapist (HB). A group of six patient-participants were invited to share their experiences around 
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the process of “return of function of their elbow movement”, all six attended.  The restored 
function (of active elbow flexion) was identified to the whole group via a picture, so as to frame 
the discussion with all commencing with a shared starting point. The whole process was 
recorded with consent from all involved to a digital audio recorder. The process was approved 
by the clinical ethical review board of our institution 
 
Two researchers (TQ and HB) then analysed the hour long discussion separately. Each 
researcher listened to the audio file numerous times and the transcript read and re-read to get a 
sense of the whole. Through this process the two researchers were able to attend to both the 
verbal and non-verbal elements. The researchers allowed the appreciation of the the non verbal 
assessment (including subtle pauses, intonation and emphasis) to inform the reading of the 
transcript. 
 
Following this repeated and considered immersion in the discussion each researcher highlighted 
on a digital copy of the transcript fragments that represented text that (to that researcher’s 
opinion) represented an aspect of ‘what this experience is like’. These ‘significant statements’ 
were then shared between the two researchers and over two discussions these were explored. 
Following the process of the Colaizzi method (Colaizzi 1978, Sanders 2014) these significant 
statements were then carefully considered again to determine a sense of its meaning. These 
were then again brought to group discussion where bracketing was performed recognising the 
varied reflexivity of the two researchers differing character, experience, training and personality.  
 
These formulated meanings were then combined in to themes and then further clustered into 
groups. These theme clusters were again analysed to identify emergent themes- which were 
characterised by a identification of statement (in the patient-participants own words as a direct 
quote from the transcript) which the researchers agreed represented a valid and candid 
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expression of the emergent theme. Thus we returned, in our final stage of this analysis, to the 
direct truth contained in the patient-participants’ own words. 
 
9.10  Summary 
 
This study has been a inductive phenomenological analysis arrived at through a process of 
theming and coding (after Colaizzi 1978) of a group discussion [transcript attached as an 
appendix] between a varied group of six patients who were invited to talk on their views and 
experience on living through motor reservation of elbow flexion following nerve transfer. 
 
As part of the process of integration of the Royal National Orthopaedic Hospital Peripheral Nerve 
Injury Unit’s (RNOH PNI) clinical and basic science research projects the team wished the 
patient voice to be central to the direction of study. There is now a wealth of phenomenological 
study in healthcare which has informed service improvement, training, outcome design and to 
frame research questions (Starks & Brown Trinidad 2016, Shaw & Connelly 2013, Tanner et al. 
2007). Numerous studies have been carried out that report on the functional outcomes following 
traumatic brachial plexus injury (TBPI), but there is a noticeable lack of qualitative evidence that 
explores the subjective experiences of people following such an injury. The recent work of the 
RNOH PNI unit has been in assessing quantitative outcomes from motor recovery and nerve 
transfer. Assessing this as a discrete and standardisable intervention to renervate essential 
motor functions. This work has identified that measures deemed valid to the patient body have 
not been clearly identified. Many qualitative studies have been published measuring maximal 
peak force following nerve transfer to restore function of elbow flexion (see review of literature in 
chapter seven) A recent study by this team has shown that peak force is not viewed as valid 
primary outcome measure.  
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One of the five major themes identified in Wellington’s 2010  study of five men with isolated 
brachial plexus injuries was that of the impact of lack of movement and muscle bulk on body 
image and function but also that of specific surgical interventions. This further supports the 
methodology of selecting a series of nerve transfers and exploring the experience of motor 
recovery.  
This study builds upon this lack of available evidence and introduces the brachial plexus injury 
patient and investigates their experiences. 
 
9.11 Results 
 
The original recording was sixty-eight minutes long, the transcript 10,279 words long. Significant 
statements were first identified by each of the researchers (TQ and HB) these were condensed 
via agreement to a collection of significant statements by consensus agreement. [tabulated data 
attached as an appendix]. 
 
These significant statements after conversion by each researcher to formulated meanings were 
again considered in discussion and numerous themes were identified and these were further 
collapsed to four major themes. We present this hierarchy under the headings of the emergent 
themes. 
 
9.12 Findings 
 
The four primary themes (Figure 9.2) are all extracted from the analysis of ‘significant 
statements’ made by the participants during the interview process. The significant statements 
are grouped into primary themes within which there is a sub-architecture of ‘secondary themes’ 
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Figure 9.2: 
Major themes identified from the phenomenologic analysis of the discussion group. 
 
 
9.13 The complete understanding of pain 
 
The most commonly raised comments within this discussion on motor recovery were those 
characterised as relating to pain. All of the patient-respondents produced significant statements 
that relate the experience of pain within the remit of the recovery of motor function. 
This is in line with clinical experience and previous studies which have highlighted pain as a 
major feature of nerve injury. 
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 “The complete understanding of pain; I don’t think I thought, or had any concept of what 
the nerve pain was going to be like” JT 
 
9.13.1 The severity, nature and intensity of the descriptors of pain varied from an aching 
sensation  
 
“what I do suffer with is just a bit of arm ache” TB 
 “I just have like an achiness and that just drains you after so many hours you cant take it 
you just have to go to sleep” LJ 
 
Through to accounts of much higher severity: 
 
“at the start some of the pains were horrendous” PA 
“sharp shooting pains” SB 
“Oh my god the pain” JT 
 
The trend through all participants was for the pain to slowly change from more evaluative words 
suggestive of difficulty with coping with pain through to more sensory aching type sensations as 
time progressed.  
 
“I mean at the start some of the pains were horrendous so much pain there. Then it got 
better over time” PA 
 
One participant described the sensation of “fixing pains” in his biceps when he initially felt and 
saw signs of renervation. Perhaps it could be interpreted as a concept that the body is healing 
and the surgery will be successful changes patient’s perception, acceptance and tolerance of 
pain once they see it is for the “greater good” 
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“I didn’t know if they were fixing pains or if the pain was just there” SB 
 
The quality of pain that was reported also varied from strange feelings (paraesthesia) through to 
those of unpleasant feelings (dysthesia). 
 
 “really right elastic band” LT, 
 “fixing pain” SB, 
 “very weird, hypersensitivity” LJ  
“kind of rubbery.”LJ 
 “a real pulling” JT  
 “heavy aches” JT  
“pins and needles pain” TB 
 
 
9.13.2 Evolution & external environment 
Pain is an ever changing quantity in the lived experience, with past recollection of pain often 
being worse than the current reported experience. Patients often reported external influences 
such as work, weather or just the temporal accumulation of time and daily routine affecting the 
pain. 
 
“the pain was horrendous before” JT 
“still feel kind of rubbery” LJ 
“I find the pain worse in the cold” SB 
 “but come after a few hours or a tiring day then I get arm ache” TB. 
 
9.13.3  Impact & Understanding  
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This relates the associated feature of the pain and ways that the impact of the experience of 
pain influence the patient’s daily life. 
 
“I just have like an achiness and that just drains you after so many hours you cant take it 
you just have to go to sleep” JL 
“that I was in so much pain that at best I could use a pen just couldn’t use my arm” TB.  
“But so much pain there I  couldn’t actually feel what the movement was and then it got 
better over time” PA 
 
Further relating to the experience of pain it is reported that preparedness and education on the 
likely nature and impact of pain is something that the cohort would consider useful to reduce its 
impact. 
 
“The complete understanding of pain; I don’t think I thought or had any concept of what 
the nerve pain was going to be like” JT 
 “Education what actually kind of symptoms I would get and where the pain would be” JT 
 
 
The experience of pain shows much commonality that the pain is complex and made up of 
differing pain. Undoubtedl, aspects of this pain are related to the underlying nerve injury, but 
also there are elements from the muscle renervation process. There is a concept of some pains 
representing healing processes ‘fixing pain’ (re-innervation) and others being ‘just pain that was 
there’. There is also the recognition that some of the pains hypersensitivity, parasthesiae and 
dysthesiae are related to the nerve transfer surgery donor morbidity.  
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9.14 Patience & positive thought 
The element of time of recovery following nerve injury is so different from other bony or soft 
tissue recovery courses. This primary theme is picked up by our interlocutors with a number of 
secondary themes: 
 
9.14.1 Hope & expectation 
The ‘expectation’ is often simple and clear: 
 
“I just wanted my bicep to work again” JT 
“I just thought it would be fixed” JT 
 “that was my intention to make sure everything worked again” GP 
 
but it is also recognised that it can be ‘complex, different and personal’. 
 
“so many different scenarios you could give then person a realistic idea at the start of 
what they can expect” PA 
“I don’t think I had even thought that it might not be back how it was, I don’t think I even 
had any expectations” JT 
 
9.14.2 Delay- patience and the effect of time 
All agreed however about one thing; ‘delay’: 
“my bicep didn’t look like it was doing anything for ages” GP 
“patience is needed” TB 
“and you expect it to not, nothing happened for ages, and then still keeping going and 
going trying to work the extra little bit” JL 
“I was very naive thinking next month I will be fine” JL 
“I was told I was going to have to be patient but I thought I don’t think do” JT 
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“I just felt that I could see the progress I was making and the made me more determined 
to carry on more progressing” GP 
 
9.14.3 Emotion 
The element of emotion demonstrates the impact of restrictions in activity and the effect of pain. 
This seems by many to be mitigated in some manner by being prepared for the way things will 
be. 
 
 “if I had done that earlier I might have been less frustrated “JT 
 “yeah and its difficult because pre surgery I just wanted my arm back and I don’t think I 
had any perception about what that would mean afterwards” JT 
 “I was so angry I couldn’t take care of myself and that was my thing I wanted to do that 
“TB 
“didn’t think it had worked so I was kind of getting really despondent about it” GP  
 
Including a progression over time from ‘frustration’ to ‘acceptance’. 
 
“bit of a roller coaster ride” TB 
 “I was so angry I couldn’t take care of myself and I that was my thing I wanted to do 
that” TB 
 
Also that this was variable between individuals 
 
“I wasn’t really concerned about or hadn’t even though what that would mean post- 
surgery. I just wanted my bicep to work again” TB 
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“you are not going to be training everything else depends on the level of the injury but the 
important thing is to motivate people correctly at the start and give them some realistic 
expectation and motivation” PA 
 
9.15 Functionality & daily lifestyle 
 
The patient voice is very clear that function is about activities of daily living (ALDs). The ability to 
care for one’s self, for reason of function, of independence and of self respect are repeatedly 
seen. 
 
9.15.1 ADLs (activities of daily living) feature as clear markers of function and metrics for 
rehabilitation: 
 
Perception of function 
 “You can do what you want to do but you are doing it in a different way” SB 
“I think general day to day life, so like job side of things- getting the kettle, getting the 
dishes done, brushing your teeth anything like general living if you did functionality like 
that “LJ 
“any function is better than non so the is kind of just the starting point” SB 
 
Functional goals 
 “everybody’s goals are different because of lifestyle and all injuries are different” SB 
“because some people will have unrealistic expectations everyone different.” PA 
“just to move it was a reasonable outcome” PA 
 “one of my goals was that i could wash and dress” GP 
“being able to drive was the first milestone one for me” LJ 
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Being normal 
“my ultimate goal is always that nobody that doesn’t know me would know that I have 
got an  
injury” GP 
“what I wanted was just to be able to go to the loo and take care of myself” TB 
 
9.15.2 Coping  
There are many methods described as hope to best cope with the impairments experienced: 
 
Forced use 
“I make a really conscious effort to use my weaker arm far more than I would have done 
previously it is not my natural arm to use” GP 
 
Strategies for use 
‘Compensation’ or adaptation are oft-discussed strategies to attain function. 
“You can do what you want to do but you are doing it in a different way” SB 
“if I am taking something down from somewhere I will get so far then I will change my 
tactics” TB 
“I learned how to do everything left handed so I didn’t have to rely upon it or anybody” 
GP 
As is the technique of avoidance 
“ I have got used to opening doors using hips, bum foot everything I use now rather than 
use my right arm” JT 
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9.15.3 Fatigue and Tiredness 
 
Closely linked with the performance of ADLs was the concept of fatigue and tiredness impacting 
on their ability to carry out activities. 
 
 “I think repetitive tasks are difficult” GP 
 “holding the phone using the phone for any length of time” GP 
 
When completing most other tasks there is a ‘tiring function’ issue 
 
 “after 10/15 minutes of using the mouse my arm is absolutely knackered” TB 
“and uncomfortable by Friday just lifting the arm on Friday is just exhausting “JT 
“I think repetitive tasks are difficult” GP 
 
As is the experience in rehabilitation from any major trauma ‘general tiredness’ also features as a 
separate secondary theme 
 
“sometimes I get a bit tired but you just do it but my life visually is quite normal” TB 
 “what is the actual fatigue and what is the meds” PA 
 
 
9.16 Don’t call me a Biceps 
 
This primary theme taken from a patient participant statement (“It is not measured as a bicep as 
it doesn’t work as a bicep, you cant call it a bicep” TB ). This means that even though the elbow 
flexors have been re-innervated and are again able to volitionally contract they are not restored 
to full function- Thus as they are not acting fully as a biceps they should not be called a biceps. 
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It is an exploration of the specific experience of recovering and putting renervated muscle 
function to use. This starts from a position of not just functional loss but ‘body image 
impairment’ too: 
 
9.16.1 Body image 
 
The importance of self esteem and not just as relating to functional loss of the arm but ‘body 
image impairment’ also was raised within the discussion.  
 
“it was completely wasted away” SB 
 
“yeah its vain but when you talk about looks you see it come back you can see the 
atrophy” JT 
 
“my ultimate goal is always that nobody that doesn’t know me would know that I have 
got an injury” GP 
 
The most simple characterisation of the lived experience following nerve transfer to elbow 
flexion can be described by this ‘significant statement’: 
 
“It is not measured as a bicep as it doesn’t work as a bicep” TB 
 
Our patient-participants consider the function of being a muscle as much more than offer just 
strength of contraction; A muscle should provide in all aspects of life, restore function, without 
fatiguing, feeling normal, easily controllable, without pain and look normal. 
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9.16.2 First initiation of movement and control 
There is a common timeline of experience as regards the process of re-innervation. The 
processes detailed above relate to the worry and concern regarding the time lag to return of 
function. The point where this period of waiting is terminated is reported as a momentous 
experience. 
Following surgery and after a long wait the ‘rehabilitation experience’ is the euphoria of 
activating the newly renervated muscle 
 
“it was the best feeling in the world when you see it move” PA 
“It made sense then that everything was going to work again.” GP 
 
During this process of learning to control the returned function it was noted that the support of 
biofeedback programme and hydrotherapy were greatly valued:  
Bio-feedback:  a process of supporting conscious awareness of which muscle are firing, (as this 
can often be difficult to directly sense). It often works through multi-sensory feedback- often 
using technology to activate a light or bell or more complex environment to illustrate when a 
particular muscle is contracting. 
Hydrotherapy:  physical therapy in a warm supportive aquatic environment (where the effects of 
gravity and often symptoms of pain and stiffness are reduced). 
 
“the biofeedback machine is good though because you can see it“  GP 
“being able to send the message out out of the water that is how I was able to isolate it” 
PA 
“I noticed I could do something and I had to really concentrate. but out of the water.” SB 
“and you could then feel bicep but having that bio feedback was just massive” JT 
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There is a thread of ‘stiffness limiting function’. Where the effects of prolonged denervation 
paralysis are felt with the muscle   
 
“you get stiff and then you can’t do things and then the muscles get weaker” GP 
“it tightens up and it is difficult to manage that” JT 
 
‘Weakness’, whilst being expected at first as the muscle returns to function is in one respondent 
identified, although not seen as an impediment to function. 
 
 “it is weak but I can do it” TB 
 
9.16.3 Integration of movement & co-contraction  
 To the process of re-learning to control the muscle function: 
 
“You can do what you want to do but you are doing it in a different way” 
“So I have a clip of biceps it doesn’t feel when I do that and it flexes when I do that” TB 
“you are almost having to undo that habit to make the bicep kick in again and it is having 
that space and time to think more often” JT 
 “am I using my bicep here or is everything else working “JT 
“I had to really yank my wrist up to get there” LJ 
 
The common feeling after all of this is that there is still a work of conscious effort. That it is ‘not 
easily integrated’. 
 
“by constantly keep working that muscle that you have got to connect your brain to that 
muscle, takes a while but yeah that’s what I keep doing and then it takes over” LJ 
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The issue of co-contraction is described by many: 
‘Co-contraction’:  a process whereby muscles that would normally be contracted at differing 
times to attain opposite effects, (bending /straightening a joint) are fired simultaneously thus 
reducing or stiffening movement of joints. 
 
 “I over compensate with other muscles” TB 
“I had to absolutely concentrate on what I was doing try and switch off all the other 
muscles to try to get it to work because everything was firing instead for it” JT 
 
 
9.16.4 Significant fatigue 
There is a strong thread of fatigue expressed by all of the patient participants. 
 
“yeah a lot of fatigue” LJ 
“the struggle I had was fatigue full stop” GP 
“20/30 minutes and I’m achy” TB 
 
9.17 Discussion  
 
Our study is a specific, focussed assessment of patient experience in recovery of an essential, 
motor function- that of elbow flexion (Mennen U. In: The growing hand. Gupta, Kay, Scheker 
2000.) following nerve transfer. As such it provides a more specific insight that other objectively 
focussed papers but is important to consider in reference to the wider picture described in other 
publications. 
 
Phenomenological research usually involves semi-structured interviews with individuals to gain 
information about the phenomenon experienced. Smith and Osborn (2003) describe semi-
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structured interviews as the exemplary method for Interpretive phenomenological analysis (IPA) 
and the vast majority of work published using IPA follows suit. The advantages of these include 
the collection of in depth information about the lived experience of each individual. The 
limitations are that the individual may only focus on one aspect, rather than giving broad 
information; which may not be generalised to others. On the other hand, this is the advantage of 
a focus group discussion; which may give rise to answers, opinions and similarities that the 
participants may have thought but may not have considered as an answer to the given question. 
Dunne and Quayle (2016) argue that this data collection technique is ideally suited to research 
investigating issues of concern to “an accessible, circumscribed and homogenous population‟. 
Dunne and Quayle (2016) further state that they consider that their participants gave essentially 
the same accounts as they would have done if interviewed individually. In this same publication 
(Dunne & Quayle 2016) they reflect on the possible impact of group dynamics in focus groups: 
They consider that through drawing the participants from a population of homogeneous 
pathology, with intimate knowledge of and concern with the research topic and a judicious use 
of moderation in the discussion; the potential problem of group dynamics taking precedence 
over discussion topic can be negated. Flowers (Flowers et al. 2000; Flowers et al. 2001; Flowers 
et al. 2003) presented structured individual interview data from many differing group discussions 
and consider that there are synergistic effects produced in group discussion adding to the 
analysis (Flowers et al. 2001). These concepts were recognised by the author; One of the 
recognised disadvantages of focus group discussions lies within the concept that some 
individuals are happier to talk in a group scenario than others. This may lead to a 
disproportionate trend towards an individual’s experience and poorly reflect others. These 
considerations were discussed by the author within the research team and eventually a focus 
group was agreed upon. It was believed that this method would demonstrate both the lived 
experience and shared experiences between the individuals. In essence this study wished to put 
equal credence on the individual’s experience and the generalisable signs and symptoms of the 
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process of motor recovery. The research team adhered throughout to the principle of Alexander 
and Clare (2004 considering the data collection. 
 
Even though the focus of the discussion was on motor recovery; pain became a very obvious 
post hoc thematic focus. We have not looked further into the nature of the pain in these patient-
participants - their testimony stands alone in this study: it may be that if the stated focus of the 
group discussion had been pain we would have seen differing themes discussed and explored 
in differing ways. We do acknowledge that, through their traumatic experience, they have 
numerous reasons to have both nociceptive and neuropathic pain generators as well as 
psychological and social magnifiers of pain. Many of the pain themes are related to muscle 
movement and many link with the theme of muscle fatigue as well.  There is a wide experience 
of pain common to all which; this is an important feature in the experience of recovery of motor 
function. Pain may predate the reconstruction, be caused by the reconstruction, or be due to 
renervation. It is clear symptoms change and can often improve with time. Pain interferes with 
the ability to recognise or control movement. It affects motivation and concentration and can 
directly inhibit movement. It is thus a direct effector of the impact of rehabilitation. It is the 
related experience that education and preparedness/ expectation management will assist in 
coping with these symptoms. Thus it is important to relate all these aspects to patients through 
education not just prior to but also during treatment 
 
In regards to the specific motor experiences of this cohort it is clear that a theme of function, 
above all else, defines the experiences most succinctly. The approach of the common clinical 
method of force qualification (the MRC muscle grade) is alluded to in the fact that patient-
participants relate having no function, notice gaining a flicker (being a moment of very obvious 
significance for a number of the patient-participants) then contraction with gravity eliminated (in 
hydrotherapy for many) then gaining the movement out of the pool and then lifting weight. It is 
though much more nuanced than that. All but one of the patient-participants related a personal 
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experience of complexity of motor control. The specific challenge in a nerve transfer is to re-
learn the motor function - this is an area which has attracted no published literature as far as we 
can see. The comments of it ‘not being a bicep’ and the fact that it is functioning but not 
normally may speak to the control or the proprioception of the muscle. That it is a function that 
is first activated through attempting the donor function (wrist flexion often) and then is separated 
as a consciously different function. It appears (from this small cohort’s opinion) that it never feels 
natural.  
 
There is a clear story of fatigue from within all four primary themes with achy pain being 
described as occurring with effort in ‘the complete understanding of pain’. General and specific 
muscle fatigue are also clear drivers of concern in ‘patience and positive thought’. Two forms of 
fatigue are demonstrated; Firstly, in tasks requiring sustained contraction or repetitive function, 
are described in ‘functionality and daily lifestyle’ as being challenging. Secondly in the ‘don’t call 
me a biceps’ theme it is obvious that even when muscle function is controlled and trained, it still 
demonstrates significant and function limiting fatigue. 
 
 
9.18 Conclusions 
The patient experience of the return of denervated muscle function is complex. It can only be 
described by including descriptions all four dimensions of space and time and psychological 
impact, pain, rehabilitation and function. We have included these aspects into four realms of  
 
• The complete understanding of pain (para 9.13) 
• Patience & positive thought (para 9.14) 
• Functionality and daily lifestyle (para 9.15) 
• Don’t call me a Biceps (para 9.16) 
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In classic clinical assessments of renervated motor function the focus is exclusively on the 
efferent function (contractile force) to the almost complete exclusion of the afferent function of 
muscle or wider aspects of patient function or psychology. Reports of MRC grade or 
dynamometer continuous force measurement are universal and comments about co-contraction 
and fatigue infrequent. Measurement or even acknowledgment of proprioception, grade-ability 
of control, integration of movements, praxic control or deep muscle pain are non-existent. 
 
The central role of historic measures (MRC graded peak volitional contraction) to benchmark 
outcomes is recognised, however, this study of lived experience throws this physician centric 
focus of efferent function into stark relief. This knowledge will, certainly influence the author’s 
future work, redirecting efforts towards developing tools to provide a more patient directed 
approach to assessing afferent function. The assessment of; impact on the patient, patient 
related outcomes, and assessment of function or body image are set to gain traction within a 
wide area of research in the care of these injuries. 
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10. 
An Assessment of fatigue and co-contrac-
tion, following nerve transfer in re-inner-
vated elbow flexor muscles. 
 
Beyond peak force assessment: an analysis of re-innervated muscle function 
through repeated and sustained isometric contractile effort. 
 
“Muscles are often recorded as normal on the basis of limited clinical tests. These, though exacting, 
may not take into consideration...the capacity for the muscle to sustain prolonged effort” 
 [Sunderland S 1972] 
 
10.1 Abstract 
 
10.1.1 Background 
 
Peripheral nerve injuries are a common outcome after blunt or penetrating trauma. Despite the 
best efforts of reconstructive surgery muscle re-innervation is often incomplete, resulting in per-
manent functional disabilities (Shreuders et al 2004, Grinsell and Keating 2014). Peak force is the 
most commonly used method (chapter five) for assessment but it is only a partial examination of 
muscle function (chapter three). Fatigue and the effect of co-contraction are important factors 
affecting the lived experience of motor recovery following nerve injury (chapters eight and nine). 
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An important step in improving treatment for these patients is to understand the ways in which 
denervated muscle differs from uninjured muscle. Little is known on the fatigue and co-contrac-
tion characteristics of re-innervated muscle following nerve transfer. 
 
10.1.2 Aims: 
 
The aim of this study is the characterisation of a range of values for the surface electromyo-
graphic (sEMG) study of re-innervated human muscle. Furthermore, to study activation frequen-
cies (to assess for fatigue) and co-activation in normal, uninjured muscle and examine the differ-
ences to re-innervated muscles. Thus to facilitate a more complete assessment of re-innervated 
muscle function and potentially identify pathologies amenable to modification to improve the 
subjective experience of re-innervation.  
 
10.1.3 Methods: 
 
A cohort of twelve patients, who have recovered force of elbow flexion following unilateral Ober-
lin nerve transfers, were studied. Data from hand held dynamometery to assess force output, 
sEMG data to assess force spectra and for quantification of co-contraction, and subjective ex-
pression of fatigue during repeated and sustained fatigue experiments were collated. These find-
ings were compared with normal controls. 
 
10.1.4 Results: 
 
The average peak force of elbow flexion following Oberlin nerve transfer was 7.68Kg (± 3.8), 
37% of the uninjured contralateral side (20.7Kg SD 6.8 p<0.0001). 
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The re-innervated mean biceps mean frequency of 49.66Hz (±15.86): 15% lower than uninjured 
muscle (p=0.10). In the injured arm Triceps median frequency was 48.72 Hz (±21.23).19% lower 
than uninjured muscle. (p=0.17). Co-contraction was seen in both arms: in the re-innervated arm 
at 18.77% in comparison to contralateral limb 12.32% (p=0.63). 
 
Re-innervated elbow flexor (Biceps-Brachialis) muscles demonstrate sEMG evidence of fatigue 
with a fall of mean frequency from 61- 49KHz, a change with a two tailed significance of p= 
0.001. with sustained (sixty second) isometric contraction at greater than eighty percent maximal 
force. No such change was seen in the control group. There was a trend towards an increased 
co-contraction of re-innervated elbow flexors muscles (biceps brachialis co-contracting with Tri-
ceps) when compared with uninjured controls which returns to normal levels as fatigue occurs. 
 
10.1.5 Discussion 
 
It has been demonstrated in this study of re-innervated human muscle that clinically relevant 
(chapter nine) characteristics (relating to function and patient experience) are demonstrable 
through sEMG assessment of median frequency change. Furthermore, these have been demon-
strated to differ from the findings in uninjured muscle.  
 
This study shows that re-innervated human muscle has a reduced tolerance to fatigue when un-
der sustained isometric contraction in comparison to controls. This clinical picture reflects ex-
perimental work showing an increase in animal models of fatigability in re-innervated muscle 
(Tonge 1974) and anecdotal patient experience findings (chapter nine). 
 
A trend towards greater co-contraction in the re-innervated limbs is seen, and this reduces as 
signs of fatigue appear with sustained contraction. This may represent a response to a 
decreased afferent supply from the muscle and an adaptive attempt to use the antagonist to 
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provide this feedback. Adoption of these metrics into clinical practice and outcomes 
assessment will allow a more meaningful comparison to be made between differing treatment 
options and drive advancements in motor recovery therapy. A similar finding of a decrease in 
co-contraction as agonist force is lost was found by Hautier et al (2000) in cyclists, (with un-
injured muscles) undertaking repeated sprints on an ergometer. 
 
10.2 Introduction 
 
Peripheral nerve injuries are a common outcome after blunt or penetrating trauma. Despite the 
best efforts of reconstructive surgery muscle renervation is often incomplete resulting in perma-
nent functional disabilities (Höke 2006, Gordon et al. 2011, Simon 2015).  
 
The restoration of elbow flexion is a common challenge following nerve injury (to the upper trunk, 
lateral cord or musculocutaneous nerve) and one where a nerve transfer has become commonly 
deployed (Oberlin et al. 1994, Leechavengvongs et al. 2006, Ray et al. 2011).  
 
The consequences of skeletal muscle denervation are paralysis and atonia. Furthermore, the 
muscle is unable to provide afferent proprioceptive feedback to control and coordinate motor 
functions. This can manifest in impairments such as weakness, pain, stiffness, deficient proprio-
ception, fatigability and co-contraction.  All of which may contribute in a reduced ability to per-
form motor tasks at the pre-injury level.  
 
Even though maximal volition force is currently (chapter five) the assessment of choice for mus-
cle assessment, it has been shown (chapter eight and nine) that patients do not recognise this 
measure as valid in their experience.    
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Analysis of patient group discussion has shown that fatigue and co-contraction are key experi-
ential outcomes for those affected (chapter nine). This study assessed these patient identified 
outcomes in re-innervated muscle. 
 
10.3 Fatigue 
 
The symptom of fatigability is a common experience of re-innervated muscle function and one 
that is ignored when outcomes are based on assessing peak force. Fatigue is commonly defined 
as an exercise-induced decline in performance (Allen et al. 2008). It is task dependent and pro-
duces impairments; either in the activation signal or muscle contractility (Merletti et al. 1988, 
Matkowski et al. 2011, Molinari et al. 2006). The inability to maintain force over time can mean 
the inability to perform repetitive tasks, or the inability to maintain a prolonged contraction. All of 
which provide significant impairment to performing functional tasks. 
 
Fatigability (as assessed through measuring force) can be identified in a number of differing 
ways: 1) force decrease over time during a sustained isometric muscular contraction; 2) number 
of isotonic muscular contractions possible (with a constant submaximal effort); and 3) evaluation 
of the decrease of the muscle force during repetitive isokinetic contractions. (Enoka & Ducha-
teau 2008).  Fatigue can also be assessed with measurement of electromyographic parameters: 
Median frequency fall is a widely used subjective manner to assess fatigue (Merletti 1992). 
These EMG changes occur prior to any decline in the muscle’s mechanical output. They are a 
measure of the changing metabolic status of the muscle and hence its inability to functionally 
produce maximal force. 
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10.4 Co-contraction 
 
When assessing functional force output (the muscle’s response to work done) and its relation-
ship with fatigue it is important to appreciate and assess all the outcomes of muscular work; not 
just the resultant force. The concept of co-contraction is an important factor contributing to mo-
tor function, and dysfunction.  Co-contraction is a process whereby muscular work is negated 
by action of another muscle (Farmer et al. 1998). It represents deployment of muscular effort 
against the intention of the movement, it decreases peak force and will exacerbate fatigue for 
any given contractile effort.  
 
Co-contraction is not just pathologic, it increases control and stiffness of any movement this can 
be of use in many physiologic conditions. Pathologic co-contraction increases work for any 
given agonist force and thus leads to increased fatigue for any given work (force x time). Co-
contraction is measured as a ratio of the antagonist muscles’ activity (as measured with Myogra-
phy) in comparison to the agonist. 
 
The action of active elbow flexion has been selected here for study as it presents a simple uni-
planar movement, where the function of the flexor and extensor masses (agonist and antagonist) 
are easily examinable. This is not the case in all joints, where the force vectors can be much 
more complicated to resolve. 
 
 The intention is to study elbow flexor muscles re-innervated though nerve transfer assessing the 
impact of co-contraction on force and fatigue. 
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10.5 Aims, objectives and methodology 
 
10.5.1 Study questions 
 
1. Is there a relationship is between pathologic co-contraction and fatigue in re-innervated 
muscle? 
2. How best to characterise fatigue in re-innervated muscle and what mechanism may 
bring this about more or less frequently in a re-innervated muscle? 
3. What is the range of normal for these quantities of peak force co-contraction and fatigue 
relate across normal controls and in re-innervated muscle? 
 
10.5.2 Hypotheses 
 
Null Hypothesis (H0): Re-innervated muscle will not differ from normal muscle in its fatigue re-
sponse to sustained or repeated assessment of isometric contraction. 
 
Primary Hypothesis (H1): Re-innervated muscle will differ from normal muscle in its fatigue re-
sponse to either sustained or repeated assessment of isometric contraction or both. 
 
10.5.3 Aims 
 
1. Characterise normal muscle sEMG behaviour and degree of Co-contraction 
2. Characterise nerve transfer re-innervated muscle sEMG behaviour and degree of 
Co-contraction. 
3. Compare the responses of each to repetitive and sustained effort. 
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10.5.4 Objectives 
 
1. To determine a range of normal values for repetitive and sustained isometric elbow 
flexor contraction as regards surface EMG spectra, and assessment of co-contrac-
tion. 
2. Identify differences in re-innervated muscle from these.  
3. Identify the relationship between force, fatigue and co-contraction in re-innervated 
muscle. 
 
10.5.5 Methods 
 
1. Identify or design a sustained and repetitive fatigue protocol for elbow flexion.  
2. Identify a cohort of Oberlin transfer patients with documented MRC grade 4 recov-
ery of elbow flexion at greater than 2 years post op. 
3. Utilise this population to study fatigue with repeated and sustained contractions 
models. 
4. Examine fatigue via monitoring maintenance of force, subjective reporting of fatigue 
and mean frequency of the elbow flexors and extensors surface EMG (sEMG). 
5. Capture sEMG assessment of co-contraction ratio (antagonist area under the EMG 
curve / agonist area under the EMG curve). 
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10.6 Materials and Methods: 
 
10.6.1 Patient group 
 
The Royal National Orthopaedic Hospital Peripheral Nerve Injury database was examined to 
identify patients who were at a point greater than twenty-four months following Oberlin nerve 
transfer. This time period (of twenty-four months post surgery) was chosen by consensus agree-
ment between the researchers as a suitable period for full motor recovery to have occurred. 
Clinically, after this time, there is very little evidence of further renervation. These individuals 
were then further reviewed against the inclusion and exclusion criteria which included docu-
mented recovery of a minimum of MRC grade IV within their medical records (full criteria are out-
lined in Figure 10.5). All patients underwent a standard regimen of post operative rehabilitation. 
An initial immobilisation period of 6 weeks followed by a milestone driven process of passive 
mobilisation, active movement and strengthening when signs of renervation returned. Sixty-two 
patients were identified as being eligible to participate in the study. All participants were con-
tacted by post with a letter to invite them to attend a clinical review. If no response was received 
after one month a second invitation letter was sent. After a process of informed consent a total 
of twelve participants were subsequently recruited to the study.  
 
10.6.2 Control group A 
The contralateral (un-injured) arm of the subject was assessed. This cohort was examined by 
two independent observers to confirm intra- and inter-rater reliability. 
 
10.6.3 Control group B 
A control group of eight volunteers was recruited as a convenience sample from the Royal Na-
tional Orthopaedic Hospital staff for comparison. Consent was gained and participants included 
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only if they were aged 27 to 69 years (age parameters of patient group), pain free with no history 
of significant trauma or surgery to their upper limbs. Inclusion and exclusion criteria were other-
wise the same as for the study group (Figure 10.6). Both dominant and non-dominant limbs were 
assessed in this control group. 
 
NB- The control group A (contralateral limb) was examined for repetitive fatigue. Due to time 
constraints and many of the study population not being able to continue with prolonged testing 
a healthy control population was utilised for the control fatigue testing. This further allowed a 
dominant non dominant comparison to be drawn. 
 
Ethical approval was gained from the NHS ethical board after IRAS application.  
 REC reference:  17/WM/0438 
 IRAS project ID:   231428  
 
After gaining informed consent both groups were invited for examination.  
 
10.7 Peak force Assessment: Hand Held Dynamometry 
 
The protocol for measurement of elbow flexion strength followed the same as published in Quick 
et al. (2016) (chapter six). The technique aims to bias elbow flexion to biceps and brachialis 
through positioning in neutral supination with the elbow statically held at 90 degrees. 
 
A M550 MyoMeter (Biometrics, Newport, UK) was used for objective assessments of force. All 
assessments were performed as ‘make tests’; The ‘make test’ is characterised by the examiner 
holding the dynamometer stationary while the subject exerts a maximal force against the dyna-
mometer and examiner. An alternative method the ‘break’ test involves the examiner trying to 
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overcome the attempt at isometric stability of the subject. The ‘make’ and ‘break’ methods of 
HHD use have been shown to be equally reliable. Bohannon (1988) stated “because the reliabil-
ity of one procedure was not clearly superior to the other in this study, other factors must deter-
mine whether clinicians use make tests or break tests with hand-held dynamometers.” We se-
lected the ‘make test’ over the ‘break test’ as we consider as others have described directly  
(Bohannon 1988, Stratford & Balsor 1994) this testing method represents are more valid test of 
day to day functional ability. The HHD plate was applied to the uppermost distal arm, on the dis-
tal shaft of the radius just proximal to the radial styloid with the arm in mid sup-pronation. Force 
as transduced from the HHD was continuously assessed and recorded by the DATALite soft-
ware (Biometrics Ltd). The raw data traces were analysed using the same software to record 
peak force for each of the repeated contractions, area under the force curve (AOCf) (Figure 10.1 
and 10.2). 
 
10.8 Surface Electromyography (sEMG) 
 
Surface electromyography (sEMG) data were recorded from the anterior (flexor) and posterior 
(extensor) compartment of the upper arm using a Biometrics SX230 (Biometrics Ltd Newport, 
UK) precision bipolar sensory with intra-electrode distance of 20mm. Prior to electrode place-
ment, the skin was cleaned with alcohol. The placement zone was standardised as per Hermens  
(2000)  as 1/3 along a line from the acromion to the centre of the ante-cubital fossa in line with 
the long axis of the arm. The posterior sEMG is placed mid-way along a line from the posterior 
acromion to the olecranon (illustrated in Figure 10.31 Page 236). 
To assure correct placement of electrodes on the muscle and to protect from any change in po-
sition if the adhesive on the electrode failed between sessions, the position of the electrodes 
was marked on the skin. sEMG signals were recorded using a 4 channel surface EMG Micropro-
cessor controlled programmable gain amplifiers (Data Log MWX8 Biometrics Ltd Newport, UK) 
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(3-dB bandwidth, 10– 500 HZ) and sampled at a rate of 2048 samples per second per channel. 
A reference electrode was placed around the contralateral wrist. 
 
 
The raw EMG was collected and analysed with biometrics software to calculate, Root mean 
squared EMG (RMS) and area under the RMS curve (AOC sEMG). The Power spectrum was rec-
orded and also rectified by being subjected to RMS then analysed for median frequency data. 
This EMG data was acquired for both elbow flexor and extensor compartments. The data was 
further used to calculate a co-contraction ratio. The 60 second sustained maximal contraction 
was divided into 6 x 10 second blocks and average within those blocks to assess change over 
time from one block to the others. 
 
 
10.9 Sample Data sheets 
 
The DATAlite software (Biometrics, Newport, UK) allowed the following assessment, maniplua-
tion and calculation from the raw data. As discussed in 10.7 and 10.8 the data was assessed 
first for the repeated contraction as detailed in 10.7. The first contraction was taken as the indi-
vidual contraction assessment data for 10.11-10.18. Then the run of three sequential maximal 
effort contractions were assessed together and shown in 10.19-10.21. 
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Figure 10.1: 
 Raw data  
Top: Examples of the dynamometer (HHD) recording of three consecutive maximal contractile efforts                
(KgF on the Y-axis, time in second on the X-axis).  
Below the same trace but overlaid with sEMG recording of flexor mass (blue) and Triceps (Orange) 
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Figure 10.2: 
 Processing the sEMG data of a single contraction with the DATAlite software: 
The top image is the raw sEMG data (blue flexors, orange triceps). Time on the X axis and mV on the Y 
Second image Time on the X axis and mV on the Y. RMS (root mean square) processed. 
Third image The RMS data is then integrated allowing a calculation of an Area under the curve (AOC)  
and the co-contraction ratio (orange: antagonist AOC/blue: agonist AOC) 
Bottom image: the DATA light software extracts the force spectra from the sEMG trace of the flexors and exten-
sors, (shown here graphically) from which the median frequency was extracted. 
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Figure 10.3: 
Processing the data for the 60 second contraction in the same manner as for the single maximal contraction for 
the over all 60 second period (as shown and described in figure 10.2). 
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In the assessment of the sustained one minute isometric contraction (protocol in figure 10.8)  the 
data was correlated as above for the repeated contractions: first the HHD recording of the mi-
nute contraction was assessed for peak force and AOC trimmed to include just the contraction. 
The sixty second contraction was then divided up within the DATAlite software into ten second 
blocks and each assessed in isolation. The sEMG data for flexors and extensors, was assessed 
in the standard manner RMS first then integrated to assess AOC then the final graph is the inte-
grated AOC for the EMG data of flexors and extensors. 
A typical block of these six, ten second blocks are shown below (Figure 10.4): Raw data, then 
RMS, Integrated sEMG, Frequency spectra. This process was undertaken for all the cases. (Fig-
ure 10.4 shows just one such individual’s 60 second sustained contraction). 
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Figure 10.4: 
The graphs here are iterations of the graphs in figure 10.2:  
The first column the raw EMG of each 10second period. The second column the normalisation through RMS 
processing of that data, The Third the work done by each agonist (blue) and antagonist (orange) The sustained 
contraction data as shown in figure 10.3 was then divided in to six, ten second periods as shown here. Each 
10second period was then processed in the same manner as for the single maximal contraction (as shown and 
described in figure 10.2). Raw data then RMS  then integrated then force spectral analysis. 
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10.10 Clinical assessment: 
 
From patient experience data (presented in chapter nine) we know that fatigue is a significant 
negative experience of those with re-innervated muscle function. Both repeatability and sustain-
ability have been investigated to provide multifaceted information which better simulates the 
stresses and demands that are placed on the arm during everyday life. Both affected and unaf-
fected arms were assessed. In order to provide a reference to the patients with nerve injury a 
convenience cohort of normal subjects were recruited and examined, with the same protocol to 
gain data for dominant and non dominant arms for comparison. 
 
10.10.1  Two measures of fatigue were measured: 
 
1. REPEATABILITY: Repeated serial peak force contractions as an evaluation of changes in 
muscle force during repetitive isometric contractions. (3 maximal contractions x 2 with a 
60 second break between the two sets)  
 
2. SUSTAINABILITY: Force decrease over time during a sustained isometric muscular con-
traction (one minute maximal effort contraction).  
 
 
Due to clinical time constraints we only performed the repeatable contractions in the nerve 
transferred subjects’ normal contralateral limbs. That is to say we were unable to assess the 
sustainability contraction in the nerve transferred subjects unaffected limbs. All assessments 
were however performed in the control group in both limbs. 
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Subjective fatigue 
 
• To assess subjective fatigue participants were asked to report if they felt the arm fatigu-
ing during the study.  
 
Objective fatigue  
 
• The sustained force was measured to assess for a reduction in maintained force. 
• A validated objective measure of a fall in median sEMG frequency from both the flexor 
mass and the extensor mass.  
 
Median frequency fall is a widely used subjective manner to assess fatigue (Merletti 1992). 
These EMG changes occur prior to any decline in the muscle’s mechanical output, they are a 
measure of the changing metabolic status of the muscle and hence its inability to function pro-
duce maximal force. 
 
Inclusion Exclusion 
Unilateral Oberlin/double Oberlin transfer – 
treated with standard post operative regimen 
>24 months post surgery 
Documented activity of elbow flexion of 
grade 4 MRC or above from clinical notes 
Adult 18+ 
Oberlin transfer <24months post surgery 
Oberlin transfer >24 months post surgery with 
MRC <4 
Oberlin transfer >24 months post surgery pro-
ceeded to free functioning muscle transfer 
Child (0 -18 years) 
Bilateral Brachial plexus injuries 
Figure 10.5: 
Table of inclusion/exclusion criteria: patient group 
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Inclusion Exclusion 
Adult aged 27-69 
No history of significant upper limb trauma or 
surgery (excluding childhood fractures) 
Pain free 
Under age of 27  
Over the age of 69 
Previous significant upper limb trauma or sur-
gery 
Pain in upper limb 
 
Figure 10.6:  
Table of inclusion/exclusion criteria: control group 
 
10.10.2 Method for the Muscle Tests:  
 
Repetition of ‘make’ tests involve the examiner resisting the patient’s maximal contraction for 4-
5 seconds at mid-range, 90 degrees flexion. A sustained contraction was held in the same posi-
tion for 60 seconds at ‘the strongest you can to keep going for a full minute’. 
 
10.10.2.1 Repeatability Test: 
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Figure 10.7: 
 Flow chart for the repeatability test for fatigue. 
 
 
 
 
Surface	EMG	electrodes	to	be	positioned	on	
the	patient’s	affected	&non-affected	arm	
(as	per	protocol)
Patient	positioned	in	supine	on	a	plinth.Arm	
rested	on	towel	2	inches	thick.Elbow	flexed	
to	90	degrees	(use	goniometer	to	place	
arm).Arm	stabilised	by	the	examiner
Dynamometer	placed	10	cm	from	elbow	
crease
Patient	requested	to	exert	maximum	forced	
against	the	pad	for	5	seconds	(timed).
repeat		prevous	step	x3
rest	for	5	minutes
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10.10.2.2 Sustainability test: 
 
  
Figure 10.8:  
Flow chart for the sustainability test for fatigue. 
 
Surface	EMG	electrodes	to	be	positioned	on	the	patient’s	
affected	&non-affected	arm	(as	per	protocol)
Patient	positioned	in	supine	on	a	plinth.Arm	rested	on	
towel	2	inches	thick.Elbow	flexed	to	90	degrees	(use	
goniometer	to	place	arm).Arm	stabilised	by	the	examiner
Dynamometer	placed	10	cm	from	elbow	crease
Patient	requested	to	exert	maximum	forced	against	the	
pad	for	as	long	as	they	feel	able	to	(up	to	1	minute	–
timed).
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10.11 Subject demographics 
 
Participant Gen-
der 
Age Affected 
side  
Dominance 
D-dominant 
ND-nonDom 
Injury Op 
date 
HHD 
(Kgf) 
Affected Non Af-
fected 
1 GP M 47 L ND Avulsion C5/6 27/08/1
4 
14.03 19.18 
2 LJ M 27 L ND AvulsionC5  
RuptureC6 
02/10/1
5 
16.27 29.62 
3 SM M 27 L ND UT neuroma 23/01/1
5 
8.92 10.01 
4 CW F 69 L ND UT neuroma 17/09/1
0 
6.33 15.63 
5 MH M 52 L ND UT neuroma 30/09/1
1 
6.83 9.9 
6 PA M 44 L ND AvulsionC5  
neuromaC6  
23/05/1
4 
9.57 25.61 
7 SB M 51 R D Avulsion C5/6 15/06/0
9 
12.3 28.97 
8 SP F 47 R D E/O Tumour 
upper trunk 
06/07/9
8 
3.12 19.76 
9 TH M 36 R D Avulsion C5/6 27/08/1
0 
5.36 19.02 
10 TB M 53 R D Muscular cu-
taneous nerve 
humeral # 
23/08/9
6 
10.38 28.71 
11 MM M 43 L D Avulsion 
C5/6/7 +/-8 
17/10/1
4 
4.65 9.9 
12 AW M 50 L ND Avulsion 
C5/6/7 
09/09/0
9 
7.2 30.45 
 
Figure 10.9:  
Subject demographics 
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10.12 Control demographics 
 
Study	#	 Age	 Gender	 Hand	Dominance	 HHD	
(Kgf)	
Left	 Right	
1	 40	 M	 R	 25.4	 31.2	
2	 28	 M	 R	 24.55	 30.03	
3	 53	 F	 R	 13.92	 11.85	
4	 49	 F	 R	 9.5	 13.71	
5	 61	 F	 R	 14,41	 16.88	
6	 29	 M	 R	 19.12	 24.33	
7	 51	 F	 R	 14.88	 15.52	
8	 36	 M	 R	 24.68	 24.15	
 
Table 10.10: 
 Control Subject demographics 
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10.13 Results 
 
10.13.1  Repeatability contractions 
 
During the 6 repetitions it was noticed that: 
 
• The peak force (taken as the peak force attained during any of the 6 consecutive at-
tempts) attained by the re-innervated muscles was 8.67Kg (3.12-16.27 ± 3.8). 
• This peak force level was on average 38% of the contralateral side in these individuals. 
Contralateral normal side 22.58Kg (9.90-32.53 ± 7.64) 
• No subjective signs of fatigue were reported. 
 
In comparing the first and last peak force attempts in the re-innervated muscle over the six re-
ceptive contractions there was: 
 
• no significant change in the peak force 7.5-7.9Kg being highly correlated at 0.943 with a 
significant at a two tailed level for correlation 0.00.  
• Biceps median frequency increased from 49.66Hz (± 16) by 8% to 53.42Hz (± 17) a non 
significant change 2 tailed significance (0.52 t -0.67). 
• Triceps median frequency rose by 3%; again a non significant change ( sig 0.78 t -0.29). 
• Co-contraction also did not change 19% to 18% (sig 0.77 t 0.30). 
• The repeated contraction data shows that the average variance between the peak force 
attempts by one individual is 0.798 (± 0.841) 
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The peak force attained across the 6 peak contractions in each group was as follows: 
 
 
Group peak force (mean) 
KgF 
SD 
Re-innervated n=12  
7.68 
 
3.80 
contralateral 
n=12 
 
20.65 
 
6.88 
Normal Dominant  
N=8 
 
20.00 
 
7.16 
Normal non Dominant  
N=8 
 
19.26 
 
6.67 
 
Figure 10.11:  
Tabulation of peak force in each group. 
 
 
The peak force (maximal volitional force) attained (Figure 10.11) in the innervated muscles is 
7.68KgF (±3.8) which is 37% of the contralateral limb which represents a significant difference 
(p<0.0001) on a two tailed analysis. (Pair 1 figure 10.12). 
 
There was no seen difference between the normal controls dominant and non dominant arms 
(Dominant n=8 20KgF ±7.16, and non-dominant n=8 19.26 ±6.67 -combined n=16 Mean 19.63 ± 
6.93) where the difference is -0.740 (95% CI -8.16- 6.68) p=0.834) (not tabulated). 
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There was no significant difference between the two controls (the contralateral controls and the 
combined (dominant and non dominant) data from the normal controls (Pair 3 Figure 10.12) dif-
ference -0.485±8.77 95%Ci -5.785- 4.4818 p=0.845). Thus the study population have a repre-
sentative contralateral control, which can be considered representative of an uninjured control.  
 
     95% CI of the dif-
ference 
   
   
 
Mean 
 
Std 
Devation 
Std 
Error 
Mean 
 
 
Lower 
 
 
Upper 
 
 
T 
 
 
Df 
 
Sig  
(2tailed) 
Pair 
1  
ObRepeat1 
Peak- 
ContraRepeat1 
Peak 
 
-12.010 
 
5.786 
 
1.604 
 
-15.507 
 
-8.513 
 
-7.484 
 
12 
 
<0.001* 
Pair 
2 
ObRepeat1 
Peak- 
NormalRepeat 1 
Peak 
 
-12.495 
 
8.231 
 
2.283 
 
-17.469 
 
-7.522 
 
-5.474 
 
12 
 
<0.001* 
Pair 
3 
ContraRepeat1 
Peak- 
NormalRepeat 1 
Peak 
 
-0.485 
 
8.777 
 
2.434 
 
-5.789 
 
4.818 
 
-0.199 
 
12 
 
0.845 
 
Figure  10.12: 
 Comparison of peak force (KgF) on first contraction 
 2 tailed paired samples test to assess difference between the peak force attained by three groups; 
Oberlin (Obrepeat1) contralateral arm group (Contrrepeat1) and the normal group (NormalRepeat1).  
Showing a Significant *(p<0.005) difference between the Oberlin group and both control groups in peak force. 
 
When comparing data from the first contraction of each of the group (figure 10.14) it is evident 
that the contralateral (un-injured) limbs are not different from the normals (controls) and the re-
innervated function is significantly less forceful (38% of the force of contralateral side). 
 
 
The Median Biceps sEMGs attained across each group for this first, unfatigued contraction 
were as follows: 
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Group Mean (MedBiceps) 
Hz 
SD 
Re-innervated n=12 49.66 15.85 
Contralateral 
n=12  
58.11 6.53 
Normal N=16 72.02 12.04 
 
Table 10.13:  
Tabulation of Median Biceps sEMG frequency in each group in the first contraction (unfatigued) 
This shows that in comparison to the normal control’s median biceps frequency (mean 72Hz ±12.04) the re-in-
nervated cohort had a lesser mean biceps frequency (49.66Hz ±15.85). in a two tailed test (table 10.11) at 
p=0.005. Assessing this as a one tailed test the difference reached a significance for (p=0.0002 95% Ci 11.543- 
33.178) a lower mean biceps EMG frequency. 
 
 
Comparing the re-innervated muscles median frequency with the contralateral biceps there is a 
two tailed difference at the p=0.005 level. The lower mean frequency in the re-innervated mus-
cles may represent a greater proportion of Type II slow twitch muscle fibres as is seen in re-in-
nervated muscles. There was no significant difference (p=0.06 two tailed) when comparing the 
re-innervated limbs with the contralateral limb.  
 
When assessing correlation (Table 10.14 ) the expected correlation between the contralateral 
control and the normal control  are not seen.  The reasons for this are not clear from this data: It 
is possible, if this a real effect, that the contralateral limb may be under a central and/or sys-
temic effect following the injury to the other limb. More work would be needed to investigate this 
effect. There was discrepancy between the spread of the figures between the re-innervated 
(±15.85) and the contralateral side (± 6.53). This shows a greater heterogeneity of groups of mo-
tor units in the re-innervated muscles. 
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Comparing Med Bi-
ceps freq groups 
Paired correlation (sig) Mean paired differences 
(t/sig) 
Normal v contra -.498 (p=.084) 13.91 (3.074/p=.010) 
Normal vs re-inner-
vated 
-.427 p=(.146) 22.35 (3.407/p=.005*) 
Contra vs re-inner-
vated 
.353 (p=.237) 8.45(2.049/p=.063) 
 
Figure 10.14:  
Tabulation of a 2 tailed comparison of the Median Biceps sEMG frequency in each group in the first contraction 
(unfatigued). There is a significant difference between the normal and the re-innervated group but not the normal 
and the contralateral group. * p=<0.005 
 
 
The Median Triceps sEMG across each groups first contraction was as follows 
 
Group Mean (MedTriceps) 
Hz 
SD 
Re-innervated arm 
n=12 
48.73 21.23 
Contralateral 
n=12 
60.08 17.85 
Normal N=16 65.9077 8.03 
 
Figure 10.15:  
Tabulation of Median Triceps sEMG frequency in each group in the first contraction (unfatigued) 
 
The re-innervated arm shows no significant differences in comparison to either control  
(Figure 10.16). 
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Comparing Med 
Tric freq groups 
 Paired correlation (sig) Mean paired differences 
(t/sig) 
Normal v contra .379 (p=.202) -5.83 (-1.27/.0228) 
Normal vs re-inner-
vated 
.112 (p=.717) 17.18 (2.836/p=.015) 
Contra vs re-inner-
vated 
.603 (p=.029) 11.35 (2.316/p=.039) 
 
Figure 10.16:  
Tabulation of a 2 tailed comparison Median Triceps sEMG frequency in each group in the first contraction (unfa-
tigued). There are no significant differences shown. 
 
Table 10.16 demonstrates no significant differences between the findings in the triceps results at 
this sample size; but the data shows a similar pattern to the biceps sEMG frequencies; in that 
there is a larger spread of frequencies in the injured patients (re-innervated and contralateral 
sides) and a trend towards reduced median frequencies in this group and compared to uninjured 
controls and again further decreased in the re-innervated muscle.  
 
This may imply that the sEMG signals are demonstrating that the re-innervated muscles have a 
greater heterogeneity of innervation (larger spread of frequencies) and a higher percentage of 
slow twitch fibres (lower frequencies). Some of these Triceps muscles in the injured limbs will 
have had an element of nerve injury (this was not controlled for  via  the inclusion criteria) and 
this may explain their findings. The fact the contralateral control showed no correlation with the 
uninjured patients control is of interest and may be explained by a systemic or central process 
of recovery and rehabilitation of loss of function.  
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Group Mean Co-contraction ratio SD 
Re-innervated 0.188 0.144 
Contralateral 0.123 0.067 
Normal 0.165 0.124 
 
Figure 10.17:  
Tabulation of the co-contraction ratios 
 (AOC antagonist:Triceps / AOC agonist:Biceps) for each group  
 
 
The Co-contraction data (Figure 10.17) demonstrates the same trend that we have seen for the 
data on sEMG for both biceps and triceps. There is a trend toward the un-injured arms being a 
population intermediate between the injured arm and the normal patient controls. The exception 
to this, is the force data (Figure 10.10) where the two control populations (contralateral and unin-
jured patients) were seen to be significantly correlated. These differences may represent a sys-
temic or central adaptation following the injury in the contralateral arm. This study was not de-
signed to identify such an effect.  
 
 
Comparing co-contraction 
groups 
Paired correlation 
(sig) 
Mean paired differences 
(t/sig) 
Normal v contra -.196 (p=.521) .041 (.976/p=.348) 
Normal vs re-innervated -.218 (p=.474) -.023 (-.398/p=.698) 
Contra vs re-innervated .641 (p=.018) -.065 (-2.049/p=.063) 
 
Figure 10.18: 
 Tabulation of a comparison of the co-contraction ratios (AOC antagonist –Triceps/ AOC agonist- Biceps) for 
each group.Showing that there is no significant difference in these first contraction figures. 
  
There are no significant differences in two tailed tests (Figure 10.18) between any of these varia-
bles in the unfatigued contractions. Thus the re-innervated muscles show no differences to the 
normal controls for co-contraction at this first contraction.  
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10.13.1.2 Repetitions 
 
Three repetitious maximal force attempts were undertaken (as detailed in Figure 10.7). When as-
sessing the first and last contraction within the re-innervated and contralateral groups the 
changes assessed over multiple repetitions were as shown in Figure 10.19. 
 
   
Mean 
 
N 
Std. `Devia-
tion 
Std. Error 
Mean 
Pair 1 
(KgF) 
ObRepeat 1 peak  7.467 12 3.855 1.069 
ObRepeat 3 peak 7.866 12 3.693 1.024 
Pair 2 
(KgF) 
ContraRepeat 1  19.477 12 6.206 1.990 
ContraRepeat 3 21.120 12 7.173 1.810 
Pair 3 
(KHz) 
ObRepeat BicepMed 1  49.662 12 15.858 4.949 
ObRepeat BicepMed 3 55.105 12 16.402 4.549 
Pair 4 
(KHz) 
ContraRepeat Bicep-
Med1  
58.108 12 6.529 1.810 
ContraRepeat BicepMed 
3 
59.646 12 9.235 2.561 
Pair 5 
(KHz) 
ObRepeat TricMed 1  48.723 12 21.231 5.888 
ObRepeat TricMed 3 56.015 12 13.112 3.637 
Pair 6 
(KHz) 
ContraRepeat TricMed 1 60.077 12 17.845 4.950 
ContraRepeat TricMed 3 64.453 12 16.402 4.550 
Pair 7 ObRepeat Coco 1 0.188 12 0.144 0.400 
ObRepeat Coco 3 0.177 12 0.104 0.029 
Pair 8 ContraRepeat Coco 1  0.123 12 0.067 0.019 
ContraRepeat Coco 3 0.112 12 0.073 0.020 
Figure 10.19:  
Tabulation of the data from multiple contractions  
Pair 1: Oberlin peak force comparing 1st and 3rd contraction  
Pair 2: Contralateral arm peak force comparing 1st and 3rd contraction 
Pair 3: Oberlin median biceps change from 1st to 3rd  
Pair 4: Contralateral arm median biceps change from 1st to 3rd  
Pair 5: Oberlin arm median Triceps change from 1st to 3rd  
Pair 6: Contralateral arm median Triceps change from 1st to 3rd  
Pair 7: Oberlin Co-contraction change from 1st to 3rd  
Pair 8: Contralateral arm Co-contraction change from 1st to 3rd  
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As displayed in Figure 10.21; there are no significant differences between the first and last con-
traction force, the median Biceps frequency or median Triceps frequency change, or the co-
contraction; in the re-innervated group (Oberlin) or the contralateral controls.  
 
  N Correlation Sig 
Pair 1 ObRepeat 1 peak &  
ObRepeat 3 peak 
12 0.943 p<0.001* 
Pair 2 ContraRepeat 1 & 
ContraRepeat 3  
12 0.860 p<0.001* 
Pair 3 ObRepeat BicepMed 1 & 
ObRepeat BicepMed 3 
12 0.262 p=0.384 
Pair 4 ContraRepeat BicepMed1 & 
ContraRepeat BicepMed 3  
12 0.802 p<0.001* 
Pair 5 ObRepeat TricMed 1 & 
ObRepeat TricMed 3 
12 0.550 p=0.052 
Pair 6 ContraRepeat TricMed1 & 
ContraRepeat TricMed 3 
12 0.908 p<0.001* 
Pair 7 ObRepeat Coco 1&  
ObRepeat Coco 3 
12 0.523 p=0.067 
Pair 8 ContraRepeat Coco 1 & 
ContraRepeat Coco 3 
12 0.223 p=0.464 
Figure 10.20:  
Tabulation of the correlations over multiple contractions  
Pair 1: Oberlin peak force comparing 1st and 3rd contraction – sig correlation 
Pair 2: Contralateral arm peak force comparing 1st and 3rd contraction– sig correlation 
Pair 3: Oberlin median biceps change from 1st to 3rd – no sig correlation 
Pair 4: Contralateral arm median biceps change from 1st to 3rd – sig correlation 
Pair 5: Oberlin arm median Triceps change from 1st to 3rd – no sig correlation 
Pair 6: Contralateral arm median Triceps change from 1st to 3rd – no sig correlation 
Pair 7: Oberlin Co-contraction change from 1st to 3rd – no sig correlation 
Pair 8: Contralateral arm Co-contraction change from 1st to 3rd – no sig correlation 
 
As shown when assessing the hypothesis that there is a difference between the first and last 
contraction- correlation is assessed (figure 10.20). There is strong correlation (P<0.001) between 
the first and last re-innervated (Oberlin) contraction of 0.943 and first and last normal control 
(contralateral) peak force of 0.860. Thus; there is no evidence of fatigue in output; i.e. the first 
and last contractions demonstrate significant correlation. 
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The contralateral sEMG assessed median frequency of both biceps and triceps show that there 
is correlation between the first and last contractions (figure 10.20). There is no such significant 
correlation seen in the re-innervated arms (figure 10.20). 
 
  N Difference Sig 
Pair 1 ObRepeat 1 peak &  
ObRepeat 3 peak 
12 -0.399 
±7.22 
p=0.798 
Pair 2 ContraRepeat 1 & 
ContraRepeat 3  
12 -1.643 
±12/71 
p=0.551 
Pair 3 ObRepeat BicepMed 1 & 
ObRepeat BicepMed 3 
12 -5.443 
±30.87 
p=0.417 
Pair 4 ContraRepeat BicepMed1 & 
ContraRepeat BicepMed 3  
12 -1.544 
±3.26 
p=0.320 
Pair 5 ObRepeat TricMed 1 & 
ObRepeat TricMed 3 
12 -7.292 
±30.83 
p=0.164 
Pair 6 ContraRepeat TricMed1 & 
ContraRepeat TricMed 3 
12 -4.376 
±32.70 
p=0.5366 
Pair 7 ObRepeat Coco 1&  
ObRepeat Coco 3 
12 0.011 
±0.230 
p=0.8324 
Pair 8 ContraRepeat Coco 1 & 
ContraRepeat Coco 3 
12 -0.011 
±0.134 
p=0.703 
 
Figure 10.21:  
Tabulation of the two tailed differences in means of  multiple contractions  
Pair 1: Oberlin peak force comparing 1st and 3rd contraction- no sig  difference 
Pair 2: Contralateral arm peak force comparing 1st and 3rd contraction– - no sig  difference  
Pair 3: Oberlin median biceps change from 1st to 3rd – - no sig  difference 
Pair 4: Contralateral arm median biceps change from 1st to 3rd – - no sig  difference 
Pair 5: Oberlin arm median Triceps change from 1st to 3rd – - no sig  difference 
Pair 6: Contralateral arm median Triceps change from 1st to 3rd – - no sig  difference 
Pair 7: Oberlin Co-contraction change from 1st to 3rd – - no sig  difference 
Pair 8: Contralateral arm Co-contraction change from 1st to 3rd - no sig  difference 
 
 
The table (10.21) above shows that there are no significant differences seen in the repetition 
contractions between any of the studied parameters. That is to say there is no evidence of any 
fatigue in this study. This does mean that the protocol for repetitive fatigue has been insufficient 
to create fatigue in either re-innervated or control populations. There was no change median fre-
quency no change in peak force and no report of subjective fatigue. 
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10.13.1.3 Summary of repetitive contraction data.  
 
We have established a set of normative data both for single unfatigued contraction in normal 
and re-innervated muscle: 
 
The contralateral (uninjured) limb cohort develops at peak volitional activity: 
 
a Mean biceps Freq of 58.10Hz (±6.53) 
and triceps of 60.08Hz (±17.85) 
whilst developing 20KgF. 
Co-contraction was 12.32% 
 
The re-innervated muscle developed: 
 
a mean biceps mean Freq of 49.66Hz (±15.86) : 15% lower than uninjured muscle  
a Triceps median frequency 48.72 Hz (±21.23). 19% lower than uninjured muscle 
at a force of 7.47KgF (40% of the contralateral limb) 
Co-contraction was 18.77% 
(an insignificance difference which had a 2- tailed significance of 0.63) 
 
There is a decreased median triceps frequency in the involved arms from the first contraction 
onwards: This is an interesting finding and may relate to an impact from the original traumatic 
nerve injury to the nerves to triceps, an effect of altering the feedback between biceps and its 
antagonist or one which may be related to the co-contraction phenomenon. Using this recog-
nised model of repetition fatigue we did not see any evidence of fatigue however. 
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10.13.2   Sustained Fatigue 
 
Sustainability assessments - 60 second contraction sustained at >80% maximal (Figure 10.22). 
 
To analyse sustained fatigue, we reviewed the mean biceps and triceps frequencies for the first 
10 seconds and the subsequent five, ten-second blocks of the one minute sustained contraction 
(and the mean force over this period). Fatigue was defined as a falling force of contraction over 
time, subjective report of feelings of fatigue or a sEMG assessed falling median frequency of ei-
ther biceps or triceps. 
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Group Force (Kg) 
1-6 
Med Bi freq 
(Hz) 
1-6 
Med Tri freq 
(Hz) 
1-6 
CoCo (ra-
tio) 
1-6 
 
Re-innervated 
6.28-6.24 
(±.2.66- 
3.17) 
61.79-49.44 
(±.10.56- 
14.66)  
65.47-55.60 
(±.13.55-
13.00) 
.256-.145 
(±.224-
.090) 
Difference between period 1-6 for 
re-innervated 
(significance of change p=) 
 
0.042 
(p=.915) 
 
12.353  
(p=.001*) 
 
9.869  
(p=.055) 
 
0.112 
(p=.101) 
 
Normal 
 
17.49-
15.13 
(±0.83-
5.03) 
 
68.41-65.26 
(±.12.87-
8.56) 
 
67.31-60.17 
(±.8.74-8.90) 
 
.156-.162 
(±. 0.79-
.101) 
 
Difference between period 1-6 
(significance normal change 1-6) 
 
2.36 
(p=.011) 
 
3.15   
(p=.343) 
 
7.14 
(p=.0001*) 
 
-.005 
(p=0.684) 
 
Table 10.22:  
Tabulation of the parameters of force, median biceps and triceps frequency (drop = fatigue) and the ratio of co-
contraction between 1(first 10 second block ) and 6 (last 10 second block) of the 60 second sustained contrac-
tion. With the SD of each below. The the significance of the change between 1-6 in that parameter. For both re-
innervated populous and the normal. * denoted significant result p<0.05.  
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 Re-innervated function Mean N Std Dev Std Error Mean 
Pair 1 ObFatigue1 Peak  6.279 13 2.658 0.737 
(KgF) ObFatigue6 Peak 6.237 13 3.172 0.880 
Pair 2 ObFatigue1 BicMed 61.792 13 10.588 2.937 
(Hz) ObFatigue6 BicMed 49.436 13 7.815 2.167 
Pair 3 ObFatigue1 TricepMed 65.469 13 13.555 3.760 
(Hz) ObFatigue6 TricepMed 55.600 13 13.000 3.605 
Pair 4 ObFatigue1 CoCo 0.256 13 0.224 0.062 
(ratio) ObFatigue6 CoCo 0.145 13 0.090 0.025 
Table 10.23: 
Tabulation of Paired samples statistic data for the 6 periods of sustained fatigue (each period a 10 second block 
of the sustained 60 second contraction) in the Nerve transferred arm. Compare with Table 10.21 for the normal 
control data. ObFatigue1 data relates to the first period of the fatigue (0-10 seconds). ObFatigue6 relates to the 
last period (50-60seconds). Peak is peak force (KgF). BicMed is the Median biceps frequency (Hz) TricepMed is 
the Triceps median frequency (Hz). CoCo is the Co-contraction ratio (AOC antagonist/ AOC agonist). 
 
 
 Re-innervated function N Correlation Significance 
Pair 1 ObFatigue1 Peak &  13 0.899 P<0.001* 
(KgF) ObFatigue6 Peak    
Pair 2 ObFatigue1 BicMed & 13 0.472 0.104 
(Hz) ObFatigue6 BicMed     
Pair 3 ObFatigue1 TriceMed & 13 0.202 0.507 
(Hz) ObFatigue6 TriceMed    
Pair 4 ObFatigue1 CoCo & 13 0.181 0.553 
(ratio) ObFatigue6 CoCo    
 
Table 10.24:  
A correlation table for the changes between the first and last sectors of the fatigue sustained contraction for the 
Nerve transferred arm. Peak force (unchanged over the period) and the sMEG changes in biceps, triceps and 
the change in co-contraction ratio. * denotes significant correlation p<0.05. The force is maintained well over the 
60 seconds but there are no other correlation. 
 
 
There is no drop in force over the period 1 to 6 in re-innervated muscle. Force is maintained over 
the sixty second contraction. 
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 Normal function Mean N Std Dev Std Error Mean 
Pair 1 NormFatigue1 Peak  17.492 16 5.836 1.459 
(KgF) NormFatigue6 Peak 15.131 16 5.028 1.257 
Pair 2 NormFatigue1 BicMed 68.413 16 12.875 3.219 
(Hz) NormFatigue6 BicMed 65.253 16 8.563 2.141 
Pair 3 NormFatigue1 TricepMed 67.306 16 8.745 2.186 
(Hz) NormFatigue6 TricepMed 60.169 16 8.902 2.225 
Pair 4 NormFatigue1 CoCo 0.156 16 0.079 0.020 
(ratio) NormFatigue6 CoCo 0.162 16 0.101 0.025 
 
Figure 10.25: 
 Tabulation of data for the 6 periods of sustained fatigue (each period a 10 second block of the sustained 60 se-
cond contraction) in the normal controls, Compare with Table 10.19 for the re-innervated muscle data. . 
NormFatigue1 data relates to the first period of the fatigue (0-10 seconds). NormFatigue6 relates to the last pe-
riod (50-60seconds). Peak is peak force (KgF). BicMed is the Median biceps frequency (Hz) TricepMed is the Tri-
ceps median frequency (Hz). CoCo is the Co-contaraction ratio (AOC antagonist/ AOC agonist). 
 
 
 Normal function N Correlation Significance 
Pair 1 NormFatigue 1 Peak &  16 0.831 p<0.001* 
(KgF) normFatigue 6 Peak    
Pair 2 NormFatigue1 BicMed & 16 0.333  p=0.208 
(Hz) NormFatigue6 BicMed     
Pair 3 NormFatigue1 TriceMed & 16 0.875 p<0.001* 
(Hz) NormFatigue6 TriceMed    
Pair 4 NormFatigue1 CoCo & 16 0.868 p<0.001* 
(ratio) NormFatigue6 CoCo    
 
Figure 10.26:  
A correlation table for the changes between the first and last sectors of the fatigue sustained contraction for the 
Normal Control arm. Peak force (unchanged over the period) and the sMEG changes in biceps, triceps and the 
change in co-contraction ratio. * denotes significant correlation p<0.05. There is clear maintainance of the force 
in biceps and no fatigue in triceps or increase in co-contraction.  
 
 
Similar to the re-innervated muscle there is sustained contraction over the sixty second contrac-
tion as shown by a correlation between period 1 and 6. 
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     95% CI of the dif-
ference 
   
 Re-innervated 
Muscle 
 
 
Mean 
 
Std 
Deva-
tion 
Std 
Error 
Mean 
 
 
Lower 
 
 
Upper 
 
 
t 
 
 
Df 
 
Sig  
(2tailed) 
Pair 
1  
ObFatigue1 
Peak- 
ObFatigue6 
Peak 
 
0.423 
KgF 
 
1.405 
 
0.390 
 
-0.807 
 
0.891 
 
0.109 
 
12 
 
p=0.915 
Pair 
2 
ObFatigue1 Bic-
Med- 
ObFatigue6 Bic-
Med 
 
12.354 
KHz 
 
 
9.754 
 
2.710 
 
6.460 
 
18.248 
 
4.567 
 
12 
 
p=0.001* 
Pair 
3 
ObFatigue1 
TriMed- 
ObFatigue6 
TriMed 
 
9.869 
KHz 
 
 
16.774 
 
4.652 
 
-0.267 
 
20.006 
 
2.121 
 
12 
 
p=0.055 
Pair 
4  
ObFatigue1 
CoCo- 
ObFatigue6 
CoCo 
 
0.111 
 
0.226 
 
0.063 
 
-0.025 
 
0.248 
 
1.777 
 
12 
 
p=0.10 
 
 
Table 10.27: 
 2 tailed comparison in re-innverated muscle sustained fatigue (60 second). The median frequency of the bi-
ceps from the first to the last sector in the sustained contraction- showing a significant difference (a drop of 
12.35 , range 6.46-18.25) demonstrating fatigue. * shows significance p<0.05. Compare with Table 10.24 where 
the normal muscle data is shown for the same sustained fatigue. 
 
 
Fatigue is evident in the re-innervated muscles, as demonstrated by a drop in the median fre-
quency over the period from the first to the last ten-second block in this sustained contraction. 
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     95% CI of the dif-
ference 
   
 Normal 
Muscle 
 
 
Mean 
 
Std 
Deva-
tion 
Std 
Error 
Mean 
 
 
Lower 
 
 
Upper 
 
 
T 
 
 
Df 
 
Sig  
(2tailed) 
Pair 
1  
Norm Fatigue1 
Peak- 
NormFatigue6 
Peak 
 
2.361 
KgF 
 
3.247 
 
0.812 
 
0.630 
 
4.0917 
 
2.908 
 
15 
 
0.011 
Pair 
2 
NormFatigue1 
BicMed- 
NormFatigue6 
BicMed 
 
3.150 
KHz 
 
12.873 
 
3.219 
 
-3.710 
 
10.010 
 
0.979 
 
15 
 
0.343 
Pair 
3 
NormFatigue1 
TriMed- 
Norm Fatigue6 
TriMed 
 
7.138 
KHz 
 
4.418 
 
1.104 
 
4.783 
 
9.492 
 
6.462 
 
15 
 
0.000** 
Pair 
4  
NormFatigue1 
CoCo- 
NormFatigue6 
CoCo 
 
0.005 
 
0.051 
 
0.013 
 
-.323 
 
0.022 
 
-.415 
 
15 
 
0.684 
 
Figure 10.28:  
2 tailed comparison in normal muscle in sustained contraction there is no change between the median fre-
quency of the biceps from the first to the last sector in the sustained contraction. The triceps does show a signif-
icant change however this change of 7.138KHz is less than the change in fatigue we see in the biceps in the re-
innervated muscle s of 12.354. 
IN the normal arms the Co-contraction ratio is 15% and similar to the end point of the drop in Co-contraction 
ratio in the re-innervated arms. 
 
There is no change in the median frequency of the biceps in the normal muscle controls. There 
is no evidence of fatigue in these muscles. 
 
 
 
 
 
 
 
 
 
234 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.29: 
 Histogram of re-innervated muscle (Oberlin) showing the drop in median biceps frequency  (Y axis) over time as 
divided by the 6 10 second time periods (X axis).  As shown in 10.23 there is a drop of 12.35 from 1st to 6th sector 
which is significant (0.001). 
 
 
 
Comparing the biceps change over time the re-innervated biceps are showing a significant drop 
in median frequency pattern. When we look at the drop of Biceps median frequency graphically 
we see this drop occurs in the last 10 second period of the minute sustained contraction: 
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Figure 10.30:  
Histogram of the normal controls (both limbs) showing no drop in median biceps frequency (Y axis) over time as 
divided by the 6 10 second time periods (X axis).  No significant change demonstrated. 
 
 
 
There is no change in the median frequency of biceps in the normal controls- no evidence of fa-
tigue and no difference between dominant and non dominant arms. 
 
In the above data we see that the force is well maintained in the re-innervated biceps flexion at 
6.2 Kgs (6.2/7.68Kg= 80%).  Change over 60 seconds from 6.28- 6.24 is not significant 
(p=0.915). Over this period of sustained contraction at 80% peak force the Biceps demonstrate 
the onset of fatigue (in that the biceps median frequency has dropped over this period from 61- 
49KHz (44Hz a change with a two tailed significance of (0.001). The Triceps did not fatigue (me-
dian frequency drop of 9.87Hz was not significant p – 0.055). The Co-contraction ratio in the re-
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innervated arms (triceps AOC/Biceps AOC) over the sustained contraction decreased (0.256- 
0.145) a change that was non significant (p=0.09) but the trend was for a decrease in the co-
contraction and a tightening of the spread of values and in doing so has dropped to near normal 
(ratio of 0.144).  
In the normal population: the biceps does not show any significant fatigue but the triceps does 
have a significant reduction in its median frequency of 7.14 Hz demonstrating fatigue. There was 
no significant change in the co-contraction. 
 
During the 60 second sustained isometric contractions it was noticed that: 
 
• The peak force attained in the re-innervated elbow flexors was 6.90Kg (SD 3.07).  
• This sustained force is 80.69% (46.96-108.67) of the peak possible.  
• The force did not deviate significantly over the 60 second sustained contraction (p value of 
0.00). 
• The mean frequency of sEMG biceps in the re-innervated muscles fell during the last 10 se-
cond period in the re-innervated muscle biceps median frequency dropped over the 60 se-
cond period from 61- 49KHz (44Hz a change with a two tailed significance of 0.001). 
• Co-contraction in the re-innervated arms dropped; the trend was for a decrease in the co-
contraction and a tightening of the spread of values and in doing so has dropped to near 
normal (ratio of 0.144).  
• In the controls: the biceps does not show any significant fatigue but the triceps does have a 
significant reduction in its median frequency of 7.14 Hz demonstrating fatigue. There was no 
significant change in the co-contraction. 
• No subjective signs of fatigue were reported in either group. 
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Figure 10.31:  
Clinical photograph demonstrating the position of surface electrodes as described in 10.8 pg 202. 
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10.14 Conclusions 
This study set out to: 
 
1. Identify a cohort of Oberlin transfer patients with documented MRC grade 4 recov-
ery of elbow flexion at greater than 2 years post operatively. 
2. Utilise this population to study fatigue with repeated and sustained contractions 
models. 
3. Examine fatigue via monitoring maintenance of force, subjective reporting of fatigue 
and mean frequency of the elbow flexors and extensors surface EMG (sEMG). 
4. Capture sEMG assessment of co-contraction ratio (antagonist area under the EMG 
curve / agonist area under the EMG curve). 
 
These data have demonstrated that: 
 
• a re-innervated biceps demonstrates a differing spectrum of EMG frequency in comparison to 
the contralateral limb- and thus by inference a change in spectrum following nerve injury.  Via 
a comparison of the means this difference does not read a significant difference however the 
populations are very different 49.66 SD 15.86 in renervation in comparison to 58.11 SD 6.53 in 
their opposite limb with t=-2.05 at a two tailed significance of 0.063 
• the re-innervated biceps contractions elicit more co-contraction- suggesting either an injury to 
the triceps (but they have a normal frequency spectrum in comparison to the contralateral 
side), or, a response to a pathology of the afferent signal from the re-innervated biceps. This 
difference is small 6% and has a t score of 2.049 with a two tailed significance of 0.067 
• with 3 repeated contractions there is no evidence of fatigue: the biceps med frequency is un-
changed  
• re-innervated biceps under sustained contraction (80% maximal for 60 seconds) fatigues more 
than an undamaged biceps. 
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• this fatigue is linked with a drop in the Co-Contraction ratio with the biceps’ antagonist- per-
haps in a method to protect the fatiguing muscle. 
 
 
Several studies have attempted to compare the variations in fatigue during prolonged isolated 
muscle contractions  (Place et al. 2009, Neyroud et al. 2012, Vøllestad 1997) and some following 
nerve pathology in humans (Pagala et al. 1993; Allen & Doherty 2011).  Only two  publications 
have been identified which focused on assessing parameters of fatigue following re-innervation 
of elbow flexion in humans (Chammas et al. 1997, Maricq et al. 2014). Both of these studies rec-
ognise the clinical validity of the issue of fatigue, and both use dynamometry to further the un-
derstanding in this area. The first (Chammas  et al. 1997) set out to compare the variations of 
muscle isometric strength during a prolonged effort between graft reconstructed, re-innervated 
muscle, and normal, uninjured human muscles. The enrolled ten subjects (four with unilateral up-
per trunk injuries and six with unilateral total plexus injuries) were treated with nerve grafts (in 
nine subjects) and an intercostal nerve transfer (using three intercostal nerves) in one. They were 
followed up at an average of twelve years (range 7.5-16 years). A supportive device was used 
(as many subjects did not have shoulder control) which held the arm in an internally rotated po-
sition. Injured arms were compared with the contralateral arm. Isometric force as assessed with 
a dynamometer with the elbow at 90 degrees. Maximal force was recorded from a series of 
three, five-second maximal efforts. A fatigue phase; where by a 100% maximal effort was re-
quested for one minute. Then a subsequent period where 50% maximal effort was requested for 
5 seconds every fifteen seconds during five minutes then at six , seven and ten minutes.  Their 
results showed the peak force was twenty-two percent of the contralateral normal side (with no 
difference between the upper trunk and the total plexus groups). 
The fatigue index (a measure of percentage of maximal force) fell by 10% within twenty se-
conds. This was similar between the normal and the re-innervated arms. 
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The second study (Maricq et al. 2014) also recognised the clinical issue of fatigue and the defi-
ciencies of studying motor outcomes with only MRC grading. This paper assessed nerve trans-
fer re-innervated elbow flexion (in five subjects) at a mean follow up of forty-seven months. Their 
trial end point was a 50% reduction in force They utilised a isokinetic elbow flexion test (of six 
repetitions of elbow flexion/ extension at 60 /s speed, then six at 90 /s, then four at 45 /s. Data 
was then collected during three cycles at 60 /s and five cycles at 120 /s.). Then a sustained iso-
metric test at 45 degrees elbow flexion, the time was measured for a 50% decrease of maximal 
contraction strength. Their population demonstrated 70% peak force from the re-innervated 
muscles in comparison to their normal. Maricq found that ‘No patient was able to maintain an 
isometric contraction during sufficient time to evaluate fatigability’ due to muscular pain. Their 
summary was that “the recovered elbow flexion remains quite weak, despite at first approxima-
tion an acceptable clinical result. There seems to be also an extremely quick muscular fatigability, 
causing pain upon sustained isometric contraction.” 
 
Historically these studies of fatigue only used assessed change in force output recording but 
signs of fatigue can also be objectively measured independently of the ‘mechanical manifesta-
tions’ (Cifrek et al. 2009). It is possible to interpret changes in myo-graphic signals to show the 
impact of biochemical and physiologic changes prior to loss of contractile force (De Luca 1994, 
Stulen & De Luca 1982).  
 
As a muscle fatigues there is a change in the power spectrum as detected from surface elec-
trodes. Under fatigue there is an increase in the amplitude of the low frequency band and a rela-
tive decrease in the higher frequencies. Physiologically, this reduction in frequency has been at-
tributed to changes in conduction velocity, changes in intra-muscular pH, modification in the re-
cruitment and synchronisation of the motor units and the fibre (Wang et al. 2014, Rogers & 
MacIsaac 2013, Dobkin 2008). The muscle frequency spectrum is a complex spread of elec-
tronic signals and derived variables from it have been assessed to quantify the degree of fatigue. 
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These include central tendency measures (mean, peak and median) and ratios of the power of 
high and low frequency bands. Since the muscle frequency spectrum from the surface elec-
trodes is not normally distributed the often used median frequency was selected as as the 
marker of fatigue (Yaar & Niles 1992, Thongpanja et al. 2013, Allison & Fujiwara 2002). 
 
Many clinical reports present series of patient demonstrating co-contraction around the elbow 
(Hierner et al. 2001, Rollnik et al. 2000, Hébert et al. 1989, Rouard & Clarys 1995). The degree 
and the manner of co-contraction are known to vary with fatigue within a normal population in 
isometric elbow flexion (Williams et al. 2002). It was not possible to identify any clinical studies in 
nerve injury which present an assessment of the co-contraction ratio (or any other similar objec-
tive continuous measure of co-contraction) or any that link this with fatigue. It has not been 
known what the incidence of pathologic co-contraction is in re-innervated muscle. 
 
 
10.15 Discussion  
 
The data has demonstrated novel data for force spectra within re-innervated human muscles 
and assessed co-contraction ratios. The findings of this study are novel findings in a human clin-
ical model of nerve injury and contribute to the development of understanding about the impact 
of re-innervation on human muscle function. The two previous studies in this area (Chammas et 
al. 1997; Maricq et al. 2014) have been advanced upon in that fatigue has been demonstrated 
within this model and characterised with electromyography. 
 
It has been clear in this  study that the patient’s experience of motor recovery following nerve 
injury was not represented by the standard method of peak force assessment. The assessments 
have over this time evolved from routine use of MRC grade to the use of a HHD to assess force 
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continually (Quick et al. 2016). When this was compared to patients’ expectation and satisfac-
tion following nerve transfer there was little correlation found between patient experience and 
their peak force of elbow flexion. In order to progress a more comprehensive appreciation of re-
innervated muscle function the study was to re-focused on the elements which have been iden-
tified as meaningful to the patients; Through a thematically coded focus group discussion exer-
cise fatigue was identified as a central theme of muscle recovery and through deploying a rede-
signed study, and widening the examination to include co-contraction as an important feature of 
this experience; thus relevant data were collected. Thus the state of clinical knowledge agreed 
that fatigue was a clinical issue. It further suggested that there may be a difference between the 
outcomes as regards fatigue between nerve grafting and nerve transfer, that there may be deep 
pain associated with fatigue. 
 
This study set out to characterise the pathology of human muscle dysfunction following re-inner-
vation; with specific attention to fatigue and the contribution of co-contraction: However, it can-
not be ignored that the success of re-innervation following chronic muscle denervation has 
many contributory elements: All of these factors may contribute to the clinical dysfunction that is 
demonstrated in this model: 
 
• The effects of chronic denervation on the distal stump are well characterised (Fu 1995) and 
are majority contributors to the success or failure of the acutely axonotomised donors in this 
model (and still in the chronic axonotomy when graft repair is performed).  
• The changes within the muscle with progressive loss of capillary density, motor fibre num-
ber, down regulation n contractile protein, increase in intracellular fibrosis and reduction of 
satellite cell numbers (Carlson 2014). 
• There is also evidence for a higher order pathology which is a factor with neural fatigue inter-
acting with muscular  fatigue (Taylor et al. 2016)  
• Psychological impact of injury and paralysis to recovery of function (Collins & Long 2003) 
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The findings of this study are presented as a further characterisation of the clinical problem and 
do not offer any evidence towards etiology of differential contributions of the above pathologies 
to this pathology. That will be the aim of future prospective studies. 
 
This study has demonstrated that a cohort of subjects following nerve transfer to elbow flexion 
have developed a mean peak force of 7.68 Kg SD 3.8 (38% of the contralateral side) this is 
within a range of what others researchers have found. [see literature review in Chapter 7] thus 
establishing this to be a representative population to further study. 
 
10.15.1 The selection of sEMG median frequency assessment of fatigue 
 
There is debate surrounding the use of this myoelectric marker of muscle fatigue; it is used by 
many experienced authors in this area (Mannion & Dolan 1996; Phinyomark et al. 2012) and has 
been shown to be reliable and repeatable (Gazzoni et al 2017). There are other more direct 
markers of muscle metabolic change; as discussed below: 
 
10.15.2 Reduced Mean frequency in unfatigued nerve transfer re-innervated human muscle 
 
The finding that re-innervated muscles demonstrate spectra that have an un-fatigued power 
spectrum which is 80% lower than the contralateral controls is likely to be a demonstration of 
the impact of renervation; where by the motor pools are larger less heterogeneous and a greater 
percentage of slow twitch type I motor units (MUs). The fast twitch/ type II units are of the fre-
quency range = 126 - 250 Hz and due to their aerobic nature fatigue more quickly than the tonic. 
Slow twitch /type I units which have a spectral range of 20-125Hz. Thus the spectrum shifts 
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downwards; with the onset of fatigue and the build up an hypoxia metabolic load. Also it is de-
creased if the new, un-fatigued, population of a re-innervated muscle has a higher ratio of type I 
fibres. As shown by Bagust and other authors (Bagust et al. 1981, Dum et al. 1985, Gordon et al. 
1988) the characteristics and ratios of motor units are determined by the innervating axons. That 
is to say the type and make of the motor units and thus their fatigue resistance are characterised 
by the type of axon that establishes contact. Foehring (1986) and Rafuse (1998) demonstrated; 
even within self-re-innervated (analogous with the spontaneous recovery or nerve graft repair 
patients)  muscles; a growth in the MU pool with a decrease in the MU number and an increase 
in the ratio of type I MUs. 
 
10.15.3  Demonstration of earlier Fatigue in re-innervated human muscle 
 
The results demonstrate no effect of fatigue with 6 repeated maximal contractions either on sub-
jective or objective assessments. In fact, anecdotally, the subjects reported that they felt 
stronger throughout the attempts.  In that none of the subjects demonstrated fatigue within the 
repeatability trial it was obviously therefore submaximal in stressing the ability of the muscles 
(both uninjured and re-innervated). This is a clear weakness of the study design. 
The sustained isometric model of fatigue did however demonstrate a differential response be-
tween the re-innervated muscles and uninjured controls. 
The assessment of a muscle with sEMG demonstrates the population of motor units within the 
muscle, the Fast twitch (type II) units have a higher frequency of activity and make up the top 
end of the spectra.   Thus it is shown that a muscle that is re-innervated will have a novel force 
spectra, with a right shifted spectra as there is a higher ratio of type I fibres. These data suggest 
such a trend. During fatigue significant changes occur in the intra and extracellular environment 
(Dimitrova & Dimitrova 2003) the increase in intramuscular pressure determines occlusion of 
blood flow (Matkowski et al. 2011) the electric properties of the muscular fibre membrane 
change ( Dimitrova & Dimitrova 2003), and myoelectric manifestations of muscle fatigue become 
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evident (Merletti et al. 1988). These myoelectric changes with fatigue are recognised by examin-
ing the sEMG frequency domains; median frequency fall is a widely used subjective manner to 
assess fatigue (Merletti et al. 1992). These EMG changes occur prior to any decline in the mus-
cle’s mechanical output, they are a measure of the changing metabolic status of the muscle and 
hence its inability to function produce maximal force. 
 
10.15.4 Co-contraction ratios in re-innervated human muscle 
 
This study has shown no difference (2 tailed significance p=0.63- insignificant at an alpha of 
0.05) between the re-innervated and contralateral arms (18% re-innervated vs 12% contrala-
teral). The levels of co-contraction drop over the fatigue period from 25.6 % (SD 22.4%) to 
14.5% (SD 9%) a change again not reaching an alpha of 0.05 (0.101). 
These findings are in line with the literature;  
 
Frey-Law (Frey-Law 2013) found when assessing co-contraction (in healthy subjects’ elbows 
and knees) that muscle co-contraction is determined by local, joint-specific, and generalised, 
individual-specific influences. They also found large variation in person to person difference con-
cluding that person-specific variations in the propensity to use co-contraction as a motor-con-
trol strategy across multiple joints indicate the presence of a generalised response.  
 
The levels of co-contraction in neuromuscular disease showed similar finding with no differences 
(but a trend towards a difference with large SDs in both groups). In  a study assessing the levels 
of co-contraction in hamstrings during knee extension exercises in differing neurological pathol-
ogies (Busse et al. 2006) noted percentage co-contraction rates of 11.8%  in normal controls 
performing isometric exercise (this increased to 20.5% when a dynamic sit to stand exercise 
was assessed- as would be expected in a un-restrained system where balance was required). 
When compared to a range of differing neurologic conditions the conclusion of this study.  
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Co-contraction can be physiologic or considered pathologic if it hinders function. Co-Contrac-
tion increases joint stiffness in response to environmental instabilities (Kornecki 1992, Osu et al. 
2002) and greater control while performing tasks that require a high degree of accuracy (Smith 
1981, Enoka 1997, Selen et al. 2006). It is variable and specific to tasks the environment and the 
training for that task. Co-contraction has been seen (Gordon & Ashton-Miller 2009) to give the 
greatest damping of movement at around 30%. This proprioceptive effect is a potential reason 
why there is a trend towards increased rates of co-contraction on attempted elbow flexion fol-
lowing renervation with nerve transfer. It is suggested that this is a compensatory mechanism for 
a re-innervated muscle which has reduced afferent connections and thus the higher motor pro-
gramming is reaching out for more information on the movement- it thus increases triceps feed-
back via increasing its sensitivity or co-contraction to a near optimal level for this from 15% to 
25%. 
 
10.16 Study limitations 
 
The study design can be criticised in a number of ways: 
 
• The retrospective nature of the study and the low rate of response when selecting pa-
tients introduces significant bias. We intend to introduce these assessments as part of 
prospective studies with this same model. 
 
• The contralateral arm was only used for comparison of the peak force and sequential 
contraction- it was not used for fatigue analysis as well this was a failure of trial design - 
we had not envisaged the assessment would take the time it did and thus we did not 
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capture this information. The normal controls have allowed us greater freedom with sub-
jects that were geographically closer and available for assessment under lesser time 
pressure. 
 
• The selection of sEMG median frequency assessment of fatigue; although there is much 
debate surrounding the use of this myoelectric marker of muscle fatigue it is used by 
many experienced authors in this area (Mannion, 1996, Phinyomark2012) and has been 
shown to be reliable and repeatable (Rainoldi et al, 1999).. 
 
• The protocol for elbow assessment was limited to isometric single position (ninety de-
gree flexion in neutral supination) further dynamic and range, and rate of movement  
studies could be further undertaken. 
 
 
10.17 Other factors 
 
The effects of chronic axonotomy, chronic distal stump denervation and the contribution of 
chronic muscle denervation were examined by Gordon (2011) and quantification of the contribu-
tions from each were made: First they demonstrate in a rat model that immediate nerve repair 
via a nerve graft does not lead to full recovery. Then the effect of chronic axonotomy was shown 
to show a decline in regenerative capacity relative to immediate nerve repair which is compen-
sated for by motor unit enlargement. It was then demonstrated that prolonged distal nerve 
stump and muscle denervation have the most deleterious effect on regenerative success. This 
series of experiments has shown reduced contractile properties including that of fatigue to be 
linked with a reduction in motor pool, increase in size of the motor units and a shift to type II 
MUs. 
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The conclusion pertinent to this model of nerve transfer (where chronic axonotomy is not an is-
sue) “chronic denervation of Schwann cells in the distal nerve stump and the chronic denervation 
of the muscle of re-innervation together inhibit the capacity of even freshly axonotomized moto-
neurons to regenerate their axons and to re-innervate muscles. However, it is not simply that the 
chronically denervated muscles are replaced by fat (as is commonly believed) that accounts for 
the very poor axon regeneration and muscle re-innervation. Rather, it appears that, the chroni-
cally denervated muscle has a negative retrograde effect on the capacity of motoneurons to re-
generate their axons” (Bain et al. 2008). 
There is evidence that chronic muscle denervation is not the prime factor that accounts for poor 
functional recovery after proximal nerve injuries (Fu & Gordon 1995). Functional recovery is lim-
ited primarily by the progressive fall in regenerative capacity of axonotomised neurons and de-
nervated SCs with time and distance. Loss of muscle fibre number and failure of re-innervated 
muscle fibres to fully recover their former size is an additional factor limiting motor recovery. Sat-
ellite cells may be reduced in number, ability to replenish muscle nuclei, and/or proliferative ca-
pacity (Anzil & Wernig 1989). 
Beyond the function of the re-innervating axons the changes in the muscle are also obviously 
pertinent; the metabolic, biochemical, structural, physiological changes are well reviewed in 
Midrio (2006). 
 
10.18 Summary 
 
Control and fatigue of human muscle is a feature of a very complex motor system- even more so 
when this system has been disturbed by a process of re-innervation. Simplistic assessments (as 
have been undertaken) will not identify a cause; only describe the symptoms. This study has 
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only started on looking at the symptoms and has only (intentionally) considered the contribution 
from the peripheral aspects of the neuro-muscular system. 
 
 In a review article on the history of fatigue assessment Enoka (2011) highlighted the central ef-
fects in fatigue and stated: 
 
“The activation of muscle by the nervous system can be compromised during fatiguing 
co-contractions and contribute to the amount of fatigue experienced by the muscles in-
volved in the task. There is a great deal of work to characterise the impairments ex-
pressed in re-innervated muscle and how these vary between auto-re-innervated muscle 
(through natural nerve regeneration or through a graft repair) and muscle re-innervated by 
a foreign nerve (via nerve transfer).” 
 
There is indeed a great deal more work to do to move this work forward. 
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1.Patient demographics. Taken as a quote from BJJ Quick et al. 2016 
 
Case1 (NA): A 40 years old right hand dominant (RHD) printer sustained a left brachial 
plexus injury following a road traffic accident (RTA) 5years ago. There was an associated 
proximal humeral fracture, treated with plate fixation and a head injury, treated conserva-
tively. Clinically, he showed little recovery for C5 and C6. Hence 5 months later, he under-
went neurolysis and exploration of his left supraclavicular brachial plexus. Intra-operatively, 
there was nothing to distal stimulation for biceps either palpably or needle EMG, was noted. 
As there was no improvement in biceps function, 3 months later Oberlin procedure was per-
formed. 
Case 2 (TH): A 34 years old construction manager sustained a right-sided brachial plexus in-
jury, and C1-C2 fracture in a RTA in the Carribean 4years ago. He underwent immediate sur-
gery for C1-C2 there, and was later got operated at our institute for his plexus injury, follow-
ing his return to the UK. Intra-operatively, C5-C6 avulsion injury was confirmed. 
Case 3 (RR): A 70 years old lady sustained a partial cord lesion from spinal nerve injection 
with infarction of C6 neurones, 6years ago.  Some residual biceps function only as single re-
innervated most units seen under voluntary control and hence the decision taken to proceed to 
Oberlin’s transfer. 
Case 4 (GM): A 50 year old left hand dominant (LHD) builder who sustained a road traffic 
accident, motorcycle versus car, 6years ago, with multiple injuries, lung contusions and frac-
tured Cervical spine, iliac wing fracture, inferior pole of scapular fracture on the left side.  He 
also had an associated head injury.  He had no Tinel’s sign, no Horner’s, nothing clinically for 
C5, 6 or 7 but preservation for C8 and T1. Intra-operatively, the plexus was found to be em-
bedded in scar tissue with distal activity noted in supraspinatus and deltoid but none in biceps 
on stimulation. No recovery of biceps function at 3 months post-op (almost 6 months post-in-
jury), prompted to proceed with Oberlin transfer. 
Case 5 (AW): A 47 years old gentleman had RTA when his motorbike collided with a car at 
30mph, 5years ago.  His injuries were C4 – C7 and T2 transverse process fractures, T7 wedge 
fracture, left sided rib, clavicle and scapula fractures and a brachial plexus injury.  He was op-
erated for right postero-lateral corner injury of knee, four days post injury but his remaining 
fractures were managed non-operatively. Ten days post injury his brachial plexus was ex-
plored and an avulsion of C5-C6-C7 was confirmed and decision to proceed with Oberlin pro-
cedure in the same sitting was undertaken. 
Case 6 (DB): This 24 year old RHD Carpenter was a motorcyclist who had a head on colli-
sion with a tree riding at 30mph, 6 years ago.  He had multiple injuries including facial frac-
tures, right humeral head fracture, C1 fracture and head injuries with contusions of the left oc-
cipital and frontal lobes.  His brachial plexus injury consisted of the C5 and C6 avulsion in-
jury. His head injuries prevented him from earlier exploration and reconstruction of the plexus 
and hence the delay in reconstruction.  Because of this delay of more than 5 months, the deci-
sion was to go directly to the nerve transfers rather than exploration of the plexus. 
 
266 
Case 7 (FG): This 72 years old woman was sitting on her stationary moped when hit by a cy-
clist coming downhill at speed and thrown off her moped, 6 years ago.  She sustained frac-
tures of C6 and C7 lateral masses, as well as the T1 transverse process.  She initially had a 
dense brachial plexus palsy involving the entire left upper limb, which was completely flail.  
Intra-operatively, C5, 6 and 7 spinal nerves were encased in scar tissue over a long segment 
extending to the upper and middle trunk. The release of scar tissue exposed a crushed and 
flattened nerve segment that was still in continuity.  However, on stimulating C5, C6 and C7, 
there were no SSEPs recordable proximally and no contractions in the muscles distally (? 
avulsion). It was therefore felt that recovery in this spinal nerve would be most unlikely, and 
hence a staged nerve transfers were undertaken.  
Case 8 (RA): This gentleman was in a motorcycle RTA 6 years ago sustaining bilateral frac-
tures of the wrist as well as a complex fracture of the distal femur and right brachial plexus 
injury. He had operative fixation of his fractures and a month later was sent over to our unit 
for brachial plexus surgery. Intra-operatively, an avulsion injury to C5-C6-C7 was confirmed 
and staged nerve transfer was undertaken. 
Case 9 (SA): A left-handed apprentice mechanic had a road traffic accident when his bike col-
lided with a car. His brachial plexus injuries were only picked up a week down the line in 
fracture clinic and then a referral was made to our unit. He underwent an exploration where 
his injuries were characterized as C5 rupture and C6 avulsion and nerve transfers were under-
taken. This was followed with a staged Oberlin procedure. 
Case 10 (LC): A right-handed hairdresser who suffered a severe injury 8 years ago following 
a road traffic accident, motorcycle versus car sustained serious injury to his brachial plexus, 
(stable) cervical spine and also a hematoma within the spinal canal involving the spinal cord. 
At exploration avulsions of C5, C6 and C7 were noted and staged nerve transfers performed. 
Case 11 (BA): This 49 year old RHD carpenter was involved in a RTA 2 years ago and sus-
tained multiple injuries including intracranial bleed, facial fractures, lung contusions, medias-
tinal injury, left scapula fracture, left distal radius fracture (ORIF) and bilateral femoral frac-
tures (IM nailing). After his initial stabilisation at his local hospital he was noted to have fea-
tures of a left brachial plexopathy and had an inpatient transfer to our unit. At the time of 
plexus exploration, clear rupture of suprascapular nerve- distal part of which was not identifi-
able in the wound and evidence of a long traction injury of the upper trunk distal to take off 
Dorsal Scapular and Long Thoracic nerves was noted. Following the failure of functional im-
provement post decompression, nerve transfer procedures were performed. 
Case 12(SP): A 19 years old sustained a left non-dominant brachial plexus palsy following a 
rugby injury 3 years ago. He underwent exploration 2weeks post injury, which showed avul-
sion of C5 & C6. This was addressed with nerve transfers. 
Case 13 (MH): A 48years old right-handed gentleman had a road traffic accident, when his 
van hit another van at 60mph. He sustained pelvic and mandibular fractures, and injuries to 
spleen and liver for which he underwent laparotomy. He was in induced coma in ICU for 
2weeks at his local hospital. His brachial plexus injury, C5/6 avulsion, was explored and ad-
dressed with nerve transfers 5 months post injury. 
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Case 14 (CM): A 46 years old RHD Carpenter was involved in a RTA, bike versus van, in 
France 3years ago, sustaining multiple injuries including left distal tibial fracture, L1 fracture 
(managed non-operatively), head injury, left brachial plexus injury, axillary artery occlusion 
and posterolateral corner injury of right knee with associated fibular neck fracture and pero-
neal nerve palsy.  Posterolateral corner reconstruction for his knee was performed in France.  
His vascular and brachial plexus injury were addressed at our institute 2 months post injury. 
At the time of exploration, he was found to have an avulsion of C5 & C6 that was managed 
with nerve transfers to regain shoulder stability and elbow flexion. 
Case 15 (DB):  A 38 years old right handed kitchen porter, cycled into a lamp-post 3 years 
ago sustaining facial fractures, minimally displaced left clavicle fracture, C7-T2 transverse 
process fractures, and left sided rib fractures (rib1, 2 & 3).  He underwent Brachial plexus ex-
ploration 4days post injury and C5-C6 avulsion and injury to Accessory Spinal nerve were 
identified. As a result, standard nerve transfer could not be attempted for shoulder stability. 
Hence, an attempt to repair C5 avulsion was undertaken, and Oberlin transfer was performed 
later as a staged procedure 7 months post injury.  
Case 16 (BP): A 26 years old sustained a brachial plexus injury 3 years ago to his right non-
dominant side following a RTA, motorbike versus metal fence. No other injuries identified. 
Three days post injury he had exploration of his brachial plexus and staged nerve transfers, 
first to stabilize shoulder at the time of initial exploration followed by Oberlin transfer for el-
bow flexion, 4 months later. 
Case 17 (SB):  A 44 years old gentleman had a RTA 3 years ago when he lost control of his 
motorcycle and sustained a polytrauma. His injuries included a transverse scapular fracture, 
acromion fracture, 1st rib fracture and brachial plexus injury to his right dominant side. Four 
days post injury he underwent an exploration of plexus where a C5-C6 avulsion was identi-
fied and a staged Oberlin transfer was performed 4months later. 
Case 18 (SP): This 49 years old gentleman crashed into a stationary bus whilst on his motor-
bike, travelling at 20mph 3 years ago.  He collided on the left side of his neck/shoulder.  A 
trauma review, radiographs and a CT neck did not reveal any bony injury and he was dis-
charged from A&E.  At follow-up in fracture clinic a day later he was noted to have focal 
neurology in C5/C6.  Three days post injury he underwent a brachial plexus exploration that 
showed avulsion of C5 & C6 roots, and he had nerve transfers in the same sitting to regain 
shoulder stability and elbow flexion. 
Case 19 (KP):  A 57 years old gentleman came off his motorbike when was hit off by a car, 
4years ago, sustaining left clavicle, humerus and distal radius fracture, and infraclavicular in-
jury to left brachial plexus. At exploration, next day following his accident, there was signifi-
cant infraclavicular plexus injury in form of contusions to medial and posterior cords and 
avulsion of musculocutaneous nerve. 
Case 20 (SW): A 25 years old was hit by a car, 4 years ago, sustaining a brachial plexus in-
jury to his left non-dominant side. There He also had left humerus fracture that was fixed sur-
gically at the time of injury. He was referred 4 months following his injury with signs of re-
covering Supraclavicular plexus injury but no biceps and weak triceps function. Hence, he un-
derwent an Oberlin transfer to improve elbow function. 
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Case 21 (KC): A 40 years old sustained a brachial plexus injury to his left non-dominant side 
when his pushbike hit a lamppost, 5years ago. He had exploration of his plexus a week down 
the line, when an avulsion of C5 & C6 was confirmed. At the same sitting, he underwent 
nerve transfers to improve his shoulder stability and elbow flexion. 
Case 22 (DC): A 33 years old gentleman had an RTA when his bike hit a tractor at a speed of 
40mph, resulting in injuries to his right clavicle, multiple ribs and brachial plexus, 2.5 years 
ago. Following his initial management at local hospital, he was referred to our unit and under-
went a brachial plexus exploration that confirmed an avulsion of C5-C6. He had multiple 
nerve transfers to improve shoulder stability and biceps and triceps functions. 
Case 23 (PJ): A 41years old gentleman had a RTA, 4years ago, motorbike versus car, sustain-
ing injuries to his brachial plexus on his right dominant side. At initial exploration, a long 
traction injury to upper trunk was confirmed and hence no nerve transfer was undertaken. 
However, following poor recovery over next 6months, it was decided to proceed with the 
Oberlin transfer. 
Case 24 (CB): A 37 years old gentleman had a RTA 2.5 years ago, when his bike was hit by a 
car, resulting in right brachial plexus injury.  He was referred 3months post injury and under-
went brachial plexus exploration and nerve transfers to improve his right upper limb func-
tions. 
Case 25 (TB): This 52 years old gentleman had a RTA in 1995 when his bike was hit by a car. 
This resulted in comminuted humerus fracture and injury to musculocutaneous nerve on his 
right dominant side. He was referred 14 months post injury for his nerve injury and underwent 
an Oberlin procedure.  
Case 26 (IB): This 41 years old lady was a front seat car passenger that was hit by a tractor, 
resulting in a left brachial plexus injury. She was referred the same day and went a brachial 
plexus exploration to confirm C5-C6 avulsion and had nerve tranfers to improve upper limb 
function. 
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2. Transcription of patient discussion group.  
 
KJ -Everything is going to be confidential, no wrong answers, no names mentioned.  Very much an open forum if you have 
any mobiles please put them on mute.  If you feel you need to get up and have a break just get up and go. 
Just a recap to start with, shall we show video which most people have already seen in the questionnaire in the beginning. 
HB - The focus is on the actual elbow bend and straightening, this is the movement we want you all to concentrate on be-
cause the surgery that we have looked at that you have all had is to make you be able to do this movement.  You’ve probably 
had or may have had other surgeries as well, other muscles or nerves but this is our focus today.  We know it is very much 
not a straight forward injury; it’s a very complex injury. 
KJ - So to start with do people want to say how long it is that they have had their nerve injury or nerve surgery in the elbow?  
Just to give people a bit of an idea of where everybody’s at, that might be a good way to start. 
 
TB - My accident was June 1995 and I, do you know what I can’t remember if it was 95 or 96 I had surgery but it was around 
then.  That long ago I can’t remember if it was late 95 or early 96. 
KJ - Tony, when was the nerve surgery in the elbow? 
TB  – That came because I was in hospital for about a month and they didn’t diagnose it until the day of discharge.  The 
physio asked me to move my arm and I said I can’t, she ticked me off for being a bit lazy and I remember one of the nurses 
saying stop making a fuss and lift your arm up.  I said ‘I can’t, I can’t’ I have a plaster cast, and it was on the day of dis-
charge.  One of the consultants said medical plexus refer him on to Rolfe Birch and so then I was referred and then I had 
some tests.  So I think it was the actual 1st operation, pretty sure could have been that year so I would say 1995. 
KJ – Ok, so you had it quite a while ago 
TB  – Yeah 
KJ - Anybody else as long? 
LJ – Mine was October 2015, my surgery so that is quite recent compared to yours.  I had a nerve graft on my shoulder and 
the oberlin transfer?  When I first had it I think it was those 2 fingers just very weird, hyper sensitive 
TB – What the first 2? 
LJ – yeah, I had those 2 i don’t know if that was to do with the shoulder or the biceps 
KJ – So you had that experience after having the oberlins, the sensitivity?  Or was that before? 
LJ – That was I can’t remember now, if after the accident or before or after the surgery 
KJ – but particularly the index, the middle? 
LJ – Yeah yeah, and it still don’t feel – they feel much better – but they still feel kind of rubbery.  A little bit, but much better 
than they were. 
KJ – Do you feel that affected your recovery from surgery? 
LJ – No I just, it was just there, that was it.  Just carried on really.  
KJ – and Jenny you were saying your.. 
JT – Yeah 14months ago. I had key hole surgery and then the musculocutaneous nerve got damaged in my shoulder, I’m a 
PE teacher as well so... devastated  
TB – What was the keyhole surgery? 
JT – I had dislocated shoulder, and they were doing keyhole up here.  For some reason, nobody’s really sure what happened 
but it took them 9/10 months to diagnose that.  November, so it’s been 3 y ears since the keyhole, ongoing really since injury. 
TB- Sorry I know it isn’t very interesting for you but it’s interesting for me because having a bit of a roller coaster ride it is 
reassuring from somebody else’s as mine was the same nerve trunk that I have been left with 
JT – Yes it’s still ongoing, still experiencing quite a lot of pain at times so that’s the challenge and the frustration as a PE 
teacher that I am not patient. It’s not my strong point 
6.10 
KJ - is pain more since having since the Oberlin or was the pain..? 
JT – No the pain was horrendous before.  It’s changed and it’s definitely a different pattern,  more down the UN side. 
TB – Wondering if we have the same pain, so your pain, when you say the UN  
JT – it’s shooting down this side, these two fingers and at times it’s like I’ve got a really tight elastic band. 
TB – I do get pain, but not that sort of pain 
JT – Yeah, and I just want to stretch the fingers out because it’s kind of nice feeling 
KJ - do you experience that pain as well? 
6.17 
SB – Yeah it’s quite stiff, but a similar sort of time, my accident was about 18 months ago. I had, was it the Oberlin that they 
put back in and the AN because I pulled out 3 of them, C5 6 and 7.  I find the pain worse in the cold, you can get up in the 
morning, I find stretching out does help getting going in the morning, because there is less the circulation and movement 
there you end up doing those things to bring it on yourself. 
TB - How did you do yours Steven? 
SB – motorcycle accident  
TB - It’s interesting , who was motorcycle ? 
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TB – Mine was a pushbike. My injuries were sustained as I was T boned by a car and went in to the side of it, where I was 
holding the handle bars my arms acted like blunt force so they all sort of, my joints took the.  Mine wasn’t caused by landing 
on my shoulder which I believe is quite normal, no I can’t remember my accident. 
SB – I can’t remember my accident, I’ve hit the car and this bit stretched  
TB – Mine I don’t remember, I can imagine your arms acting like platforms 
KJ – Does pain seem to be quite a common theme with quite a few of you? 
PA – it’s changed over time, I mean at the very start some of the pains were horrific but you become used to it a little bit, like 
anything.  You understand your body as well. 
PA – You cope with it 
09.10 
JT –are you still on medication for that?  Still on your gabapentin? 
TB – I’m not, is that a pain killer?  I don’t know what that is?  No, I don’t think I ever had that anyway. Mines a bit of a 
tricky one because I’ve got a bit of arthritis coming in to my elbow because where all the joints got compressed and the soft 
tissue sort of wasted or withered, pushed out.  But because I over compensate with other muscles, is it brachioradialis pick 
me up with that muscle.  My elbow sort of moves fine, but come after a few hours or a tiring day I then get arm ache, I get a 
like a tennis elbow and some!  And tennis is one of my sports which I have had to stop because if I have a knock around 
which I do now, I just have the odd 10 minute knock around but then I pay the price and if I hit a couple of gentle serves then 
that’s it. 
JT – agrees in background 
KJ – Do you feel it’s more over use than compensatory muscles? 
TB – Yeah, tennis elbow sets in and I’m in trouble, when I was playing tennis moderately regularly there came a point that I 
was in so much pain that at best I could use a pen, just couldn’t use my arm.  Had it in a sling, so it was knackered.  But now, 
I have stopped tennis if I have a busy ish day, because I still lift things, I still do things as normal.  I forget, because you do.  
You just sort of get on with it don’t you. 
JT – I am really struggling with that, and that was part of the problem with my bicep didn’t look like it was doing anything 
for ages, but all my other muscle groups was compensating and my brachioradialis is still one of my biggest problems.  Still!  
And uncomfortable, by Friday just lifting the arm on Friday is just exhausting, throwing you hair and all this kind of regular 
tasks. 
GP – holding the phone, using the phone for any length of time. I do it deliberately with the weaker side. I keep using it, but 
it is being locked in that position for a length of time and then it will start aching down the forearm. 
JT –and that’s really when I knew there was something wrong with my bicep was this was getting massive and this was get-
ting smaller so..and it is really dominant on this side. 
TB- do you get creaks and cracks ? 
JT – I don’t get creaks and cracks but the knocks in that muscle are huge so lots of massage. Heavy, aches. 
TB – I now find that if I have a busy day I get not that painful it’s really not that painful, but I get a tiredness.  I don’t need to 
take any pain killers for it, it’s uncomfortable but I can feel it, I have got it now and it starts sort of around here and it goes up 
here.  This is the bit that I will sit there, normally when you massage yourself you don’t get the benefits do you?  And I will 
sit there and prop my neck, it just gets me here.  I don’t know what, you probably have more knowledge of that.  I don’t 
know, because that seems like a treatment.  It’s not really life stopping, I still carry on it is just uncomfortable. 
KJ- are any of those symptoms you’ve mentioned attribute to having occurred following the Oberlin surgery, as they changes 
occurred and started to get regeneration in the biceps do you feel there is any particular sensation or symptom that come with 
that regeneration of muscle that? 
SB – you’re talking about what, twitching and things or sensation as in fixing? 
KJ- Yes, so as you.  Following a nerve surgery I don’t know if generally when you’ve first started seeing any changes for 
instance, did that vary amongst you?  When did you first start seeing any change? 
JT – July, I was done in November. Quite a few months, cos I was like it is never going to happen. 
KJ – And what was different? 
JT – I had to absolutely concentrate on what I as doing try and switch off all the other muscles to try and get it to work be-
cause everything else was firing instead of it 
KJ – did you feel any sensation around there, what made you feel something was happening.  What drew you to the attention 
that something might be first happening. 
JT – It was coming in and being attached to, that was the first bit when you’re attached to you can see the bio feedback was 
massive for me.  It was then being able to concentrate and see all that sensation and concentrate enough to feel the bicep was 
working, rather than just letting the other muscles take over. And you could then feel bicep, but having that bio feedback was 
just massive. 
KJ – Would you agree with that? 
P A– We heard it here, I was trying to ask and I couldn’t get it.  We haven’t got that locally with my physio and so I had it 
put on here and as soon as you try and get that movement, then all of a sudden get that beep and you know that’s what you 
have to do, but when I’ve gone back I can’t do it again.  Without that feedback once you’ve isolated that movement it’s just 
something beeping to let you know you’re doing it, and it worked.   
14.47 
KJ – And that was the first time you were aware of anything changing? 
P A– Yeah, getting hit in the right 
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TB -  Mine’s been coming back a bit from that, this is even when it wasn’t diagnosed that I had any problems with my biceps 
but when I was in the ward and it was one of the nurses that used to come, because my arms were mashed up anyway and 
was in plaster.  It looked like a scene out of a carry on film, that they had to just keep my limbs moving, just so they didn’t 
seize up.  The guy would come every day and just gently move my arms up and none of us knew that I had a problem with 
my nerves that I used to get some real tinging sensations going up and down my arm and it was a real sense of relief.  We 
hadn’t realised that I had a problem, but that was quite a comforting thing.  So there was obviously some sort of conduction 
there.  Although my arm didn’t work at all. As he stretched it I could feel a sort of tingling down there, so there was obvi-
ously something  
KJ - it sounds like Paul you mentioned local services quite different, everybody experiences of therapy are very different.  
How often do you feel would be helpful to be monitored after the surgery, or just been seen.  What do you think would be 
helpful in the scheme of things, from a rehab point of view, in an ideal world? 
SB – I haven’t had any of those, until we did that induction stuff.  Nobody really plugged me in until they did in the first 
place they give me a? I didn’t have anything afterwards.  What I started noticing was in the pool first of all, I wasn’t moving 
but it would go in.  it wouldn’t be a smooth movement, but yeah I noticed I could do something and I had to really concen-
trate but out of the water, with gravity there was nothing there because you can’t push it on against the weight, and it was 
completely wasted away.  But when you are in the water, it was like oh yeah I am doing that myself.  And as rubbish as it 
was and as small as the movements were I am bending my arm doing that and I was getting a little bit of abd as well. 
KJ - so you talk about the water, was it hydro therapy ? 
SB – no just the swimming pool, again to help with the range of motion because obviously you can bend by the side and 
that’s a good place to do it because I could stretch myself and all that sort of stuff, but that’s when I started to notice it. 
PA –I has the same thing here in the pool, I had hydro-therapy and I couldn’t do any movement with my arm or feeling, and 
slowly it was the best feeling in the world when you see that move but so much pain there I couldn’t actually feel what move-
ment it was, it just moved slightly in the water and then it got better over time but the bio feedback when it gave me that mes-
sage.  Being able to send that message out of the water, that is how I was able to isolate it. 
SB – I did wonder in the first place because I was on a lot of pregabalin because they were saying, because there were 
twinges first of all, because I was on a higher amount, I couldn’t feel it because it was stopping the nerve sensation to an ex-
tent so I wouldn’t be aware of the sensation of it kicking in because, I just wondered if that was the case? It starting to go, 
were the sensations there all along?   
KJ– when you say sensations, do you mean deeper sensations or touch? 
SB – well it was always a sharp shooting pain, but I have had them from the beginning so I didn’t know if they were fixing 
pains or just pain that was there. 
TB – did any of you, were any of you strapped to a tens machine? electric shocks 
LJ – yeah the stimulation machines, yeah.  I used them daily 
TB – I had mine strapped to me for quite a few weeks  
KJ – did that help? 
LJ– yeah I walked I used the one that Anna showed me to use and I’ve got a private physio now they gave me another one, 
but that’s more for my shoulder.  My bicep came back quite well actually, so that’s more for my shoulder at the moment.  I 
used it on my bicep to start and I had to really yank my wrist up to get there. 
JT – whereas i had to really rotate (supinate) to try to switch this one (BR) off more. 
TB –I didn’t get any of those spasms at all, mine were gradual.  All I did get was when I used to go to physio because my 
elbow in bits, my arms wouldn’t bend for that reason but I remember they did some hot wax treatment, and just dip your arm 
in wax and they wrap it in bandages it was like molten metal, I couldn’t put my hand in it it was too hot, they said it isn’t that 
hot but I said it is it’s really boiling.  If I didn’t have a beard then, if I was unshaven I sort of face felt a porcupine, needles 
coming out of it.  Mine was really subtle; I didn’t really have the spasms.  If I was eating dinner, because eating is really per-
sonal isn’t it?  I used to have my hand on the table and my hand would work at that point, I used to just go down to my hand 
and sort of do it that way.  Eventually I used my little index finger and just gradually like that, but I didn’t get the spasmodic, 
just sort of gradual.  You just put up with it, didn’t pay much attention.  I used to get a lot of the pins and needle pains. 
LJ- Hypersensitivity? arm face? 
JT – I think I don’t know if I had done that earlier I might have been less frustrated, I didn’t think it had worked so I was kind 
of getting really despondent about it and I don’t know if that had been earlier and there had been a  little sign I don’t know if 
that would have helped. 
GP – did you do a week at Stanmore? 
JT – no  
GP – I did, and that made a huge difference to me doing the week 
KJ – how long after your elbow surgery did you have the rehab week? 
GP – 2 months, had surgery at end of August and then end of October I did the, and that was the first time I came out of the 
sling,  
TB – I had a hunter sling, do you still use that? 
GP - just a standard sling.  Nothing spectacular 
KJ - yeah very similar but softer than hunter tape 
TB – bit like a strait jacket. 
KJ – don’t think any are comfortable,  
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GP – that week in Stanmore I had the tiniest twitch of a movement and I had the tiniest and from that point onwards it is easy 
to or it made sense then that everything was going to work again, that was my intention to make sure everything worked 
again. 
TB – how long ago was yours? 
GP – 2014, I pay for physio now and I have that every 3 weeks that makes a huge difference keeping everything mobile.  The 
biggest problem I found was the stiffness, you get stiff and then you can’t do things and then the muscles get weaker so just 
having that release from a physio.  Not so much the exercises but just getting that release makes a huge difference from the 
shoulder down through in to the bicep and so on. 
TB – my wife, in bed every night does massage my forearm, my neck.  It is a nightly routine because I am creaking and 
cracking.  It is aching quite a bit and it is not the same if you do it yourself, she says do you want me to do your arm?  She 
really gets in there the forearm, my neck. 
KJ – lots of people nodding there, 
JT – I find it hard with the stress and the stressful jobs oh my god the pain, yeah definitely.  It tightens up and is difficult 
managing that. I have real tightness even trying to straighten my arm is a real challenge, especially when you elevate it and I 
weren’t really sure what that was, real tightness.  And it felt like a real pulling, and it still does.  But only when I am lifting it 
above, but it has got better over time 
KJ – so tightness was there when you first started recovering ? 
JT –yeah and a real pulling, it is coming back slowly but can’t lift my arms above my head without it being  bent without that 
pulling sensation 
TB – can you show me? 
JT – I can get to here, but I can’t do it straight.  Now it starts to pull here, a real pulling but I can do it bent. 
PA – I get the same sort of thing but because I’ve had tendon transfers and they are wrapping stuff around different places 
you don’t know whether it’s the muscle that’s tight or as the tendons have been wrapped round you don’t know if that was 
the pulling. 
TB – have you got scars? 
JT – yeah down to about here. 
TB – my scar used to pull until I took some of that scar tissue out.  The scar starts here but that was like an electric cable dur-
ing one of the surgeries I think they removed some of the scar tissue.   
LJ – do you have massages to help with it? 
JT – I’ve tried but just myself really.  Acupuncture also does help. 
TB – yours is quite young, and mine is quite old but I can lift my arm now I used to dive, look forward to diving but couldn’t 
stand up straight because obviously I couldn’t do it. 
JT – I’ve tried to teach badminton and that’s been frustrating as just can’t do it. 
TB – I think we are quite similar and that mine has got better over the years it has 
KJ – it’s interesting just hearing you say the things you can’t do, you could do previously or you are doing it in a different 
way.  Just bringing us on to how you would classify whether the outcomes been a positive one for you how would you clas-
sify that?  How would you recommend that we assess that, because at the moment, medically we talk about MRC grades, we 
talk about questionnaires which as far as you’ve done, you will talk about lifting weights kg and I don’t know, how meaning-
ful is that to you?  As a guide to measure success? 
TB – it has worked for me but not as a bicep because I have just used other muscles, I can lift quite heavy weight now it is 
difficult to do that.   Call it a preacher curl where you actually do that, I will do it like that and I will do it differently but I can 
lift quite heavy weights.  I have got a bike shop and get bike deliveries and lift them, if I am taking something down from 
somewhere I will get so far then I will change my tactics 
KJ – and that is what the majority of people have said, wrote in the questionnaire that they had realistically expected to go 
ahead with the surgery and be able to bend the elbow and lift some weight.  I am trying to interpret that and is that different 
to how everybody would interpret some weight 
JT –I find the weight question difficult.  I think it is more about functionality and daily life style I think.  yeah and it’s diffi-
cult because pre surgery I just wanted my arm back, and I don’t think I had any perception about what that would mean after-
wards.  I don’t’ think I had any idea about whether it would mean full function or not.  I just wanted my bicep to work again 
so I wasn’t really concerned about or hadn’t even thought through what that would mean post-surgery. 
KJ – Your expectation was to visualise..  
JT – yeah,  and I don’t think I had even thought that it might not be back how it was.  I don’t think I had even had any expec-
tations. 
KJ – it would be harder to classify that in more detail ? 
JT – I didn’t think that I would have thought through, oh I might not be able to do that, might not be able to do that.  I just 
thought it would be fixed 
KJ – you hadn’t thought to that level?  
29.34 
 
TB – when I had mine done mine was with Rolfe Birch and I remember him in Stanmore, and it sort of a bit like young 
Frankenstein, all these registrars and doctors and he was saying to them, what do you think the success rate is and they were 
all saying 5% 10% and he said 95% of these operations will be successful.  But I thought originally I was going to have a 
bicep and I think oh I have got my bicep back, but what they done is fixed my ulnar ? nerve so I have got a clip of a bicep 
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there but it doesn’t work as a bicep it doesn’t flex when I do that and it flexes when I do that so in terms of bulk I look rela-
tively normal, but it doesn’t work as a bicep but so if you measured me this way it is still weak in that. 
KJ – so by using that form of measurement the MRC like you say it’s not necessarily a true measurement of the success for 
you.  Am I right in thinking that everybody’s definition of success is probably quite individual? 
SB –yeah, if you put down specific measurements you are limiting people, you could think I am done but do 20 more de-
pending on technique. You are actually not helping in some cases or with other people it might be numbers by putting things 
down like that, when you are not sure yourself or could be the outcome, could be the fact that  
HB – I wonder going back to what you were saying Jenny you mentioned the word function and about a measure of function 
and you all seemed to nod at a similar time, does anybody have any ideas about what might be a good way of us to measure 
functional for you to feedback ? 
LJ – I think general day to day lift, so like job side of things.  getting the kettle, getting the dishes down, brushing your teeth, 
anything like general living if you did functionality like that  
JT – I think the repetitive tasks are difficult where I still find, like everyone saying you get tired but I think to do one flexion, 
one lift of the kettle but if you are doing stuff repeatedly that’s when I find I struggle.  And I don’t know whether the defini-
tion of functionality there was flexion and I think that is what I didn’t have any concept of that would be there. 
TB – Jenny you said you were right handed. Who of us has the injury on the dominant side?  You are not, because I am right 
handed.  I mean at first I started to do everything with my left hand and tried to play tennis and didn’t enjoy it.  I would give 
you left handed lessons,  
JT – agrees in background 
PA – it is going to be different for different people because some of you have lost one of the nerve functions but not every-
thing, you still had some.  I had total loss of the arm, it was just hanging there no ability to move it at all not flick one little 
finger, so the arm is just dead like this.  Just hanging down, trying not to fall over all the time because you have this heavy 
weight.  Me, a successful outcome would have been to measure, all I wanted to do.  Spoke to another guy I knew 10 years 
earlier and he had his arm cut off because of the same situation.  Just to move it was a reasonable outcome, imagine if you 
felt that you want to do a lot more with it so to measure it to a person specifically to what is a realistic outcome, and maybe 
based on as you see so many different Scenarios you could give the person a realistic idea at the start of what they can expect, 
because some people will have unrealistic expectations everyone different.  But knowing what the likely outcomes you can’t 
make any promises but give them some idea that was never really there at the start. 
33.46 
JT – That was never really any conversation about the outcome, so I just thought I imagine it isn’t going to be back to that 
(normal) 
KJ – What information did people get, if any? 
PA –more from other patients actually and the nurses, the nurses seem to know and the physio seem to know what’s going on 
and the consultants are really busy and I understand that they have got to do their thing, they understand what they are talking 
about but a lot of the time they are talking in Latin terms but yeah I found out a lot from speaking to other patients in the jubi-
lee ward and the people with similar injuries, they were telling you stuff on what to expect and what can happen.  I found out 
more from them than I ever got explained in technical terms. 
TB – I was explained that this tens machine was trying to train my brain to get my bicep to work as a bicep and I think I 
wasn’t unhappy about anything, but in hindsight I was sort of feel that I was led to believe that a bicep would regenerate as a 
bicep, but what’s happened is my bicep flickers with my ulnar nerve which is fine, I just look sort of quite normal.  I won’t 
ever have army guns but I have got a bicep that I use, so you just live your life. 
GP –is that to do with the way that you’ve dealt with it and had say full on physio for say 3 months, would you be any differ-
ent? 
TB – I did have physio, I had the week at Stanmore and then because I live in Hertfordshire we had Herts County Hospital 
which had a physio Dept which I visited every day.  5 days a week for several weeks, that was a few months.  But it didn’t 
work independently, it picked up the current from the ulnar nerve but it didn’t ever work independently as the pain subsided 
as I gained more movement so on and so forth my life became better, and when I do things I look quite normal.  I do pay the 
price, not in a serious way but in a pain and achy and up here but I do do things quite normally and like brushing my teeth, if 
I am tired I will just hold my index finger up.  I will carry on as normal, pouring something at the dinner table if I am tired, I 
normally just prop my arm up.   
KJ – again, it’s function that is the common theme. 
TB – I am happy with mine because I am used to it. 
KJ – you was just saying Gary about the therapy input you had, you feel that that made a difference? 
GP – yeah, it makes a big difference for me anyway.  I just felt that I could see the progress I was making and that made me 
more determined to carry on more progressing.  It might be a mind-set thing but it was just always, see the physio and feel 
that something’s changed, get on again and go again and know that in 2 weeks’ time they are going to look at me and think 
right let’s go again. 
KJ – Did any of you have functional mile stones in mind do you feel, and it sounds like what you say earlier probably indi-
vidual, do you think you all had your own functional milestones? 
GP – yeah, being able to drive was the first one for me, as well as the movement aspect, being able to use the gear stick and 
then put my hand back on the steering wheel and gear stick, those sort of movements once I got those without having to 
worry and then after that the milestones have been just some personal and trying to, my ultimate goal is always that nobody 
that doesn’t know me would know that I have got an injury. 
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TB – I am there, because nobody knows that and they just have no idea and it’s sometimes, where was I when he picked me 
out of a group of people and said you’re a large person, I need some muscles to lift and I thought oh no, but I did It.  It was 
carrying a plant pot for an elderly lady, I was able to do it because I could lift it that way so that was alright. 
GP – I make a really conscious effort to use my weaker arm far more than I would have done previously because it is not my 
natural arm to use. 
JT – but I am avoiding it, don’t know if that is good thing not using it.  Writing, marking kids work.  Really struggle to do, 
the pain increases. 
TB – at the beginning my right hand looked like my left hand  
GP – I swapped sides of the mouse, as I  normally use it with my dominant hand but I used it with my left hand and I do a lot 
of mouse work and CAD drawings, I use a small mouse as well and that just doing that  a lot makes a real difference. 
TB – I use a computer all the time but using even just a touch pad because my arm is rested on the desk and after 10/15 
minutes of using the mouse my arm is absolutely knackered 
40.30 
JT – yeah mine too 
TB – really tired. Sometimes because I run a shop and can only get work done when I’m dead and I have my little laptop tray 
and I am undisturbed half an hour do my work, but then in bed with my elbows rested under the pillow I am all nice and 
comfortable but 20/30 minutes and I’m achy. 
KJ – so functional tasks do require endurance don’t they? 
TB – yeah when I am not moving my arm but I am just doing this.. 
40.52 
KJ – can I just clarify, have you all got hand function have some people not got full hand function as well? 
SB – My flexors work but extensors dont – when you guys are talking about function for me it was sort of right round my 
right hand more than used for everything and learning things again, so your perception of function is a little bit different 
LJ – you adapt 
SB – you want maximum outcome so you learn how to do that again so it is a little bit different.  You can do everything, you 
find a way.  You can do what you want to do but you are doing it in a different way.      
KJ – life style, all your injuries are different. And what you said earlier on, everybodies goals are different because of life 
style and all injuries are different. 
SB – Everybodies markers are different. I won’t be able to write left handed because i was right handed before 
HB – what would people say would be their minimal important difference to make seeing as we are on that kind of subject.  
What would be the minimum thing after the surgery that you would expect? 
SB –well your arm not there or having heard other people who have had it amputated then any function is better than none so 
that is kind of just the starting point, if it doesn’t work. 
KJ – there are a few nods there  
TB – I think my problem was personal opinion, I was slightly different in both my arms were hindered in my incident, this 
had ulnar nerve injury which repaired itself, but that was from wire, screw both my arms were hindered.  I think being right 
handed this arm didn’t move so I couldn’t touch my face and it is not relevant to this conversation but yeah mine was the 
very thing I wanted was just to be able to go to the loo and take care of myself and not have my wife and my friends carrying 
my wee bag around and stuff, I just wanted that.  So personal maintenance something I could manage 
42.25 
GP – one of my goals was just that I could wash and dress so I could have learned how to do everything left handed for a 
start whilst I was strapped up 
TB – see, I couldn’t do that with my left hand. 
GP – just getting that back so I didn’t have to rely upon it or anybody. 
TB – there was one occasion where I was on the loo, then came the moment where I had to seek some help as fractured my 
foot/toe by kicking the radiator I was so angry I couldn’t take care of myself and I that was my thing, I just wanted to do that. 
PA - Dignity. 
KJ – is that different experiences pre surgery and I think generally speaking people said they didn’t get that much infor-
mation so their expectations were 
GP – I did, I had plenty of information and I knew what the possible outcome was so I was happy that I was fully briefed on 
what the likely outcome was and what the possible outcome was and what the downside was 
KJ – do you feel your expectations before and after were similar 
GP – no, because I was told I might get 95% of my function back but it’s still the fact that all I wanted was some function.  
95% was that wasn’t really relevant it was just to have that function that I didn’t have an arm just say beside me.  
KJ – so thinking about your minimal change? 
GP – yeah, it didn’t change that,  
KJ – other people that did have different expectations either pre surgery or post-surgery or they’ve changed, it sounds like 
quite a few people’s expectations changed?  Because of the information, am I right in saying that or not? 
LJ – I think I was just a little naïve I got the information was that I am having surgery, like a broken bone it kind of meant 
that you get better and you expect it to not nothing happen for ages and then still keep going and going and going still trying 
to work that extra little bit, I was very naïve thinking next month I will be fine 
JT – yeah I agree, I didn’t realise the length of time I think that and the frustration the effect would be, oh I have had surgery 
now it’s going to work, it didn’t and I found that quite frustrating.  
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TB - I was told, certainly all the way along regeneration would be ages and ages and ages.  You know you are looking at a 
couple of years  
JT – think I was told but I don’t think I believed it, I was told I was going to have to be patient, but I thought I don’t think so 
KJ – I think it depends your mind-set as well, that all comes in to it 
TB – I was quite prepared for it and was happy to make those little advances, and I remember the day that I could touch my 
face and just yeah I was quite patient.  Mine is slightly different because I had other injuries which it was a month before they 
diagnosed mine, 3 weeks before they diagnosed mine.   
GP – think one of the things I have found is not to rest when you get to, you know you don’t have milestones necessarily but 
when you get to the point where you are functioning, and think oh I  am functioning now it is then pushing on then, to keep 
going and going and going. That’s one of the things when I am doing something fine, I will then think right try something 
else.  Maybe change things 
TB -  I have got used to it now, but every day I will think I will do something, whether carry some shopping on this arm, I 
can make a bit of traction and pull my elbow apart give a bit of relief.  Everything I do is still taking care of that, but I am so 
used to it and it is second nature and I am quite happy even now I am feeling pain up here but I am used to it. 
PA – you have got to be positive, 
TB – yes it isn’t irritating me anymore, tennis elbow when that comes in that is quite painful and it is a bit irritable.  They did 
offer to put a new elbow in, but that carry’s it’s own complications so I refused that.  That is not to do with the oberlins that is 
to do with the arthritis, I am happy with where I am at.   
KJ – it sounds like function on an individual basis is the key way of measuring that difference in improvement that has to be 
individually tailored, but also movement as well because at first you did say you wanted to be able to wash yourself, thinking 
about dignity but then a few people said just to have movement and it felt important for still to look at range and strength but 
our ultimate goal being function and what we need to break down particular tasks, what we need to do to achieve those.  So 
we need to also look at pain levels and need to look at compensatory different muscles working. 
TB – I think that is the key, certainly with me. The biceps still measuring the function is not strictly true, we can all lift a bit, 
do a bit in terms of kilos but it is how the nitty gritty of how that function is measured, it is not measured as bicep because it 
doesn’t work as a bicep. 
JT – It cheats 
KJ – in isolation? 
TB– yes.  I have quite a well-functioning arm and I am quite happy with it and my disabilities they are there but they are not.. 
KJ – it sounds like everybody is quite different, different muscles are taking over for different people so is there an element 
of education about having that awareness of what is working and what is taking over, or do people feel they.. 
JT – I don’t know doing the biofeedback more would help, because your day is so busy at times you don’t think and I think 
as long as you are in a habit then you are almost having to undo that habit to make the bicep kick in again and it is having 
that space and time to think more often am I using my bicep here or is everything else working and that is quite hard when 
you go back to everyday life, and you are back in work the problem is then you are just reinforcing the habit all the time.  
And you have got to have that time to try and break the habit otherwise it is just going to continue to take over.  
JT – have they said your function will come back? 
52.33 
JT – yeah, it is coming back but it is just not everything else is just kicking in too much so I am probably not using  it as 
much as I should do 
TB – but is yours connected to your ulnar nerve? 
JT – yeah it is my ulnar nerve  
TB - do you click a finger and your biceps contracts? 
JT – yeah. Its vain but when you talk about looks you see it come back you can see the atrophy. 
TB – I can’t go to the gym and do curling as mine just doesn’t work like that 
PA - Its quite amazing how quick your muscles waste away.  They did explain some stuff that your muscles are going to 
waste away in 3 months. And you can’t believe, I was a really big guy and massive biceps and they just disappeared to bone 
in 3 months and they were gone. You do become very conscious of that, and vain, my hand just wasted away.  I was aware of 
an imbalance in my body. 
SB – the information of the in balances still going forward, you developed ways of coping.  But you kind of found that out, 
looking back thinking about that, they said if you are going to have to work these muscles or use your body in this way or 
how to compensate, information on that would be good. 
JT – and it is now, knowing whether I should still be compensating or actually now I should be using it, does that make 
sense?  I have got used to opening doors using hips, bum foot everything I use now rather than use my right arm and I don’t 
know whether now I should actually be trying to use my right arm, it is just now a habit. 
KJ – that is hopefully something therapy will help with. 
GP – I make a conscious effort to use it and try and make the movements that I do as close to what they used to be.  Like tak-
ing a coat off, using your right arm.  I can now just get it off just about normally. 
54.40 
TB – take this as good news, I am 20 years down.  I use my right arm normally really honestly, sorry I will rephrase that, I do 
pretty much everything as I did before with a little help from my index finger on my left hand.  The tennis and stuff I have 
had to stop 
JT – that’s what I worry about, I don’t want to have to stop 
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TB – I am quite fortunate as I am a cyclist and I still ride my bike, when I had the tennis elbow I had difficulty changing gear, 
both on the road bike and mountain bikes but one of our customers has a BP injury and he got some movement back but we 
have adapted his bike.  I do pretty much everything I did with a little help. 
KJ – you are compensating to a degree but you use the word normal, your definition of normal is different 
TB  – I can still brush my teeth, still with personal cleanliness, ride my bike, have a little knock around at tennis, I can’t do 
anything too.. But you know I am 20 odd years down the line and I’m sort of ok, what I do suffer with is just a bit of arm 
ache.  So long as I don’t overdo it, if I play tennis then I will have my tennis elbow and that will be 4/5 weeks do I tend not to 
do the sort of hard exercise that I can still lift and go about heavy duties with the help of my index finger, brushing teeth, 
pouring out water and even drinking my coffee.  Sometimes I get a bit tired but you just do it, but my life visually is quite 
normal.   
56.44 
KJ – we need to measure the fatigue, which is a key thing coming through.   
HB - And if there is difference, like Jenny you were saying repeated activity but then you were saying Tony that when you 
were sometimes when you have been holding your arm still for a long time, is there a difference between the 2?  How would 
you define that?   
JT – I don’t think there is, it is like if I have to hold a tray I am still very conscious.  I often forget, and go and tell people to 
sit down in a restaurant, and then really worry because I have to carry the tray.  Even a little way and it begins to fatigue, so it 
isn’t just repetitive stuff.  Having to hold stuff, even stationary it can increase quite quickly. 
TB – I am just trying to think, the fatigue comes from working the mouse and the touchpad.  It comes quite quickly in fact 
quicker that physical, if I was lifting bikes and doing stuff and that comes along quickly.   
GP – the struggle I had was fatigue full stop.  I would, not so much in the muscles but post operation I would be doing nor-
mal work and then all of a sudden the brain would go blank and couldn’t think and that’s only just 2 years.   
JT – I thought it was just the medication - my memory is awful 
PA – what is the actual physical fatigue and what is the meds because they just, you can’t isolate as you get both and they 
sometimes come together.  You don’t know what’s what.  You just know you are doing strange things and people look. 
TB – yeah, I don’t have meds.   
LJ – I never took any meds 
KJ – but do you still experience that fatigue? 
LJ – yeah, a lot of fatigue.  My accident was July 2014 and my op in October 
 
1.00 
PA – it’s interesting because once you explain it to people and you put it down to the medicine.  When you are in pain all the 
time as well that wears you out as well.   
LJ – I don’t have the sharp pains that you have all had, so you probably have meds for that.  I just have like an achiness and 
that just drains you after so many hours. You can’t take it, you have to just go to bed to sleep or  
JT – I thought there was something wrong with me, I went back to the doctors and said I think you need to take my blood.  I 
thought there was something wrong with me, I had no idea that that sensation was going to be, I thought I was suffering with 
something.  And it was just, that is what it is, that is what it is like.   
LJ – I do 2 days’ work a week and I start off doing half days and I was dead, now I do 2 full days a week now and I am still 
like quite tired, I need a nap when I get home but I can do them now.  And I couldn’t do that before at all.  I do removals You 
can get better but you will still get tired. 
SB – I was trying to get back to work, and asking is it the medication making me like this?   
KJ – so trying to get that next step in getting back to work? 
SB – exactly, and then you move the goal posts.  I wanted to be able to it, so was doing half days and now I am doing full 
days.  It is that side of things that you quickly learn…. 
KJ – and finding an employer that is open to that? 
TB – if I could invent something that would make me comfortable at the end of the day I would invent some sort of contrap-
tion that would hold my arm right through to my palm up here, like putting your arm around somebody, that is a lot of relief 
to me.  Sometimes I just splint my arm up, I have got some crutches and so every now and then I have a prolapsed disc and 
put 2 of them up there and I just rest my arm.  That offers quite a lot of relief, don’t know if it is to do with the nerve you get 
a few pins and needles when I stretch the nerve but it is just nice relief.  Little things like that have found which never really 
shared with anyone before. 
KJ – it is interesting to share, and hopefully today you have found  
TB – Sometimes we have been shopping and I am with Sian my wife and I have asked, can I put my arm around you.  Liter-
ally will just walk like that and it is so comfortable and I am doing it for medical reasons not anything else, I have been with 
her for 30 years and I wouldn’t change her for anything but …. 
KJ  – again, it’s pacing isn’t it? 
TB  – yeah, but that offers a lot of relief suspending my arm up like that.  It is just lovely. 
KJ – There is one thing I wanted to pick up on, the wrist.  You are still bringing the wrist in to activate the movement, or you 
were at the beginning? 
LJ – yeah, at the beginning I would do that just to get flickers and I did that with like a little stim machine, I don’t know if 
you had those?  You would put them on and then eventually take stim off and then do it and then eventually work that out by 
constantly keep working that muscle that you have got to connect your brain to that muscle, takes a while but yeah that’s 
what I keep doing and then it takes over. 
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1.03 
JT – my own personal biofeedback would have been nice. Would have given me positive reinforcement of actually you are 
getting it right is quite hard and trying to make that connection. 
GP – the machine is good though because you can see it flickering then can’t you when you have got the pads, it will give 
you that jolt and then you really feel that it is benefiting  
KJ – has that affected people wrist movement at all or?  The action of having to bring the wrist down to activate the bicep has 
that affected your wrist function? 
JT – I find turning keys in doors still really difficult,  
TB – I am ok with keys and screwing a screw driver I can do really quite mild actions if I take my time, I get there eventu-
ally.  If I can use a drill to screw it I will do it, but if I can’t get the builders bit it is quite hard.   
GP - My bigger problem is the rotator cuff, that is not related to the bicep.  It is getting that hand movement round so my 
hand is flat that’s  
KJ – trying to get  forearm position? 
GP – yeah, that’s more of a challenge for me but that’s just being in a sling.  My stiffness is from the sling rather than that 
TB – I can do it now, it is weak but I can do it.  I get pain but that is more the arthritis. 
LJ – I have got stim down here, at the moment tells my hand to turn over so I am using that to build up this part of my arm.  
That is what I am working on at the moment, so don’t k now if you use the stim machine to do that? 
GP – I do a stim machine on my rotator cuff, the back there that’s the one that I find is weak.  I mean this one here isn’t too 
bad, it is trying to come out. 
KJ –the shoulder movement and forearm movement? 
PA – yeah I have not had the stim used in the physio department, apart from Andre who has left now.  When in rehab he put 
one on, but he was using it more to see how successful.  Because if there is no nerve conduction it doesn’t work, the muscle 
don’t work.  And he was just using it purely to diagnose people that were maybe saying they had worse injuries than they did 
or to see how successful it was to show that there was no muscle there, but it gave an electrical signal.  I have never had them 
used by a physio to make my muscles work but just that’s the only time I have used one,  just to diagnose to tell him he said 
he used it as a trial to see if like the transfer is successful, as it sends an electrical current/message doesn’t it?    
GP – They didn’t give you the needle ones there? 
PA – I went to somewhere and had loads of that done at another hospital, 3 hours of being prodded with pins.  They said it 
wouldn’t hurt just might be uncomfortable, just stuck needles in you which sent a charge all over your body.  For me, it was 
one in the thumb. 
1.08 
KJ – it sounds like there is quite a lot we can take from this as well in trying to get a bit more consistency in information that 
people get before their operation, just even the therapy afterward.  So people have exposure to similar experiences.  That has 
been useful for us today and I hope you would agree, but also it sounds like there are quite a lot of common themes as to go-
ing back to the question ‘how would you describe changes in elbow movement’? And how will we measure that minimal 
difference; I think function and movement and on an individual basis are key factors.  So is it a general agreement that meas-
uring kilograms as such and strength isn’t that meaningful but maybe the bio feedback is more meaningful as a measuring? 
TB – it is definitely about functionality. 
KJ – Does the functionality and trying to break that down in to what you need to get to reach that individual goal? 
SB – Yeah, if you looked at us all now elbow movement following our surgery we are all 100% aren’t we?  Because we can 
do that so… 
KJ – but 100% maybe different to different people? 
SB – Yes but as in able to turn keys, clean yourself, things like that.  It is those sorts of things that are a little bit more indi-
vidual. 
PA – Very much so, because that is just a physical movement and that’s the first movement I got back and I could do this 
with my arm so I could do that great across the body.  No use of the hand couldn’t use the shoulder so yeah I had a bicep, 
what can I do with it?  But that’s what was comfortable and being able to move it.  You got use of your hand and your shoul-
der, and that is the only thing you needed to get back then you have got to get a different kind of functionality.   You are not 
going to be training everything else, depends level of injury but the important thing I think is to motivate people correctly at 
the start and give them some realistic expectations and motivate them.  This guy I met on the ward is 5 years down the line 
and same injury.  Wizard arm, his advice to me was go a 150% on the physio and do everything you can.  He said I just mo-
ped around feeling sorry for myself after the first surgeries and nothing ever happened and he had no functionality at all.  So 
that was really good advice, but you meet other people who just take the meds, lie in bed and give up on life. 
KJ – So that motivation is different for each individual isn’t it, but that is quite key? 
TB – Certainly for me they 2 key things were patience and positive thought.  Patience because it isn’t like taking a headache 
tablet. 
JT – The complete understanding of pain, I don’t think I thought or had any concept of what the nerve pain was going to be 
like.  Education what actually kind of symptoms I would get and where the pain would be, I think it would have been….oth-
erwise you just go on YouTube and watch the surgery.  If you really want to know, and I maybe should have asked more. 
TB – I still get that now, if I stretch it is almost like having the stim machine plugged in.  if I stretch my arm up I still feel the 
MCN, but it is now comforting rather than pain I just think it feels lovely I am really stretching my muscle and I can feel it 
now.   
KJ – well hopefully that is a positive note to end on really, just having that further down the line.  That is a nice way to sum 
up the session really.  
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TB – yeah, patience is needed.  If only it was as easy as taking an ibuprofen to cure a headache, patience and keep positive.  
Its fine I’m alright. 
KJ – Well thank you very much everybody, I hope everybody has got something from it as well and meeting everybody.  
You have had long journey to get here so really appreciate your time.   
TB – are you riding a bike again? 
GP – yeah I am riding a bike and TTing as well which puts a real strain on yourself.  When you are positioned like that for an 
hour or so, that is when you really feel it.  Staying in the exact same position for ages and ages and ages, but it’s all good. 
TB – I am sort of ok, tired when sometimes changing gear but I have got a winter hack bike which you have to push to 
change gear but my posh bike is quite easy to do, changing gear electronically.   
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3. 
COREQ form for the Phenomenologic analysis
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DELPHI explicit statements 
There is little guidance for researchers who wish to use the Delphi technique, even though as-
pects of its methodology can be interpreted in a variety of ways. Most published work has 
provided guidance based on authors’ experiences, rather than empirical research or theoretical 
justification for the methodological decisions made. One systematic review describes a vari-
ety of consensus techniques used for designing clinical guidelines (Murphy et al. 1998). The 
explicit statement of their guidelines is included below 
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Table 5.9. Recommended checklist that should be reported in studies using the Delphi technique to determine which out-
comes to measure in clinical trials or systematic reviews. (Sinha et al. 2011) 
 
5.8 Explicit statement of information (as per Table 5.9) 
 
Size and composition of the panel – 9 International Consultant Surgeons working in peripheral nerve sur-
gery from 5 differing countries (US, Canada, Sweden, Netherlands, Finland, Norway, Germany, India, 
Scotland and England) 
The respondents were all Consultant (Attending)Surgeons they were selected via invitation from two inter-
national meetings of Surgeons working in the field of peripheral surgeons. 
 
Methodology of the Delphi process – The questionnaire was delivered via Google forms on line assess-
ment. The respondents had received a 5 minute talk covering the concept of the Delphi process and the in-
tention of the study. The Experts were invited to answer from their own experience. The questionnaires are 
included as an appendix. Between first and second rounds the results of the first answers were sent to the 
group. There was complete anonymity with the responses. There was no predetermined definition of con-
sensus used. There were no individuals added to the process – those who responded to the first question-
naire were invited to respond to the second. 
 
